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"There I see the philosopher spending the whole day in his musty study, 
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Jerome Gaub (1763) (in Health Bulletin 1993; 51: 384) 
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SUMMARY 
Objective: To describe the epidemiology of invasive Haemophilus influenzae (HI) disease, 
and to explore the relationship between socioeconomic disadvantage and invasive HI disease 
in the two years immediately before (October 1990 to September 1992), and following 
(October 1992 to September 1994) the introduction of HI type b (Hib) conjugate vaccine. 
Design: Multiple sources of case ascertainment were used to identify children with invasive 
HI disease in the West Midlands Health Region (WMHR) and compile a case register. An 
ecological study examined socioeconomic disadvantage using selected socioeconomic 
census data for enumeration districts, and the Townsend index of material deprivation. 
Setting: WMHR, England from October 1990 to September 1994. 
Subjects: Children under 5 years of age with invasive HI present on the West Midlands 
invasive HI case register (HICARE). 
Results : The incidence of invasive HI disease in the WMHR fell from 28.3/105 (95% 
CI=24.5 to 32.6) children <5 years of age in the pre-conjugate vaccine period to 5.4/105 (3.8 
to 7.4) after the vaccine had been introduced. Nine vaccine failures were identified. Those 
aged 6-11 months were most at risk in the pre-conjugate vaccine period (OR=2.69,95% 
CI=1.14 to 6.55). In the post-conjugate vaccine period those aged 24-35 months were at 
most risk (OR=2.64,1.16 to 5.94). More cases of meningitis were identified in girls than 
boys but the difference was not statistically significant. Significantly more cases of invasive 
HI seen in children of South Asian origin aged less than 12 months than in non-South Asian 
children (OR=2.88,1.07 to 7.86). Children from affluent areas were at significantly reduced 
risk of disease compared to children from the more deprived areas (OR=0.73,0.54 to 0.99). 
In the second period of the study a number of significant risk factors were identified. 
Children living in areas containing predominantly rented accommodation (p=0.0025), mobile 
populations (p=0.013) and a low density of children aged <5 years per km2 (p=0.039) were 
at increased risk of invasive HI disease. Following meningitis, children from deprived areas 
were more likely to suffer sensorineural hearing loss (p=0.035). Case fatality was higher in 
the second period of the study, although not significantly so (OR=3.64,0.88 to 15.05). 
Conclusion: This four year study provides the first detailed account of the relationship 
between deprivation, , socioeconomic risk factors, ethnic group, and invasive HI disease in 
Britain. The incidence of the disease fell dramatically in the post-conjugate vaccine period. 
A number of socioeconomic risk factors were identified in the second period of the study. 
The data suggest that although Hib conjugate vaccine has greatly reduced the incidence of 
disease, children from deprived areas remain at greater risk than children in more affluent 
areas. They also indicate that the disease is still responsible for considerable sequelae and 
mortality. 
Keywords: H influenzae, immunisation, deprivation, risk factors, ethnicity, West Midlands 
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INTRODUCTION 
The practice of medicine in general and paediatrics in particular was altered 
dramatically two hundred years ago when Edward Jenner inoculated James Phipps 
with cowpox material taken from a dairy maid, and provided the boy with protection 
against smallpox. ' Since then numerous infectious diseases have been targeted for 
eradication or elimination, and vaccine research and development have contributed to 
the decline in mortality and morbidity associated with infectious diseases among 
young children. 
It is young children living in socioeconomically deprived conditions who are 
the focus of this study. The discussion which follows highlights the continuing 
importance of infectious diseases and then provides a brief historical and scientific 
background to the study. It also discusses inequalities in health and its association 
with infectious diseases in childhood. There is also a brief review of the epidemiology 
of invasive H influenzae disease with the focus on socioeconomic risk factors 
associated with the disease. The chapter concludes with an overview of the thesis. 
1.1 Why communicable diseases are still important 
Communicable diseases in general, and childhood communicable diseases in 
particular, are no longer leading causes of morbidity and mortality in `developed' 
countries. Nevertheless, they still arouse considerable public interest and remain of 
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significant scientific, clinical, and public health importance as they continue to present 
a global challenge. Their continued pre-eminence is supported by evidence which 
may be grouped into four main areas. 
Firstly, there are the phenomenal economic and human costs associated with 
infectious diseases. Direct and indirect costs are believed to exceed $120 billion 
annually worldwide. ' The World Health Organisation (WHO) estimates that 28% of 
all deaths globally are attributable to infectious diseases. ' They also estimate that 2.9 
million vaccine preventable deaths occur each year, the majority of these as a result of 
measles. " In England and Wales infectious diseases are responsible for approximately 
50% of consultations with general practitioners, ' and 20% of deaths in infants and 
children. ' 
Secondly, there have been continuing advances and novel approaches to 
identifying causal pathogens, and developing vaccines in order to further reduce the 
burden of infectious diseases. Immunoassays and the polymerase chain reaction 
(PCR) are two of the more recently available microbiologic diagnostic techniques. ' 
Genetic engineering in the form of genetic recombination, ' the pursuit of methods for 
administering vaccines without a needle and syringe, ' the quest for effective 
combination vacciness (of which MMR [measles, mumps and rubella] is an established 
model) and microencapsulated antigens' are just a few examples of the results of 
vaccine research and development. 
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The third indicator of the continuing importance of communicable diseases is 
the availability of numerous conferences, journals and articles to inform and provide 
areas of debate, including a new journal dedicated to emerging infectious diseases. " 
Finally, there is the continuing challenge provided by diseases such as 
tuberculosis, '1,12 and influenza, " as well as the recent recognition of emerging and re- 
emerging infectious diseases. In recognition of their importance, the WHO established 
a new division to monitor and co-ordinate responses to emerging and re-emerging 
infectious diseases in 1995. '4 
Emerging infectious diseases have been defined either as those which are 
genuinely new diseases or newly identified aetiologic agents of known diseases or 
syndromes. 2 In a recent review article, McDade identified a number of infectious 
diseases, syndromes and pathogens which have emerged in the last two decades? 
These included, Hantavirus pulmonary syndrome, acquired immune deficiency 
syndrome (AIDS), Hepatitis E virus, Borrelia burgdoferi, (Lyme disease), 
verocytotoxin-producing Escherichia coli (VTEC), human immunodeficiency virus 
(HIV), Helicobacterpylori and hepatitis C virus. Recent years have also seen the 
resurgence (or re-emergence) of diseases and organisms thought to be under control. " 
Examples are tuberculosis, diphtheria, Ebola fever, cholera and invasive necrotising 
group A streptococci. Infectious diseases in this category are previously recognised 
pathogens which have typically increased in incidence, expanded into new geographic 
areas or threaten new populations. 
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Several developments may have contributed to this change in infectious 
disease epidemiology. These include changing microbial resistance to antibiotics, 
developments in agricultural and livestock practices, environmental changes, 
population growth, urban migration, rapid international travel, political change, armed 
conflict, and increasing social and material inequalities. 2"5"6 
Examination of populations living in the same geographic location however, 
indicates that they do not appear to be equally susceptible to infectious diseases"" or 
chronic diseases, 20-23 and experience differences in life expectancy. 25 
With regard to the differential risk of acquiring communicable disease, 
researchers have put forward a number of theories. One of the most favoured is the 
relationship between the social and economic circumstances of an individual and their 
health. Illness is said to be related to the social and economic conditions in which a 
person lives, and the association between infectious disease and socioeconomic 
circumstance is well documented. 17,19,26-30 
1.2 Background 
In the past human diseases such as tuberculosis, smallpox, plague and leprosy 
decimated human populations, and were thought to be the work of some supernatural 
power, or a divine visitation for sinful behaviour. ', ' The Old Testament also contains 
several examples of disease as punishment. An example is seen in Exodus 9: 16: 32 
"Suddenly lice infested the entire nation" 
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Epidemiology and other branches of medicine have however rapidly advanced 
our knowledge of infectious diseases and have made their prevention, control and 
eradication a possibility. 
Historically, the eighteenth and nineteenth centuries are sometimes referred to 
as "The Golden Age of Bacteriology". 33 During this time biomedicine made great 
strides with many new and exciting discoveries following each other in rapid 
succession. Amongst these were Snow's contribution regarding cholera, Pasteur's 
germ theory, and Koch's discovery of the tubercle bacillus as the cause of 
tuberculosis. ' From this discovery, and several others which he made, Koch showed 
that many diseases were the result of infection by a single specific bacteria. 
This led to the famous Koch postulates which defined the conditions that must 
be established before a particular infective agent can be accepted as the cause of a 
specific disease. ' Although valuable, especially in the study of the cause of infectious 
diseases, they ignored the diversity of contributing factors in the environment, and in 
the individual which give rise to the final manifestations of the disease process. 
Koch's "socially blind" model was disputed by eminent biomedical researchers such 
as Pasteur, Pettenkofer, and Virchow, who believed that something more than the 
micro-organism was involved in disease causation's 
Hippocrates, almost 2000 years previously, had in fact pointed out that in order 
to prevent disease one needed an understanding of its cause, and should consider not 
only individual factors but environmental influences as well's In the nineteenth 
century Edwin Chadwick, John Snow, William Farr and others added to this by 
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providing the foundations for modem epidemiological research and social medicine 
through their work on cholera. ' During this period there was also a rapid decline in 
infectious disease mortality. McKeown has argued that this occurred as a result of 
improvements in housing and nutrition and not specific therapeutic interventions. '" 
However, following these social improvements, vaccination contributed to further 
decreases in infectious disease mortality. " The eradication of smallpox38and the 
potential eradication of polio in the near future"are more recent examples of the 
achievements of vaccination. As a result of the decline in infectious disease 
prevalence, interest in examining the role of the environment and socioeconomic 
circumstance in contributing to the causation of infectious diseases decreased and 
scientific laboratory-based medicine which concentrates on treatment rather than 
prevention is now dominant. 
The inadequacies of the germ theory are now well recognised and disease 
causation is now conceptualised as being multicausal. This explanation, which takes 
into account many interacting variables such as demographic, biologic, ecologic, 
social and economic factors, is more appropriate than the simplistic monocausal 
model. These views are rapidly gaining ground especially with the increasing interest 
in examining the health experiences of different sectors of the population in relation to 
socioeconomic status. Almost universally there appears to be a social gradient to 
health, with the least affluent members of society experiencing greater morbidity and 
mortality 23'40'' 
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It is acknowledged that there is a third causal model which argues the case for 
a psychosomatic cause of infectious disease related to stressful life events or disrupted 
social circumstance. Several studies have investigated the role of these factors in the 
causation of infectious diseases. Meyer and Haggerty conducted a prospective study 
which demonstrated a positive association between stressful life events in children and 
streptococcal throat infections "s Boyce et al found that an increasing number of life 
events were associated with increasing duration of illness and illness severity in upper 
respiratory tract infections in children. " A recent case-control study by Stanwell- 
Smith et al in Gloucester demonstrated an association between the occurrence of 
meningococcal disease in children less than five years of age and a number of life 
events including marital arguments and change of residence. " 
Examination of stressful life events is however beyond the scope of this 
particular study. The present study will concentrate on exploring the relationship 
between socioeconomic disadvantage and primary invasive H influenzae disease using 
an ecological approach. 
1.3 Inequalities in health 
A variety of health-related risk factors have been associated with being in a 
lower social class or a disadvantaged group. Examples are inappropriate qualitative 
and quantitative nutrition, 48 a dangerous environment, 49 low birth weight, SO poor 
quality housing, " unemploymentS2 and poor access to health services. ' These risk 
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factors are manifested by increased morbidity and mortality rates in the poorer 
sections of society. The differences in health status seen between lower and higher 
socioeconomic groups are known as `inequalities in health'? ' 
WHO recognised this problem and as part of its Health For All by the year 
2000 (HFA 2000) strategy launched in 1981, stated that: ` 
"By the year 2000, the actual differences in health status between 
countries and between groups within countries should be reduced by at 
least 25%, by improving the level of health of disadvantaged nations 
and groups. " 
In 1985, WHO published targets for HFA 2000 to assist member countries in 
setting their own. 
The, then Conservative, British government endorsed the WHO targets and in 
1990 unveiled its Health of the Nation initiatives' This document was widely 
criticised for focusing on behavioural and lifestyle issues, and the individual, rather 
than addressing social and economic disadvantage and deprivation as causes of ill- 
health. 56,57 
Prior to this research into the relationship between illness and poor 
socioeconomic circumstance in the UK was given renewed emphasis with the 
publication of the Black report in 1980,21 and the Health Education Authority's 
`Health divide' in 1987.21 
The Black report defined inequalities in health as: " 
"Health outcomes which have been socially or economically 
determined. " 
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Its analysis of these inequalities were based on comparisons of mortality and 
morbidity using occupational status, as defined by the Registrar General, to measure 
socioeconomic status. The recommendations of the Black report generated intense 
debate on the relationships between deprivation and health, as well as a great deal of 
research activity. 
The Black report was however criticised for a number of reasons. One 
criticism of relevance to this thesis relates to its use of the Registrar General's 
occupational classification. This has been shown to have several shortcomings. " 
These mainly centred around its validity as a measure of social affluence or 
deprivation, and included its inability to provide an adequate indicator of the material 
conditions in which a large number of families live, as well as, its inadequacy in 
responding to the social and economic changes in the past few decades which have 
resulted in an increase in single-parent families and the development of an 
"underclass". "" These social groups, along with working mothers, children and the 
elderly, are not included in the Registrar General's occupational classification and may 
be suffering deprivation or poverty not reflected in such a measure 63'64 
As a result of the problems associated with using the Registrar Generals 
classification, the examination of inequalities in health using measures of deprivation 
based on area characteristics has been recommended. 23"5 This type of analysis uses 
social, geographic and environmental data obtained from the decennial Census at 
various geographic levels and applies them to individuals. This approach aims to 
eliminate many of the problems associated with employing occupational class as an 
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indicator of socioeconomic circumstance, but is subject to ecological (or aggregation) 
bias. 6' Ecological studies are also prone to confounding and effect modification which 
results in the `ecological fallacy'. 66,67 This occurs when relationships observed at 
aggregated area levels are attributed to individuals residing in that area. " 
Nevertheless, area measures are being increasingly used to provide evidence 
for the influence of material deprivation on various aspects of health. Furthermore, 
reports have shown that they may be comparable with individual measures of social 
status especially where the smallest geographical areas are used to group 
individuals. "'-"' The rapid development of geographic information systems (GIS) in 
the past decade has facilitated this process. GIS integrate epidemiologic and 
environmental data allowing detailed analysis of the links between the environmental 
characteristics of an area and the risk of disease. 69 This technique has several 
applications in relation to health including epidemiologic investigations and the 
targeting of scarce resources to identified areas. ", " 
Area characteristics have been shown to have a significant influence on health 
as residents have little or no control over their physical environment. This is 
especially so in the case of the poorest families living in the most deprived areas. 
These areas generally have high levels of unemployment, large numbers of single 
parent families, low owner-occupancy rates and poor housing. ", ", " Furthermore, 
when comparing the availability of medical care in affluent areas with that in deprived 
areas, Tudor Hart found that" 
"The availability of good medical care tends to vary inversely with 
the needs of the population served. " 
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This statement, known as the `inverse care law' is still relevant more than 25 
years after it was first published. 
In an attempt to identify environmental characteristics of areas associated with 
social and economic deprivation and increased risk of disease, several researchers have 
devised indices of deprivation. Those of Townsend, ' Carstairs and Morris" and 
Jarman"are the best known. These composite measures of deprivation use 
transformed social and economic data from the decennial census to provide a defined 
geographic area with a deprivation score. 
Various explanations for how relative social and economic positioning have 
led to social inequalities in health have been proposed, with the artefact theory, 
cultural/behavioural factors, the materialist/structural explanation, and theories of 
natural/social selection being the most widely described. " Amongst these competing 
theories, the Black report pointed to material and social circumstances as the major 
contributors to inequalities in health. " 
The Black report provided recommendations to reduce inequalities in health 
some of which were specifically targeted at improving the health of children and 
families. " Amongst these were recommendations regarding health education, school 
health and environmental changes. The report however only gave a passing mention 
to immunisation and neglected to mention the importance of communicable diseases 
as a consequence of deprivation. 
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British studies examining the relationship between inequalities and health have 
concentrated on mortality, 7 77 and health service utilisation. 12,78,79 with relatively few 
reports on the association between morbidity and deprivation. Although morbidity is 
more difficult to measure than mortality, Blaxter has argued that it is possibly a more 
important indicator of inequality, especially with life expectancy at birth increasing. " 
A number of recent publications have indicated that social and economic 
reform are required to address the issue of inequalities in health rather than a 
predominantly medical approach. 8' The current (Labour) government appears to 
have placed this issue high on its agenda and has published a Green paper `Our 
Healthier Nation' which attempts to tackle this area of concern as 
1.4 Links between socioeconomic disadvantage and infectious 
diseases in children 
Inequalities in health between children from the most disadvantaged areas and 
those from the most affluent areas is acknowledged to be a major public health 
problem, and has been demonstrated for a number of variables including: perinatal and 
infant mortality rates, " sudden infant death syndrome (SIDS), 8` low birth weight, 87 
child abuse, "' developmental delay, "' growth9° and accidental injury. " Relatively few 
studies have examined the relationship between socioeconomic disadvantage and 
infectious diseases in childhood. Of those that have, a number indicate that 
tuberculosis, " bronchiolitis, 26 gastroenteritis, " dental caries, 92 meningococcal 
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meningitis, "' whooping cough93 and HIV94 are related to living in areas of deprivation 
or having a low socioeconomic status. Low socioeconomic status in childhood is also 
believed to be linked to infectious diseases such as Helicobacterpylori in adult life's 
There are also infectious diseases, such as otitis media where the relationship 
with socioeconomic disadvantage is not clear. 
96,97 Others, for example chickenpox, 
suggest that children from affluent areas appear to be at greater risk. " 
Disadvantaged families also tend to have problems accessing and utilising 
health services, ""10' have longer hospital admissions1°2 and experience multiple 
admissions. 103 All of which may contribute to increased risk of morbidity and 
mortality from infectious diseases. Furthermore, they may live in adverse 
environmental and social conditions, which in addition to influencing their ability to 
use health services may increase their risk of acquiring an infectious disease. A 
number of studies have demonstrated an association between poor housing conditions 
and respiratory tract infections, ", '", " while overcrowded households are one of the 
most frequently cited risk factors for infection. '7,18,95,98 
Although there is a paucity of published literature which has examined the 
association between socioeconomic disadvantage and infectious diseases in children, a 
large amount of literature on risk factors associated with immunisation uptake is 
available. `-` However, a systematic review of the literature revealed a scarcity of 
British data analysing risk factors associated with the uptake of H influenzae type b 
(Hib) conjugate vaccine. 
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1.5 Epidemiology of H influenzae 
Six strains (or serotypes) of H influenzae are responsible for the majority of 
cases of invasive disease attributed to this organism and these are designated `a' 
through to `1' (table 1.1). 1' 
Table 1.1: Haemophilus influenzae: Serotypes and disease syndromes 
Serotypes of H influenzae Disease syndromes 
Encapsulated: type b Meningitis; epiglottitis; cellulitis; bacteraemia; septic 
arthritis; osteomyelitis; pneumonia; empyema; 
pericarditis. 
Encapsulated (non-type Rarely cause invasive disease. 
b): types a, c, d, e, f 
Non-encapsulated Bronchitis; otitis media; sinusitis; conjunctivits; 
urinary tract infections. 
Adapted from Booy et al"` 
The strain which is a major cause of severe bacterial infection in young 
children throughout the world is type b (Hib), which may cause meningitis, 
epiglottitis, pneumonia and other systemic diseases! """0 Children aged under 5 years 
are particularly susceptible to invasive Hib disease. "' The high proportion of 
deaths, ' 19,1224"' neurologic sequelae'21"25,126 and antibiotic resistance 127,128 worldwide are 
strong indicators of the need for an effective vaccine. In addition, there has been 
controversy surrounding the benefits of using dexamethasone to reduce mortality and 
sequelae, particularly hearing loss, in children with Haemophilus meningitis. '' 
Furthermore, despite the advent of new and more powerful antibiotics for the 
treatment of meningitis there has not been an appreciable fall in mortality or morbidity 
resulting from Hib meningitis. These and other factors probably led to increased 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 14 
Chapter 1: Introduction 
vaccine research activity using the polysaccharide polyribosyl ribitol phosphate (PRP) 
capsule of the organism. The results of which were the production of a number of 
conjugate vaccines to combat invasive Hib diseases (table 1.2). 
Table 1.2: Haemophilus influenzae type b conjugate vaccines 
Conjugate vaccine Manufacturer 
PRP-D a conjugate of PRP and Connaught Laboratories 
diphtheria toxoid 
PRP-T* a conjugate of PRP and tetanus Pasteur-Merieux 
toxoid 
PRP-OMP a conjugate of PRP and a Merck, Sharp and 
meningococcal outer membrane Dohme 
protein 
HbOC a conjugate of PRP and CRM17 Lederle-Praxis 
mutant diphtheria protein 
"HIib conjugate vaccine used in the UK 
Adapted from American Academy of Pediatrics1° 
In the pre-Hib conjugate vaccine era, Hib was the most common cause of 
bacterial meningitis in children less than 5 years of age in the United States, with 
incidence rates ranging from 23 to 67 per 100 000.131-133 The introduction of Hib 
conjugate vaccines resulted in a rapid decline in the incidence of invasive Hib disease 
in this age group to 4 to 6 per 100 000 by 1991,134,133 Other countries which have 
introduced Hib conjugate vaccines into their immunisation schedules have witnessed 
similar reductions. 
136138 
Surveys of invasive H inf uenzae meningitis in various parts of the UK in the 
pre-Hib conjugate vaccine period, revealed incidence rates ranging from 20 to 40 per 
100 000 in children aged less than 5 years. '"'42 These were associated with mortality 
rates of up to 5% and complications in approximately 10% of survivors. Hib 
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conjugate vaccine was introduced into the UK immunisation schedule in October 
1992, and by 1993-4 disease incidence had fallen to an estimated 2 per 100000.143 
Despite this impressive progress, the true incidence of invasive H influenzae 
disease is not known as non-meningitic diseases are not notifiable and estimates are 
based mainly on epidemiological studies of Haemophilus meningitis which have relied 
on passive surveillance systems. Underreporting is known to occur, and several 
reports indicate that Haemophilus meningitis suffers more from incomplete 
notification than meningococcal meningitis. 144'1°s Furthermore, little information on 
preventive practices in the UK related to invasive H influenzae diseases such as the 
use of dexamethasone and chemoprophylaxis are available. 
1.6 Socioeconomic disadvantage and Hinfluenzae 
Invasive H influenzae disease has been consistently linked with various 
markers of social and material disadvantage in several countries. These and other risk 
factors, all of which may be classified using the classical public health triad of host, 
agent and environment, interact to increase a child's risk of developing invasive H 
influenzae disease. "", "' 
Those considered to increase the risk of H influenzae disease in children by 
increasing the risk of exposure (environmental factors) include household 
crowding, "', "' living in areas of high population density, "= parental smoking, "' low 
family income, "' coming from a single parent family, '", "' belonging to certain ethnic 
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groups........ having school age siblings, 154 and attending day-care outside the home. "' 
Low socioeconomic status has also been associated with an increased likelihood of 
sequelae following H influenzae meningitis. "' 
Other factors operate by increasing the child's susceptibility to infection (host 
factors) and the following are among those implicated: low birthweight, 'S' preceding 
viral infection, "' age less than 5 years 131,112 and certain genetic factors. 117,159,160 In 
addition, non-breastfed infants have also been found to be at increased risk of 
disease. "a'ss 
There are also factors related to the pathogenicity of the bacterium (agent 
factors) which may increase the likelihood of diseases occurrence, including the 
invasiveness of the organism. 146 
Although definitions vary and different methodologies are used, the majority 
of these factors have been examined in studies conducted in different parts of the 
world. Much of the available literature has however originated from North America, 
with sizeable contributions from Scandinavia and Australia. There are no comparable 
British data. It is important that risk factors are determined using a population-based 
approach, and that any changes following the introduction of Hib conjugate vaccine 
are evaluated. 
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1.7 Summary 
Historically the link between socioeconomic disadvantage and infectious 
diseases has been well documented. An explanation of the exact nature of this 
relationship has however proved elusive. Today, infectious diseases still present an 
immense challenge to public health and child health practitioners, and the quest for 
effective measures to control and prevent their occurrence continues. One such 
measure are vaccines and of particular interest to this study, the conjugate vaccines to 
combat invasive Hib disease. Prior to the introduction of Hib conjugate vaccines, 
invasive Hib disease was one of the leading causes of bacterial meningitis in children 
aged less than 5 years. Young age is just one risk factor linked with invasive Hib 
disease. Others include various markers of poor socioeconomic circumstances. These 
risk factors have been determined in a number of countries. However, there are no 
published UK data on risk factors for invasive Hib disease either prior to the 
introduction of Hib conjugate vaccine or following its introduction. 
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1.8 Overview of thesis 
This chapter has provided a brief introduction to the thesis, an overview of 
deprivation as well as a number of socioeconomic characteristics associated with 
invasive H influenzae disease. Chapter 2 presents the aims and objectives of the study 
while chapter 3 provides a more detailed review of the literature. A description of the 
methods used to obtain data and achieve the objectives of the study are outlined in 
Chapter 4. The main findings of the thesis are then presented in Chapter 5. In chapter 
6 the results of the study are discussed in relation to the literature, and methodological 
issues are profiled. Chapter 7 summarises the thesis and concludes by providing 
recommendations and suggesting areas for further research. Each chapter has a brief 
introduction which attempts to set the chapter in the context of the general framework 
of the thesis. 
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AIMS AND OBJECTIVES OF THE STUDY 
The introduction of Hib conjugate vaccine provided an ideal opportunity to 
examine one of the most significant additions to the UK immunisation schedule in 
recent times. It also provided an opportunity to determine whether the introduction of 
a health intervention affected existing health inequalities in a multi-ethnic area of 
Britain. Previous British studies have not examined this question in relation to Hib 
disease. This study therefore set out to provide an original contribution to knowledge 
in this area. 
2.1 Aims of the study 
Previous experience with the measles vaccine has shown that even after 
achieving high coverage levels, differential uptake rates are likely and that some areas 
will fall below the levels required to block transmission. """' These areas may then 
act as reservoirs of infection and contain groups of susceptible children. 162 Those 
particularly at risk are likely to be children living in deprived circumstances as they 
have previously been shown to have lower immunisation uptake rates. 
106,113,163 There 
may also be cultural or ethnic factors which reduce the acceptance of immunisation 
amongst certain groups. 
114,164 
Prior to the introduction of Hib conjugate vaccine into the UK primary 
immunisation schedule a number of concerns were raised. These included whether 
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invasive disease would occur in those who were incompletely immunised, "' the effect 
the vaccine would have on non-type b Hinfluenzae serotypes, '" the duration of 
protection afforded by immunisation and whether a booster dose of vaccine would be 
required in the second year of life. 16"67 One other question that needs to be asked is 
how will the vaccine perform amongst the different ethnic groups in the UK, 
especially in view of the poor efficacy of one of the conjugate vaccines which had 
been highly protective in Finland but performed poorly when given to a group of 
Native Americans. '" 
Given that immunisation programmes carried out at local and national levels 
tend to control rather than eradicate the target disease, then long-term surveillance will 
be required. In addition, it will be important to identify and focus on vulnerable 
groups of children such as those who are not immunised for various reasons. These 
vulnerable children are the focus of this study in relation to their area socioeconomic 
characteristics as previous British studies on Hib disease have not examined risk 
factors associated with invasive H influenzae. 
In order to evaluate the health gain achieved by Hib conjugate vaccine, it is 
necessary that valid and reliable epidemiological information about patterns of 
infection be available, both prior to and following the introduction of the vaccine. 
Additionally, it is desirable to have information about which factors make some 
children more susceptible to the disease. 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: VVWM 1990-1994 21 
Chapter 2: Aims and objectives 
The introduction of Hib conjugate vaccine provides an opportunity to explore 
possible risk factors for invasive H influenzae and determine whether they remain the 
same following the introduction of Hib conjugate vaccine. 
Using the GIS (Geographic Information Systems) technique, together with 
other epidemiologic methods, links between several potential environmental risk 
factors and invasive H influenzae disease in the period prior to and following the 
introduction of Hib conjugate vaccine will be examined. This method will also 
identify population characteristics of those areas likely to require targeting of 
resources in order to improve and maintain high levels of uptake for Hib conjugate 
vaccine, as well as for future vaccines against meningococcal, pneumococcal and other 
diseases of childhood. 
The aim of this study is to contribute to the understanding of the relative 
importance of deprivation and other risk factors in the aetiology and outcome of 
communicable diseases in children in Britain using invasive H influenzae disease as a 
model, both before and following the introduction of a public health intervention. 
The working hypothesis of this study is that following the introduction of Hib 
conjugate vaccine children from deprived areas will not be at increased risk of 
invasive H influenzae disease compared to children from more affluent areas. 
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2.2 Study objectives 
The objectives of this study are to: 
1. explore the relationship between invasive disease and deprivation, 
and determine whether children from deprived areas are at 
increased risk of invasive H influenzae compared to children from 
more affluent areas following the introduction of Hib conjugate 
vaccine. 
2. identify socioeconomic and environmental factors associated with 
the occurrence and outcome of invasive H influenzae disease using 
GIS techniques. 
3. provide a register of cases of invasive H influenzae disease which 
may be used to assess the completeness of invasive H influenzae 
surveillance and identify `vaccine failures'. 
4. describe the incidence of invasive H inf uenzae meningitis and 
other manifestations of H influenzae disease in an ethnically 
diverse population. 
5. detect any changes in the epidemiology of invasive H influenzae 
disease following introduction of Hib conjugate vaccine. 
6. describe some of the clinical, laboratory and treatment 
characteristics associated with the disease including the use of 
dexamethasone and rifampicin chemoprophylaxis. 
These objectives will not only identify vulnerable groups of children and their 
families, but will also provide a platform for the targeting of appropriate or alternative 
health services and other resources to areas where social and medical inequalities 
exist. 
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LITERATURE REVIEW 
The purpose of this chapter is to provide a review of the literature relating 
to the surveillance of communicable diseases and to discuss the epidemiology of 
primary invasive H influenzae disease. The review will also examine the risk 
factors associated with primary invasive disease by focusing mainly on population- 
based studies. In addition, the possible role played by social class, deprivation and 
other parameters used to classify families on a socioeconomic scale will be 
examined. The final section consists of an overview of preventive measures, with 
particular emphasis on Hib conjugate vaccines, their impact on invasive Hib 
disease and the occurrence of vaccine failures. 
3.1 CASE ASCERTAINMENT 
3.1.1 Communicable disease surveillance 
Surveillance systems for communicable diseases in the UK are primarily 
passive and rely to a great extent on the voluntary reporting of cases by physicians, 
laboratories and health care facilities to local and national health departments. 
Although these systems are simple and inexpensive they have been shown to be 
incomplete and to have different degrees of accuracy, 
14S, 169,170 
Certain specified infectious diseases are statutorily notifiable, that is 
doctors have a legal obligation to notify any suspected case that they encounter. 
Conclusions drawn from notification data may however be flawed due to 
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underreporting which may occur for a number of reasons. Physicians are confused 
as to who should notify, which diseases are notifiable and how to fulfil their 
statutory duty to notify. 10473 A study by Goldacre and Miller, in the North West 
region of England examined the completeness of meningitis notifications in 
1976. ' They found that notifications varied by organism, age and outcome and 
that only 16% of H influenzae meningitis cases were notified compared to 50% of 
meningococcal meningitis cases. Furthermore, there was a low notification rate for 
neonates and deaths were notified less often than survivors. Harvey et al when 
auditing completeness of bacterial meningitis notifications found that only 35% of 
H influenzae meningitis cases had been notified compared to 65% of 
meningococcal cases. "" Almost 20 years after Goldacre and Miller's14 study, a 
report from Nottingham reported similar results! " The investigators also showed 
that those more frequently notified had a shorter mean duration of hospital 
admission than those that were not notified. 
Although H influenzae meningitis is statutorily notifiable, other forms of 
invasive H inf uenzae disease are not, consequently it is difficult to obtain reliable 
estimates of incidence. Few studies have examined the issue in the UK and 
estimates have to be extrapolated from epidemiological studies which are usually 
focused on local situations. 
Given these shortcomings and recognising the need for accurate 
epidemiological data prior to the introduction of Hib conjugate vaccine, the Public 
Health Laboratory Service (PHLS), Communicable Disease Surveillance Centre 
(CDSC) initiated enhanced surveillance of invasive H influenzae disease in six 
regions (East Anglia, Northern, North Western, Oxford, South Western and Wales) 
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in 1990.140 Despite using the same methodology in each of the regions, a review by 
Macleod of the first year of surveillance revealed underreporting to the CDSC of 
between 15% to 41%, while the regional survey experienced underreporting of 2% 
to 27%. 175 
Inaccuracies in the identification of the number of cases of meningitis and 
other communicable diseases not only affect the estimated incidence rates, but 
probably results in inadequate contact tracing and failure to offer 
chemoprophylaxis to all those potentially at risk. 
3.1.2 Disease registers 
Disease registers rely on multiple sources of data such as notifications, 
laboratory reports and death certificates to identify cases. """ They have mainly 
been used for chronic conditions such as cancer1', diabetes"" and congenital 
disorders. "' Registers are also employed to monitor children with special needs, 
including those with sequelae following infectious diseases. "' Disease registers 
can be used to monitor, evaluate and plan health services and strategies and 
facilitate the estimation of educational and personnel needs. 
'81,182 They can also 
facilitate epidemiological research, act as sampling frames and provide insights 
into demographic risk factors. 177,183 In addition they can monitor populations at risk 
and provide reliable estimates of the current burden of disease and sequelae of 
disease. 182,133 Disease registers should however be applied to geographically 
defined populations. 184 
Disease registers are difficult to compile as they are dependent on the 
goodwill and co-operation of a variety of people in identifying cases, necessitate 
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the handling of a large amount of confidential data, and are time-consuming 
requiring extensive resources. "' Despite these drawbacks they can provide useful 
information about health problems and the performance of health services. 
3.2 EPIDEMIOLOGY OF INVASIVE H INFL UENZAE 
DISEASE 
3.2.1 Colonisation and pathogenesis 
Both encapsulated and non-encapsulated strains of H in, fluenzae are found 
in the upper respiratory tracts of most members of the population. "" Non- 
encapsulated strains are more prevalent than the capsulated strains and commonly 
cause otitis media, bronchitis and sinusitis. ""' Rarely are they associated with 
invasive disease. Encapsulated H influenzae type b strains are found in 
approximately 5% of nasopharyngeal cultures of healthy children, other capsulated 
strains are rarely seen. 'e6 
Hib is transmitted from person-to-person by respiratory droplets, or contact 
with secretions from carriers. 1e'. 'ea The factors that cause one child to become a 
carrier, and another to acquire invasive disease are poorly understood. The 
literature shows that approximately 95% of all invasive Hib disease occurs in 
children less than 5 years of age. ': '''. ' Systemic Hib disease is uncommon in 
infants under 6 months of age. 117,142 This has been attributed to decreased exposure, 
transplacentally acquired antibodies and the protective effect of breastfeeding. ''186 
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By 5 years of age the majority of children possess protective antibodies against 
Hib. 186 
Colonisation with H influenzae is made easier with close contact, either in 
the home or day-care setting. In households where a case of invasive disease has 
occurred, colonisation rates of up to 70% in siblings, and 20% in parents have been 
documented. "', '90 In day-care facilities in which a case of invasive disease has 
occurred, point-prevalence colonisation rates of over 55% have been reported 
amongst the other children. 
191"92 An 18 month prospective study was carried out in 
a day-care centre in Dallas where no cases of invasive H influenzae had 
occurred. 193 The researchers reported that approximately 70% of children aged 18- 
35 months were colonised at some time during the study. This suggests that these 
children may be the source of colonisation in younger children. 
There is also some evidence to suggest that preceding viral upper 
respiratory tract infection may increase Hib nasal colonisation and the possibility 
of bacteraemia. 'ss, '9a The exact pathogenesis of invasive disease however, remains 
obscure. Much of what is known has been obtained from animal models, and it is 
believed that in invasive H inf uenaae disease, the organisms cross the mucosal 
barriers of the nasopharynx and enter the bloodstream. 195 The exact route is 
unknown, but they are thought to travel via the lymph system or within 
lymphocytes seeding all serous surfaces. This may cause meningitis, pneumonia 
or other invasive disease syndromes. "' 
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3.2.2 Clinical disease 
Although meningitis is the most common form of invasive Hib disease and 
the most widely reported, several other syndromes are recognised. Studies have 
shown that approximately 30-50% of children with culture proven invasive H 
influenzae disease have diagnoses which are non-meningitic. 117,126,196-198 These 
include epiglottitis, pneumonia, cellulitis, septic arthritis, osteomyelitis and 
septicaemia. 
3.2.2.1 Meningitis 
This is an inflammation of the meninges, and commonly refers to the 
arachnoid membrane, the subarachnoid space and the pia mater covering the 
brain. '" 
It is characterised by the presence of polymorphonuclear cells in the cerebrospinal 
fluid (CSF). 
There are no particular clues to the aetiological diagnosis of H influenzae 
meningitis. History taking and clinical examination will reveal similarities to other 
causes of bacterial meningitis. The clinical features are well described in a recent 
review of the literature by Tunkel and Scheld. 200 The onset of disease may be 
sudden or occur insidiously, with signs and symptoms being less specific in young 
infants. 20' Diagnosis is primarily by isolation of H influenzae from either the CSF 
(obtained by lumbar puncture) or blood? oz 
It is recommended that suspected meningitis be treated with antibiotics 
prior to hospital admission. 203, ma This is believed to reduce the mortality and 
sequelae associated with the disease. "--"" A study from the United States has 
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however indicated that the converse may actually occur as the duration and course 
of the disease in pretreated children may be altered. 20' 
Meningitis is responsible for 40-70% of cases of invasive H influenzae 
disease, and in most populations is found mainly in children below 2 years of 
age. ' 17,123,209,209 It is a life-threatening infection which may result in neurological 
sequelae or death. Reports indicate that 10-40% of children suffer neurological 
sequelae following an episode of H influenaae meningitis. 121'12a, us, 209,210 Examples 
of neurological sequelae experienced by these children include learning 
disabilities, behavioural disorders, emotional problems, seizures and hearing 
loss. 110-: u These sequelae may occur alone or in any combination. Sensorineural 
hearing loss (SNHL) is one of the most devastating sequelae of meningitis, and 
may affect up to 20% of children following H inf uenzae meningitis. '56'2's SNHL 
may also be associated with other problems such as ataxia, developmental delay, 
learning disabilities and behavioural problems. It is important that all children 
should have an age-appropriate test for hearing loss following an episode of 
bacterial meningitis. Unfortunately, recent research in Britain has shown that 
hearing tests are not routinely carried out following an episode of bacterial 
meningitis. 1162" 
In recent years, dexamethasone has been advocated as adjunctive therapy 
for H influenzae meningitis. "'"" It appears to beneficially alter the host response 
to infection by decreasing the inflammatory reaction, and this action is believed to 
reduce mortality and neurological sequelae, particularly hearing loss. 21 22' Section 
3.5.4 contains more detail on this aspect of the review. 
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Mortality from H influenzae meningitis has been reported to range from 1- 
5% in industrialised countries. 
13"" It may however reach up to 40% in less 
industrialised countries. 123"24,222 
3.2.2.2 Epiglottitis 
This refers to a rapidly progressive infection of the epiglottis and 
surrounding structures, and may cause life-threatening airway obstruction. "' 
Clinically, these children may present with sudden onset of fever, 
respiratory distress, dysphagia, drooling (because of inability to swallow saliva) 
and toxicity. "' Visualisation of a "cherry red" oedematous epiglottis on direct or 
indirect laryngoscopy is said to be diagnostic. It is essential that airway patency is 
maintained, and nasotracheal intubation is the preferred method? ' Research 
indicates that where blood cultures are performed in children, 70-90% of cases of 
acute bacterial epiglottitis are due to Hib 22622' 
In mainly Caucasian populations, epiglottitis is commonly the major non- 
meningitic manifestation of invasive H influenzae disease. It has been observed in 
16-37% of children with invasive disease. 209,230-232 In Britain blood culture 
confirmed incidence rates of up to 6.2 per 100 000 children aged less than 5 years 
have been reported. '2 3 These are similar to those reported from Europe and parts 
of the United States, 
126,230,234,235 
There are several epidemiological features associated with this disease. A 
greater proportion of males are affected than females. Male: female ratios of 
between 1.4: 1 and 2.1: 1 have been reported for epiglottitis2o9,116, u1,232 compared to 
almost equal gender ratios for meningitis. 
139'209 Also, in contrast to H influenzae 
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meningitis, children presenting with epiglottitis have been noted to be older, 
usually between 2 to 4 years of age with a peak incidence occurring at around the 
age of 3 years. 229,229 Recent reports from North America have indicated a 
downward shift in the age of presentation, with up to 36% of children presenting 
before their second birthday, compared to 20% in previous accounts. 23' In 
addition, there have been reports of a decrease in the incidence of the disease 
following introduction of Hib conjugate vaccine. 
13U37' 8 
Epiglottitis has been reported as absent or extremely rare in the native 
populations of the United States, '" Israel234 and Australia. "' Similar reports have 
also been obtained from Africa, 16 Hong Kong" and South America. "' This 
particular epidemiological feature is seen in populations with a high incidence of 
Hib disease and is thought to be related to the earlier age of disease occurrence in 
these populations. 
A number of reports have indicated that secondary foci are uncommon. 117,226 
The most common extraepioglottic infection appears to be pneumonia, which has 
been identified in up to 25% of patients? `'"'241 In children the case fatality rate is 
low, generally between 0% and 3% in most series. "' 224,229 
3.2.2.3 Pneumonia 
As a proportion of invasive H influenzae disease, pneumonia is usually 
responsible for under 15% of cases in industrialised countries. "7'209'233'242 In other 
parts of the world, it may contribute up to 25% of invasive H influenzae cases. 
116,243 
The relative frequency of pneumonia is high in certain populations such as the 
Australian Aborigines, where in one series 43% of infections were due to 
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pneumonia, compared with 30% for meningitis. "' Research has indicated that up 
to 40% of H influenzae pneumonia cases may have evidence of infection 
elsewhere, for example meningitis or epiglottitis. "', 2°2 
Defining the aetiology of bacterial pneumonia has been a problem for many 
years, and has probably led to an underestimation of the impact of H influenzae 
pneumonia. In studies where blood culture has been used as the diagnostic tool 
most cases of H influenzae pneumonia were attributed to serotype b. '", "' 
However, in these studies only a small proportion of isolates yielded positive 
cultures. 
In a study conducted in Papua New Guinea, Shann et al reported that when 
lung aspiration was used only 5 of 31 (16%) strains of H influenzae serotyped were 
type b. "" Non-serotypable strains accounted for more than half (58%, 18 of 31) of 
the remainder, with other serotypes contributing the remaining 8 (26%). Other 
reports support the finding that non-serotypable strains of H influenzae are 
important causes of pneumonia in children. 246-243 
Funkhouser and colleagues have pointed out that these contradictory results 
may confound the role played by Hib conjugate vaccines in the prevention of H 
influenzae pneumonia. "' 
Mortality from pneumonia due to H influenzae is low in Western countries, 
less than 5%, 24U49 it may be as high as 16% in other areas. 
196'243 
3.2.2.4 Cellulitis 
H influenzae is usually the cause of acute localised inflammation of the soft 
tissue, involving the face, head or neck. "' The disease is generally of sudden 
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onset, and characterised by an area which is raised warm and tender. 12° Diagnosis 
depends on isolation by blood culture. '" The literature indicates that cellulitis 
accounts for between 4% to 12% of invasive H influenzae cases. 
126,197,234 Because 
of the accompanying bacteraemia, secondary foci such as meningitis may 
develop. 117,242 
3.2.2.5 Septic arthritis 
Septic arthritis may occur as a result of bacteria entering the joint space 
from the circulation, alternatively, it may follow trauma or occur as an extension of 
osteomyelitis 250 The most common pathogen in all age groups is Staphylococcus 
aureus, while H influenzae is predominantly seen in infants under 2 years of 
age. 251,252 There are however no specific features to distinguish septic arthritis due 
to Staphylococcus aureus and other bacteria from that caused by H influenzae. The 
larger joints are commonly affected, and children generally present with fever and 
a warm, swollen joint, which is painful when moved "' Diagnosis is by presenting 
history, physical examination, blood culture and joint aspiration, while antigen 
detection tests may be performed on urine and joint aspirates to identify the 
causative agent. "' Surgical drainage of affected joints is performed and should be 
followed by long-term follow-up to detect serious sequelae such as limited joint 
mobility. 2s°, ZSa In studies where this manifestation of invasive H influenzae disease 
has been recorded, it represents up to 8% of cases. l"""6'2", 2" Some reports group 
septic arthritis and osteomyelitis together as "bone and joint infections", where this 
is the case, together they may account for about 7% of cases. 139,198 
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3.2.2.6 Osteomyelitis 
H influenzae type b osteomyelitis is mainly seen in children under the age 
of 2 years. "' Fever and localised bone tenderness, together with local 
inflammation are common symptoms. 2S3 In reported series of invasive H 
influenzae disease, osteomyelitis has been found in about 4% of children. '17' ° 
3.2.2.7 Bacteraemia 
H influenzae bacteraemia has been defined as the presence of the bacterium 
in the blood, without a recognisable focus of infection. "' The child usually an 
infant, presents with fever, anorexia and lethargy. "' In most series it is present in 
2% to 14% of cases, """" however more than one third of cases in a group of 
Australian Aborigine children were recorded as having bacteraemia. ZS' 
3.2.2.8 Neonatal sepsis 
H inf uenzae is not commonly found in the maternal genitourinary 
tract. =sa, xs9 However, when present the organism is associated with a high risk of 
neonatal infection and may lead to severe and often fatal neonatal sepsis 260 The 
condition is more commonly observed in premature and low birth weight babies. 260 
Obstetric complications implicated in the aetiology of this disease include maternal 
fever, chorioamnionitis, prolonged rupture of the membranes and vaginal 
discharge. 261'262 Bacterial infection is believed to occur when the neonate 
passes through the birth canal, and this may lead to bacteraemia and a number of 
systemic diseases such as meningitis, arthritis, pneumonia and septicaemia. 262 H 
influenzae type b has been identified as a cause of neonatal sepsis, although non- 
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typable H inf uenaae are more common. 
260a61 The disease is associated with a high 
mortality rate, with up to 70% previously reported. 263'264 
3.2.2.9 Other systemic diseases 
Uncommon disease manifestations have been reported in children with H 
influenzae disease. These include endocarditis, pericarditis, abscesses, and 
pyelonephritis. 'm, "s Diagnosis is usually by blood culture together with the 
specific signs and symptoms associated with each disease entity. 
3.2.3 Incidence 
Much of the published data on invasive H influenzae (HI) disease has 
originated from the USA, where Hib meningitis has been the leading cause of 
childhood meningitis for many years. In Europe, the major pathogen in most 
countries is Neisseria meningitidis, and as such there have been few reports on the 
incidence of H influenzae. In recent years, with the development of vaccines 
offering protection against Hib disease, epidemiological reports have increased. 
However, this has mainly increased the wealth of information on Hib meningitis, 
while the epidemiology of other forms of invasive H influenzae disease remain less 
well characterised. 
The following section will provide an overview of the epidemiological 
characteristics of primary invasive H influenzae disease in the pre-Hib conjugate 
vaccine period in several geographic regions utilising mainly population-based 
research. Firstly, the incidence of invasive H influenzae disease will be examined 
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in Britain, then the rest of Europe, the USA, other industrialised countries and 
finally other parts of the world. 
3.2.3.1 Britain 
Figure 3.1 illustrates the rise and fall, in notifications of H influenzae 
disease over several years in England and Wales. "" The reasons for the increase 
are unknown but may reflect better culturing techniques, improved reporting or a 
true increase in incidence. The fall has occurred following the introduction of Hib 
conjugate vaccine to the primary immunisation schedule. 
Figure 3.1: Annual notifications of H influenzae meningitis <5 years of age; 
England and Wales, 1984-1995 
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A number of retrospective and prospective population-based studies 
reporting on the incidence of invasive H influenzae disease in Britain have been 
published. The majority report on the incidence and characteristics of invasive H 
influenzae disease prior to the introduction of Hib vaccine, and these are 
summarised in table 3.1. 
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Chapter 3: Literature review 
The incidence can be seen to vary from region to region. Reported 
incidence rates for H influenzae meningitis range from the mean annual incidence 
rate of 18.0 cases per 100 000 children aged less than 5 years seen in Cambridge 
between 1975 and 1981, '2= to the more recent 36.6 cases per 100 000 experienced 
by the same age group in the South West region between 1990 and 1992.249 The 
overall incidence of invasive H influenzae disease from 1975 to 1992 was between 
24.6 and 49.3 per 100 000.142,249 
Methodological differences may account for some of the variation. For 
example, prospective compared with retrospective collection of data, the sensitivity 
of the data sources, and the inclusion of cases of invasive H influenzae which are 
not culture-confirmed. Notwithstanding the influence these and other factors may 
have on the observed incidence rate, it has been noted that the six region study for 
England and Wales has reported interregional variation, as well as intraregional 
variation. "' This is despite the use of identical methods of case identification and 
ascertainment in each of the centres. Differential underreporting has been cited as 
one possible reason for the differences noted in this multicentre study. 17S 
Seasonal variation in the identification of cases has been reported. Where 
seasonality or monthly incidence has been examined in the literature, more cases 
have been found to occur in the cooler months of the year. The period from 
. 
ý39,2I9 October through March usually accounts for 58% to 66% of cases 
In case series involving children aged less than 5 years, H influenzae 
meningitis affects 41% to 49% of children aged less than 12 months. 121,139,142 As in 
North America and other parts of the world, age-related differences between 
meningitis and epiglottitis are seen. Meningitis tends to occur mainly in children 
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before they reach eighteen months of age, whereas epiglottitis is seen in children 
approaching their third birthday. 121"39 
Accounts of invasive H influenzae disease in children of different ethnic 
groups in the UK is limited. A hospital-based study carried out between 1973 and 
1984 by Dyas and George provided information on'black' and'Asian' children 
without prior definition of these terms. 268 Similarly, a prospective study of 
bacterial meningitis by Urwin et al from the North East Thames region presented 
data which also included children who were designated as 'black' and'Asian'. 267 As 
Bhopal et al have argued, continued usage of these 'ethnic' terms without prior 
definition is scientifically unsatisfactory26' 
3.2.3.2 The rest of Europe 
There are a number of population-based reports on invasive H influenzae 
disease in the English language from Europe (table 3.2), predominantly from the 
Scandinavian countries. 
The overall incidence rate for invasive H influenzae disease among children 
aged less than 5 years, ranges from 21.0 per 100 000 in France12. to 60.2 per 100 
000 in Switzerland. 209 These rates are similar to those obtained in the UK, 112,21' but 
much less than those reported from the USA. 275 
H influenzae meningitis appears to occur at a similar age to that found in 
Britain, with 38% to 46% of cases occurring in children aged less than 12 
months. 126,270,271 In contrast to the UK, most European countries have reported 
bimodal seasonal variation. Peaks have been noticed in autumn and spring, 126 as 
well as in autumn and early summer. 2 ' 
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Chapter 3: Literature review 
3.2.3.3 United States of America 
As mentioned earlier, much of the published literature on invasive H 
influenzae disease comes from the USA. Prospective and retrospective population- 
based studies have reported incidence rates ranging from 68 to 113 cases per 100 
000 children aged 5 years or less prior to the introduction of Hib vaccines. "' 275 
The results of several population-based studies conducted in the USA are 
summarised in table 3.3. 
When compared to reports obtained from Britain and Europe, these results 
indicate that the incidence of invasive H influenzae disease is considerably greater 
in the USA. There is also a striking difference in the incidence of these diseases 
between the Native American populations and non-native Americans. An 
increased incidence has also been reported for other ethnic groups in the USA, 
especially African Americans (table 3.4). There is still some debate as to whether 
these differences are genetically determined or influenced by socioeconomic risk 
factors. 149,27B 
In the Native American populations the onset of disease occurs at an earlier 
age than in non-Native American, British or European children. In studies 
involving this population, more than 80% of cases are reported to have H 
influenzae meningitis before the age of 1 year. 281283 
In contrast to reports on seasonality from the UK indicating one peak of 
disease incidence, a bimodal pattern has been observed in the USA. In the United 
States, invasive H influenzae disease peaks in late autumn, and again in early 
spring 284 285 
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The first Hib conjugate vaccine (PRP-D) was licensed in the USA in 
December 1987, and superseded the polysaccharide vaccines? ` Since then, other 
conjugate vaccines have been licensed and incidence rates of invasive H influenzae 
disease have fallen rapidly. 134,135,287 
Recent epidemiological reports from North America have however 
indicated that in some areas the incidence of invasive Hib disease was falling in 
children too young to have received Hib conjugate. 111,13-1481 The reasons for this are 
yet to be clarified. It has been postulated that following vaccination of older 
children with conjugate vaccine reduced Hib colonisation and nasopharyngeal 
carriage led to decreased exposure in younger children and resulted in a herd 
immune effect. 
2S8'ý89 
3.2.3.4 Other industrialised countries 
This section contains reports from Australia, Israel, Canada, and New 
Zealand. Table 3.5 summarises the findings from these countries. All of these 
countries have native and non-native populations and considerable differences can 
be seen in incidence rates between the populations. The native populations tend to 
have a higher incidence of invasive H inf uenzae disease than the non-native 
population. This is especially so in the Aboriginal population of Central Australia, 
where an incidence rate of 1104 per 100 000 children less than 5 years of age has 
been reported for all invasive H influenzae disease ZS' 
The epidemiological features of the populations in these countries differs 
from that seen in Europe and the United States. 
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They have higher overall incidence rates, but comparable rates of 
meningitis. They also have a higher proportion of cases of H influenzae 
pneumonia, between 7% to 43%, "'. 18 compared to 3% to 11% in other parts of 
the world. 
"1'249'282 
Also of interest is the age distribution in these populations. It appears to be 
similar to that found in other countries. In the United States and Europe, 37% to 
54% of H influenzae meningitis cases occur in the general child population before 
12 months of age. 
'32'267,270,280 In Israel, Canada and Australia 34% to 61 % of H 
influenzae meningitis cases are seen in children before their first birthday. 
242,290,291 
The picture in the native populations of these countries is similar to that observed 
in Native Americans where a higher incidence of disease is seen in younger age 
groups compared to that found in the general child population. 
In the main, seasonality was reported as being similar to that found in other 
publications, with more cases seen in the colder months of the year. A striking 
difference was, however, observed by researchers in Israel when they examined 
admissions for Bedouin children and Jewish children according to season. 29' 
Admissions for Bedouin children appeared to increase during the summer, whereas 
more Jewish children presented to hospital in the autumn. The authors then related 
the admissions for invasive H influenzae disease with admissions for respiratory 
infections and diarrhoea! disease. They found that there were more admissions for 
diarrhoeal disease in the summer and a greater number of respiratory infections 
during the autumn. These correlated with the admissions for Bedouin children and 
Jewish children respectively. Possible explanations for this observation are 
obscure. 
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3.2.3.5 The rest of the world 
In several less industrialised countries of the world, the importance of 
endemic and epidemic meningococcal meningitis and the prominence of 
streptococcal meningitis, has probably contributed to the limited amount of data 
available on invasive H influenzae disease. The little that is available is mainly 
hospital-based and concentrates on meningitis with only sparse information on 
non-meningitic invasive H influenzae disease. This is presumably because it is 
easier to define and diagnose than the other disease syndromes associated with H 
influenzae. 
Only a few population-based studies specifically examining invasive H 
influenzae disease in less industrialised countries were found in the English 
literature, and these are outlined in table 3.6. In general studies from these 
countries show very early onset of invasive H influenzae disease. Between 59% to 
83% of cases of H influenzae meningitis occur before children reach their first 
birthday. 123,196,222 
The Chilean incidence rate for H influenzae meningitis of 15.2 per 100 000 
in children aged less than 5 years is much lower than rates found in Europe 222 
However, the researchers believe this to be an underestimate. The incidence rate 
for H influenzae meningitis from one of the hospitals in the study was estimated to 
be 25.1 per 100 000 in children aged less than 5 years. This rate is similar to that 
found in Europe, and much lower than that reported for the USA. 
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In Hong Kong, Lau and other members of the Hib study group carried out a 
five year retrospective survey 239 An average annual incidence rate of 2.7 per 100 
000 children aged less than 5 years was reported for all culture-positive cases of 
invasive Hib disease. The researchers indicated that this was an underestimate as 
previous research in this area had shown that a large number of children received 
unprescribed antibiotics prior to admission. A sub-group of the population, 
children of Vietnamese refugees, had an incidence rate of 42.7 per 100 000 
children aged less than 5 years "' These children were thought to be at increased 
risk because of overcrowding in the refugee camps. In addition, lack of access to 
non-prescription antibiotics may have increased the number of positive cultures 
obtained. 
In contrast to accounts from Europe and North America, there were no 
cases of epiglottitis in the children of Hong Kong, "" Santiago, Chile2.. or Cape 
Town, South Africa. '96 Instead pneumonia appears to be more important 
accounting for up to 25% of invasive H influenzae cases in one series. 196 The 
reasons for this are not clear, but differences in diagnostic methodology, case 
definitions and socioeconomic factors may be responsible. 
Mortality and morbidity are also much higher in these countries when 
compared to the other countries previously discussed. In Africa, mortality and 
morbidity rates approaching 40% have been reported, with difficulty in reaching 
hospital facilities cited as a significant factor. " Lower rates have been reported 
from Chile, s but even in Hong Kong which may be regarded as highly 
'Westernised' in many respects, the mortality rate is approximately 11%. 239 Case 
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fatality rates in these areas may be biased as only the very sick children who are 
more likely to die may be brought to hospital. 
3.2.4 Summary of section 3.2 
Incidence rates for invasive H influenzae vary both between and within 
countries. Less industrialised areas are characterised by high incidence rates and 
high case fatality rates. The native populations of North America and Australia are 
affected at a younger age and have the highest incidence rates for invasive H 
influenzae diseases. However, their mortality rates are similar to those of other 
communities occupying the same geographical locality. This reduced mortality in 
relation to other'less developed' populations from Africa and Asia may be due to a 
number of reasons including easier access to medical facilities. 
3.3 RISK FACTORS ASSOCIATED WITH INVASIVE H 
INFLUENZAE DISEASES 
Only a handful of studies have specifically reported risk factors for invasive 
H influenzae disease or H influenzae meningitis. Others have hidden the 
examination of risk factors within the overall data analysis. The majority of these 
studies are from the United States with a smaller number from Western Europe. 
There are none from the UK. 
Evidence from these studies demonstrates that a variety of risk factors 
appear to increase the risk of exposure or susceptibility in certain groups of infants 
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and young children thereby increasing their risk of developing invasive H 
influenzae disease. This section will outline several risk factors reported to be 
associated with an increased risk of developing primary invasive H influenzae. 
3.3.1 Individual risk factors 
3.3.1.1 Age 
As noted in the previous section, a strong and consistent relationship 
between age and the incidence of invasive Hib disease has been observed by all 
researchers. Although the bacterium has been isolated in all age groups, the peak 
incidence of invasive H influenaae is primarily seen in children aged 6-11 
months. 1 "'" By the age of 5 years, a steep decline in incidence occurs as 
concentrations of protective antibody are achieved. 'az, z32'275 Although it is unclear 
how this is accomplished, it is postulated that asymptomatic nasal carriage of Hib 
may stimulate antibody production! " Another theory is that bacteria with 
antigenically similar surface structures, such as some strains of Escherichia coil, 
may be responsible for the production of antibodies that cross-react with Hib? " 
Passively acquired maternal antibodies are thought to protect the young 
infant in the first few months of life. 196.294 However, case series have described 
invasive disease in up to 5% of children below the age of 3 months. 119,234,27S This 
would appear to indicate that not all mothers possess protective amounts of 
antibody. 
Each type of invasive disease has a characteristic age distribution. Apart 
from H inf uenzae meningitis, they all tend to occur in older children. In 
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populations with a very high incidence of invasive H influenzae disease, the age- 
specific incidence is greatest in the younger age-groups. "', "' 
3.3.1.2 Ethnic group and 'race' 
Ethnic group (or 'race') has been identified as a potential risk factor for 
invasive H influenzae disease in several population-based studies with children 
from certain sub-groups of the population having a much higher incidence of 
disease than other children living in the same geographic area (see tables 3.4,3.5 
and 3.6). There remains however, a problem with definition of ethnicity and the 
confounding effect of factors associated with socioeconomic status (SES). 
In a recent report on acute bacterial meningitis from one of the London 
regions, an increased risk of H influenzae meningitis in'black' and 'Asian' children 
was reported. 26' The authors failed to provide any rationale for the 'ethnic' 
categories used in their study, and incidence of disease in these groups were not 
reported for children less than five years of age. To my knowledge this is the only 
published report of the incidence of H influenzae in 'ethnic' groups in the UK. 
The association between ethnicity and the risk of invasive H influenzae 
disease is difficult to unravel because of the confounding effects of various 
socioeconomic variables. This observation is supported by the inconsistent results 
obtained from the mainly North American literature. A prospective case-control 
study from Los Angeles County among children aged 18-59 months found an 
increased risk of disease associated with black maternal ethnicity. "' This 
association remained even when other risk factors were adjusted for. In an earlier 
study from Atlanta, controlling for other risk factors revealed that an initial 
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association with 'black' children no longer held. " Several studies using univariate 
analyses have also reported contradictory results. 
155,277,278,292,293 
3.3.1.3 Gender 
In common with many other infectious diseases, a higher proportion of 
invasive H influenzae disease is seen in boys. ý34'279 This is most vividly illustrated 
with epiglottitis, with reports of more than 60% of cases occurring in boys, and 
male: female ratios of 1.8: 1 or more being described. 
209,231,238 
There are however instances in the literature where the ratios are reversed. 
In a report from Finland, Takala et al found that girls outnumbered boys in 
invasive H influenzae disease syndromes other than meningitis and epiglottitis. " 
These other types of invasive disease were seen in 56% of girls. In Australia a 
significantly higher incidence of H influenzae meningitis was identified among 
Native Aborigine girls. The girls were found to have a risk five times more than 
that of boys (relative risk (RR)=5.12; 95% confidence interval (CI)=1.75 to 
14.96). "' Reasons for these differences in disease incidence between boys and 
girls are unknown. 
3.3.1.4 Mode of feeding 
This relates to breastfeeding, however interpretation of the available data is 
problematic because where this factor is considered definitions vary from study to 
study, and in one particular study no definition was given. '" For instance, when 
using multivariate analysis to examine independent risk factors, Istre et al found 
that exclusive breastfeeding in the 3 months up to the time of disease was 
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protective (odds ratio (OR)=0.1; 95% CI=0.01 to 0.96) in children younger than 6 
months of age in Colorado. "' Another study from the United States reported 
similar findings for children less than one year of age, with the protective effect 
being most pronounced in infants aged 2-5 months. 18 A recent matched case- 
control study by Sherry et al from Seattle reported that breastfeeding was 
protective, but unlike other studies, failed to define any specific age group. '" In 
this study breastfeeding was defined as the consumption of any breast milk in the 
month preceding disease occurrence. An Australian study with a similar definition 
reported contrasting results. Clements et al found that significantly more controls 
had been breastfed compared to cases (OR=2.2; 95% CI=1.2 to 3.9). "' However, 
this association disappeared when adjusted for other risk factors. 
Longer duration of breastfeeding has also been shown to be associated with 
protection from invasive H influenzae infection. A study from Finland has 
reported that exclusive breastfeeding for more than 6 months has been linked with 
a protective effect. 154 
Although the data is difficult to compare, it appears to indicate that lack of 
breastfeeding is a significant risk factor in developing invasive H influenzae 
disease. The immunopathology underlying this is unclear. It has been proposed 
that Hib anticapsular antibodies are present in human milk and evidence for this 
has been provided by Pichicherio et al. 294 Another study demonstrated an enhanced 
immune response to Hib antigen in breast fed infants who were subsequently 
immunised compared to immunised infants who had been formula fed. 299 
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3.3.1.5 General health 
Low birth weight 
Low birth weight (LBW) has been defined as a birth weight of less than 
2,500 grams 300 LBW can predispose to infections in the early months of life, 's,, 3oi 
and has been associated with increased susceptibility to invasive H influenzae 
disease. In one series from Finland, where specimens were taken from sterile sites, 
7 of 9 neonates with invasive H influenzae disease were of low birth weight. 26o 
Similar results using the same diagnostic criteria have been reported by 
others. 
59,262,302 
Preceding illness 
It has been hypothesised that antecedent or concurrent viral respiratory 
infection may increase host susceptibility to invasive H influenzae disease, 
particularly meningitis. The evidence for this relationship is inconclusive. 
Krasinski et al could not demonstrate an association between laboratory confirmed 
viral infection and a recent history of upper respiratory infection in children with 
bacterial meningitis over a three year period in Dallas! " Researchers from Finland 
also failed to find any difference between serology samples obtained from cases 
with Hib disease and a group of matched controls. 's However, they reported that 
case parents were more likely to report symptoms of respiratory infection, such as 
cough (OR=2.0; 95% CI=1.1 to 3.7) in the 4 weeks preceding Hib disease than 
matched controls. This study had a number of limitations. The questionnaires 
used were mailed to control children whereas those for cases were completed in the 
presence of a nurse on a visit to the family. Recall bias may also have been a 
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problem as questionnaires for cases were sent out 1 to 11 days (median =3 days) 
after hospitalisation compared to 3 to 82 days (median 13 days) for controls. Two 
more recent case-control studies, one from North America and the other from 
Scandinavia have both failed to find any association between a history of 
respiratory symptoms and invasive H influenzae disease. 1M 154,155 
Previous hospital admission 
Takala et al reported from Finland that children with a previous history of 
hospitalisation were at increased risk (OR=2.04; 95% CI=1.07 to 3.89) for invasive 
Hib disease. 'sa The researchers believed that 'unrecognised' socioeconomic factors 
were probably responsible for the observed association. Some support for this is 
provided by Spencer and colleagues! " Results from their study in Sheffield 
suggest that children from materially deprived areas are at increased risk for 
multiple hospital admissions. However, a relationship between SES and invasive 
Hib disease is yet to be reported from Finland, where socioeconomic differentials 
in the population are said to be minimal. ' 
Predisposing conditions 
Where predisposing conditions have been considered Down's syndrome is 
one of the most commonly reported. `, `, -"-` Other conditions associated with 
invasive H influenzae disease include preceding skull fracture, cystic fibrosis, 
phenylketonuria, and the presence of a ventriculo-peritoneal shunt. '41"57,25 141,157,256471 A 
recent report from the Republic of Ireland has suggested that the presence of 
chronic illness (defined as an allergic illness such as asthma, or an illness 
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associated with reduced immunity, such as Down's syndrome), is a significant risk 
factor (OR=2.9; 95% CI=1.29 to 6.54) for invasive Hib disease. 23° 
Anaemia 
Kaplan and Oski retrospectively compared the haematological findings on 
admission of children with bacterial and aseptic meningitis303 After excluding 
possible causes of anaemia they found that 41% (45 of 109) of cases with anaemia 
had H influenzae meningitis. Of the remainder, 28% had other forms of bacterial 
meningitis, and 31 % aseptic meningitis. Children with H inf uenzae meningitis 
had significantly lower mean levels of haemoglobin on admission compared to 
children with aseptic meningitis" 
A hospital based study conducted in the West Midlands reported that 31 % 
of patients admitted with bacterial meningitis, including H influenzae meningitis, 
had anaemia. 'oa Choo et al conducted a retrospective hospital-based study in 
Malaysia? " They reported that 40 of 58 (69%) children with bacterial meningitis 
were found to have anaemia, with haemoglobin levels below 1 Og%. A 
retrospective chart review of children with H influenzae disease in Bangkok using 
a similar case definition identified anaemia in 34 of 50 (68%) children. 2a3 
Similarly, Bijlmer et al found that 69% of their cases of H influenzae meningitis in 
The Gambia had haemoglobin levels below the minimum threshold for healthy 
Gambian children. "" The high proportion of children with anaemia and bacterial 
meningitis in the reports from these centres may reflect the methodology used. 
None of these reports indicated whether children with other possible causes of 
anaemia, such as haemoglobinopathies had been excluded. 
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Underweight for age 
Children who are underweight for age also appear to be at increased risk for 
invasive H influenzae disease. Using expected weight for age to determine 
nutritional status, a group of researchers in Cape Town found that children with 
septicaemia and arthritis were significantly more malnourished than children with 
other H influenzae diagnoses. 196 Nottidge reported similar findings from his study 
on H influenzae meningitis in Nigeria, where 76% of cases were below the third 
centile for healthy Nigerian children. 124 Another series from The Gambia found 
that on admission, 27% of children aged less than 24 months were equal in weight 
to, or weighed less than the third centile. 12' UK data on this aspect are lacking. 
3.3.1.6 Immunodeficiency 
Children with deficient immune function have been identified as being at 
increased risk for invasive H influenzae disease. Among the immunological 
disorders associated with invasive H influenzae disease are sickle cell disease, 
HIV/AIDS and other immunodeficiency syndromes, malignancies, receiving 
immunosuppressive therapy and congenital or acquired asplenia. 157,195, u 94,306,412 
Although the mechanisms which increase the risk of invasive disease remain 
obscure in this group of patients, it is believed that failure of cell-mediated 
immunity may be involved. "' Current evidence indicates that these conditions do 
not contribute greatly to the overall incidence of invasive H influenzae disease. 
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3.3.1.7 Genetic markers 
The role of genetically controlled cell surface characteristics and 
susceptibility to invasive H influenzae disease has been investigated in North 
America. A number of studies have indicated that certain genetic factors may be 
associated with an increased risk of invasive H influenzae disease. These include 
human leucocyte antigen (HLA), immunoglobulin light chain Km(1), the 
immunoglobulin heavy chain G2M(n) and certain blood phenotypes 30""0 
However, other studies have not been able to support these observations 31'": This 
lack of consistency may have arisen because a number of these studies carried out 
multiple cross-comparisons using small numbers, and therefore any significant 
results may have been due to chance. 
3.3.2 Family and community risk factors 
3.3.2.1 Family size and structure 
Few studies have explicitly examined family size as a risk factor. It is often 
used as a proxy for, or interchangeably with, household crowding. As with other 
factors, conclusions are difficult to arrive at because the variable is often not well 
defined, but the evidence appears to point to an association. 
Istre et al conducted a case-control study in Colorado and family size was 
one of the risk factors which they examined. `' They reported that the total number 
of individuals in case households (4.3 ± 1.7), was different to that in control 
households (3.9 ± 1.1). Univariate analysis indicated that this difference was 
significant (OR=1.2; 95% CI=1.0 to 1.5) however, the authors did not enter this 
variable into the multivariate analysis. A prospective study conducted in Fresno 
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County, California looked at the relationship between family size and ethnic group. 
The researchers found that cases of invasive H influenzae involved 'white' people 
who were from significantly smaller households (4.27 ± 1.58) than other ethnic 
groups (5.22 ± 2.17; p<0.05). 278 
In a report from Los Angeles County, living in a household which 
contained more than six individuals was associated with an increased risk 
(OR=3.71; 95% CI=1.10 to 12.60) for invasive Hib disease. "' Petersen et al have 
reported similar results for cases in households with large extended families in the 
native population of Southwest Alaska. 29' In contrast other reports have not been 
able to find an association between family size and an increased risk of invasive H 
inf l uenzae. 148,132 
A recent case-control study conducted in Switzerland among children aged 
2-16 years found that living with a lone parent was associated with an increased 
risk of invasive H influenzae disease (OR=3.52; 95% CI=1.00 to 15.37). 152 A 
similar observation was reported by Jafari and colleagues for children aged 2-18 
months in the United States. "' 
3.3.2.2 Household crowding 
Household crowding is believed to increase the exposure of the infant or 
young child to possible sources of H influenzae bacteria. The evidence for its 
importance as a significant factor in the development of invasive H inf uenzae 
disease is not convincing as contradictory reports have been published with 
differing definitions adding to the problem of interpretation. 
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In a study carried out in Atlanta household crowding was defined as more 
than one person per room. "" The researchers reported that following univariate 
analysis, a significant association with invasive Hib disease was found and this 
association remained after adjusting for day-care attendance, race, breastfeeding 
and low family income (OR=2.7; 95% CI=1.3 to 5.7). In addition, a'dose- 
response' effect was seen with the magnitude of the association increasing with 
increasing household crowding. The researchers also examined another index of 
overcrowding, the number of other people sleeping in the same room. This factor 
failed to demonstrate any association with increased risk of invasive H influenzae 
disease (OR=1.5; 95% CI=0.9 to 2.4). "" 
In a report from Oklahoma 3 levels of crowding were defined using a 
crowding index (the ratio of the number of people in the home to the number of 
bedrooms), these were, less than 1.5 people per bedroom, 1.5 to 1.99 and 2 or 
more. After adjusting for possible confounders overcrowding was a significant 
risk factor for invasive Hib disease only where there were 2 or more people per 
bedroom (OR=2.0; 95% CI=1.3 to 3.1). 2'5 
However, an earlier report from Colorado using a similar crowding index, 
found no difference between cases and controls when the number of persons per 
bedroom (which was 1.5 ± 0.6 for both groups), was examined as an index of 
crowding (OR=1.0; 95% CI=0.6 to 1.5). '55 In a more recent study from 
Switzerland, Mtihlemann et al defined a household as crowded if two or more 
household members slept in the same bedroom as the child. '"' After adjusting for 
vaccination history, day-care, kindergarten or school attendance, and smokers in 
the family the researchers reported that this was not a risk factor for invasive Hib 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 62 
Chapter 3: Literature review 
disease (OR=1.03; 95% CI=0.57 to 1.89). Fogarty et al reported comparable 
results from the Republic of Ireland. 23° 
Ecological analyses in Britain" and the United States'" have also failed to 
find any differences in H influenzae meningitis attack rates in areas defined as 
having a high proportion of overcrowded households (defined as more than 1 
person per room). 
3.3.2.3 Siblings 
A number of studies have provided data on the association between siblings 
and the risk of invasive H influenzae disease, the data are however inconsistent. 
In an Alaskan Eskimo population a matched case-control study revealed 
that the mean number of siblings present at the time of illness was similar for cases 
(2.0 ± 2.1) and controls (2.2 ± 2.3) and that both cases (1.2 ± 1.1) and controls (1.1 
± 0.9) had comparable numbers of siblings less than 7 years of age. 296 Neither of 
these differences were statistically significant. 
In Finland the presence of siblings younger than school-age (less than 7 
years of age) was a risk factor for invasive Hib disease. '" The risk remained after 
conducting multivariate analysis (OR=2.62; 95% CI=1.69 to 4.05) and was 
reported to increase with each individual sibling and to be highest among children 
aged less than one year. A report from the USA found that invasive H influenzae 
disease was more likely to occur in children where there was an elementary school- 
aged household member (OR=3.1; 95% Cl= 1.6 to 5.8), but that there was no 
increased risk with additional school-aged household members! " Arnold et al 
reporting from another part of the United States found a significantly increased risk 
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associated with having 3 or more siblings aged less than 5 years (OR=2.4; 95% 
CI=1.4 to 3.9). "' 
These findings were not replicated in a study from the Republic of 
Ireland X30 This study concluded that having a child of school-age in the household 
was not a risk factor for invasive Hib disease. After adjusting for a number of 
variables, a Swiss study reported that the risk of invasive H influenzae disease was 
not associated with having siblings aged less than 4 years of age (OR=1.00; 95% 
CI=0.62 to 1.64). 152 
The differences noted in the literature may be related to cultural practices, 
socioeconomic factors and variables such as day-care attendance. 
3.3.2.4 Day-care attendance 
Several North American and European studies have demonstrated that 
children who attend day-care facilities are at increased risk for invasive H 
influenzae disease. "', 154,155,230,295,313 
One study, from Monroe County, New York State reported that Hib 
meningitis age-specific attack rates for children in day-care who were less than one 
year of age were more than ten times higher than that for children who were not 
attending day-care (877.2 per 100 00 and 86.2 per 100 000, respectively). "' 
A study from the Republic of Ireland suggested that children who have only 
recently started to attend day-care facilities are at greatest risk of invasive H 
influenzae disease (OR=1.86; 95% CI=1.02 to 3.42)209 Takala et al reported 
similar results regarding day-care and invasive H influenzae disease in Finland. " 
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The majority of reports indicate that the risk associated with day-care 
attendance decreases after the age of two years. 148 148,154,295,313 However, Istre et al 
found day-care attendance to be a risk factor only for children who were aged 12 
months or older. 155 Despite these differences all of these studies reported a 'dose- 
response' effect. That is, the risk of disease increased the longer the time spent in 
day-care or the greater the number of children attending the day-care facility. 
A number of studies have however failed to demonstrate any association 
between day-care attendance and increased risk of invasive H influenzae 
disease. ld9, "' This may have been due to differences in day-care practices, the 
number of children attending the facility and the hours spent in day-care. One 
study from North America reported that day-care practices differed according to 
ethnic group. "" Using a case-control method, the authors found that day-care 
attendance was uncommon amongst Black and Hispanic cases compared to white 
children. The differences were reported as not reaching statistical significance. In 
addition, this study also reported that fewer Black case children attended day-care 
compared to their controls (35% vs 45%, respectively). '" 
Population-based studies from Britain have not reported the occurrence of 
cases of invasive H influenzae in day-care centres or creches. 
3.3.2.5 Passive smoking 
Various studies have pointed to an association between passive smoking 
and respiratory illness in children. 34'"s The data on passive smoking as a risk 
factor for invasive H influenzae disease are however inconclusive. Contributing to 
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this may be differences in methodology, especially the lack of a universal 
definition for this risk factor. 
Vadheim and colleagues reported from Los Angeles County that after 
adjusting for other risk factors, children aged 18-60 months from homes with two 
or more smokers had an increased risk (OR=6.0; 95% CI=1.49 to 24.06) of 
developing invasive Hib disease. "' An earlier report from Oklahoma State found 
that the risk of invasive H influenzae remained significant for children who lived in 
homes where 'tobacco smoke pollution' was present after adjusting for a number of 
other risk factors (0R=1.4; 95% CI=1.0 to 2.1). 2 This association was only 
weakly significant and the researchers failed to provide a definition for 'tobacco 
smoke pollution'. 
A case-control study carried out by Cochi et al explored this factor in 
metropolitan Atlanta. " They were unable to find an association between parental 
smoking and invasive H influenzae disease (OR=1.3; 95% CI=0.8 to 2.0). A 
number of other case-control studies from Western Europe and the USA have also 
failed to find an association between smoking in the home and invasive Hib 
disease. 152,154,230 
3.3.3 Environmental risk factors 
3.3.3.1 Socioeconomic factors 
Socioeconomic status is a difficult parameter to measure and researchers 
have used various proxy measures in an attempt to determine whether an 
association between socioeconomic factors and invasive H influenzae disease 
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exists. Some of the risk factors already discussed in sections 3.3.1 and 3.3.2, such 
as ethnic group and household crowding, have also been used for this purpose. 
Early research in this area originated from North America and involved 
ecological studies which suggested that an association between increased risk of 
invasive Hib disease and low family income or low parental education existed. "', "' 
A later study by Vadheim et al employed a number of variables to measure SES. 149 
These included the annual total household income, parental education and 
occupation, as well as a combined SES score derived from the aforementioned 
characteristics. They also examined whether the usual source of payment for 
medical care was a risk factor for invasive Hib disease. They reported that cases 
tended to come from families with low incomes (35% of cases vs. 24% of controls, 
p=0.12), low parental education (39% vs. 32%, p=0.38) and the overall SES scores 
for both groups were comparable. However, the case group used 
Medicare/Medicaid significantly more frequently than the control group (36% vs 
20%, p=0.02). '49 
The complexity of factors affecting exposure to Hib was illustrated in a 
case-control study from the United States. After univariate analysis Cochi and 
colleagues found that low family income (<$15,000) was a significant risk factor 
for invasive Hib disease (OR=1.8; 95% CI=1.1 to 3.0). 18 After controlling for 
other socioeconomic risk factors such as ethnic group, day-care attendance, 
household crowding and breast feeding, the association was no longer significant 
(OR=1.6; 95% CI=0.8 to 3.3). In a report which looked at children attending day- 
care centres in one New York county, Redmond and Pichichero were also unable to 
find an association between low family income and invasive Hib disease. 313 
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Arnold et al have indicated that after adjusting for confounders such as 
ethnic group, maternal education, household crowding and day-care attendance, 
high income (annual household income of $20,000 or more) remained protective 
against invasive Hib disease (OR=0.4; 95% CI=0.3 to 0.7). " Another potential 
measure of SES was also examined in this study, maternal education (more than 13 
years education). There was no significant difference between cases and controls 
for this factor (OR=0.7; 95% CI=0.4 to 1.3). 2'5 
European studies have generally been unable to provide any evidence to 
support an association between SES and invasive H influenzae disease. A case- 
control study from the Republic of Ireland used membership of social classes 4-6 
(based on parental occupation), eligibility for free health services and living in 
housing supplied by the local authority as proxy measures for low SES. ° None of 
these parameters were associated with increased risk of invasive Hib disease. An 
ecological study conducted in the North Thames region also failed to find an 
association between Hib meningitis and deprivation using the Townsend 
deprivation score. " A case-control, study conducted in Finland reported no 
association between low level of maternal education (did not attend university or 
college) and risk of invasive Hib disease. 1S° It has however been noted that SES in 
the Finnish population is relatively homogenous. "' 
The evidence on the aspects of SES examined above have been conflicting 
and remain unconvincing. It is, however, likely that socioeconomic factors are 
confounded by other host and environmental factors. 
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3.3.3.2 Geography 
Increased incidence of disease may occur as a result of living in an urban 
area or area with high population density. Where these factors have been 
examined, the results provided have been contradictory. 
Several reports have examined the differences between urban and rural 
populations. 
"' 242,272,313 A retrospective ecological study which compared the 
incidence of H influenzae meningitis in urban and rural Tennessee found a 
significantly increased incidence of disease (p<0.01) in urban residents. "= Another 
study examined cases of H influenzae meningitis occurring in day-care centres in 
Monroe County, New York. 313 The geographic origin (city vs suburbs) of each 
child was analysed and, despite reporting wide socioeconomic differences 
geographic origin was not associated with increased risk of invasive Hib disease. 
A report from Victoria state, Australia divided the state into three regions, inner 
Melbourne, outer Melbourne and the rest of the state. "" The researchers found that 
the more populous inner Melbourne region had a lower attack rate than the other 
two regions. The difference was however not statistically significant (p>O. 15)? '2 
Population density is another measure which has been used to describe 
geographic variation in invasive H influenzae disease. An early report by Fraser et 
al suggested that the incidence of H inf uenzae meningitis decreased with 
increasing population density in the white population but not the black population 
of South Carolina. "" A later study conducted in Rhode Island reported no 
association between population density and the incidence of H inJluenzae 
meningitis. '" However, neither of these reports provided an adequate definition of 
population density. 
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Only one British study was located which had looked at this issue. " The 
study from the Thames region of London used census data at the ward level to 
divide the population into 3 groups according to levels of overcrowding (which 
was defined as >1 person per room). The groups were then categorised as most 
overcrowded, intermediate and least overcrowded. The authors noted an increasing 
incidence of H influenzae meningitis with decreasing levels of overcrowding in 
white children aged less than 5 years. " This trend was however not statistically 
significant ([Chi-square] x2 for trend, p=0.13). 
Another study examined the proportion of the total population aged less 
than 5 years in each local government area (LGA) of Sydney, Australia. "' They 
placed each LGA into one of 4 classes, which ranged from low to high proportions 
of children aged less than 5 years. The authors reported that there were no 
significant differences between the four groups. However, when they compared 
the incidence of disease for children aged 0-1 year (19.9 per 100 000) in the group 
with the lowest proportion of 5 year olds with the other 3 groups combined (60.0 
per 100 000), a significant difference was reported (p=0.03)26 Their results 
suggest that in areas where the proportion of young children is low, exposure and 
development of natural immunity to Hib may be delayed. 
3.3.4 Summary of section 3.3 
British studies on the relationship between HI and various risk factors is 
lacking. However, the mainly North American and Scandinavian literature on 
invasive H influenzae disease indicates that the risk of disease is related to several 
factors which interact at different levels. These factors are responsible for 
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increasing the child's exposure and susceptibility to the organism. The most 
important risk factors appear to be age, ethnic origin, day-care attendance and 
family size. Breastfeeding appears to protect children against invasive H 
influenzae disease. However, interpretation is made difficult by the confounding 
effect of socioeconomic factors and the lack of clear, concise and consistent 
definitions for the factors examined. Despite these problems it is unlikely that 
socioeconomic confounding could account for the very large differences seen 
between the Native and non-native populations of North America, Australia and 
other parts of the world. 
3.4 CHILDREN, DEPRIVATION AND COMMUNICABLE 
DISEASES 
The relationship between communicable disease and socioeconomically 
deprived populations is clearly illustrated from the records kept during the time of 
the Great Plague in Britain in 1665. During this period Defoe noted that: "' 
"The misery of that time lay upon the poor, who, being infected, had 
neither food nor physic, neither physician nor apothecary to assist 
them. " 
As discussed earlier in section 1.3, medical attention to the variation in 
disease distribution across social groups was rekindled following publication of the 
Black Report, " which stimulated research around the areas of poverty and 
deprivation. 
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Although closely related, poverty and deprivation are two concepts which 
are quite distinct. Townsend has defined poverty as: 317 
"Individuals, families and groups in the population can be said to be in 
poverty when they lack the resources to obtain the type of diet, 
participate in the activities and have the living conditions and 
amenities which are customary, or at least widely encouraged, or 
approved, in the societies in which they belong. Their resources are so 
seriously below those commanded by the average individual that they 
are, in effect, excluded from ordinary living patterns, customs and 
activities. " 
He has also provided a definition of deprivation which appears to have 
gained wide acceptance. 
332 
"A state of observable and demonstrable disadvantage relative to the 
local community or the wider society or nation to which an individual, 
family or group belongs. " 
Poverty can therefore be conceptualised as arising from a lack of resources, 
whereas deprivation is applicable to conditions which may be independent of 
income. 
Using available health information, it is very difficult to measure poverty or 
deprivation directly. However, with the increasing use of postcodes in routine 
statistical systems, it has become possible to examine the relationship between 
socioeconomic area characteristics, which may be classified as 'deprived' or 
'affluent', and health events at an ecological level. 
3.4.1 Measuring deprivation 
From the English Registrar General's first classification of social class, 
through to the current plethora of social classification methods, measuring 
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deprivation and assessing the health effects of 'class' on individuals, geographic 
areas and populations has been a major challenge for researchers and social 
commentators. Quantifying this complex phenomenon not only enables 
comparisons to be made, but also facilitates the development and testing of 
hypotheses. 
Social class has been employed as an instrument for epidemiological 
research for many years and is heavily reliant on the type of work an individual 
performs. This hierarchical system has been severely criticised for a number of 
reasons. One example is the lack of clear criteria for allocating occupations to 
social classes. 59 It has also been noted that there is a widening imperfection in the 
correlation between social class and income, with greater variation in income 
within social classes than between social classes. 31 
Commentators have also indicated that the Registrar General's Social Class 
(RGSC) system excludes members of the population not in formal employment, 
notably the elderly, women and children, and the emerging 'underclass'. "' For 
example, married women working outside the home are excluded, even though 
their earnings may influence the standard of living of the household. It may 
therefore be concluded that epidemiological analyses utilising the Registrar 
General's social class classification will not reveal the full extent of social and 
economic inequalities. 
The Black Report noted the inadequacy of social class for the measurement 
of health inequalities and called for: 2' 
"Study of the interaction of social factors implicated in ill-health over 
time, and within small areas. " 
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This led to the formulation of alternative social classifications to quantify 
health differences. Many of these alternative approaches employ census data for a 
defined geographic area and apply them to individuals. 
A census is carried out every ten years in the UK, and provides a'snapshot' 
of the population at that time. A large number of details regarding the population 
are collected and made available for different sized areas from the countries 
comprising the UK, to the smallest area - the enumeration district (ED). This is an 
area containing an average of 500 people in urban areas and about 150 people in 
Waal areas. "" EDs can be identified using the postcode of address and may be 
aggregated to wards, wards to local authorities and so on. "' 
Increasingly, the ED is being used as the unit of geographical analysis, and 
individuals are being classified using aggregate data obtained from the census. 
EDs are employed because they are currently the smallest geographical area 
available, and are likely to contain more socially homogenous populations than 
larger areas, such as electoral wards. "'"' Nevertheless, the problem of the 
`ecological fallacy' whereby data aggregated at a particular geographic level is not 
necessarily representative of particular individuals or households within that area, 
still exists 67 However, the use of the ED is believed to minimise the effect of 
social heterogeneity present among individuals or households when geographical 
analyses are conducted. 
Although the census provides much useful information, it was only in 1991 
that direct questions on ethnic origin were included for the first time. The census 
continues to omit questions about income which might be useful in specifically 
addressing the issues of poverty or deprivation. This, and the lack of routinely 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 74 
Chapter 3: Literature review 
collected information on wealth, income or occupation in health records, has led to 
the use of proxy measures of deprivation by researchers. Single indicators of 
deprivation such as unemployment have been used '111,121 however many measures 
are indices constructed from a number of census-based variables. 
Of the many composite indices claiming to measure deprivation or some 
aspect of it, the three most widely used in the medical literature are the Townsend 
material deprivation index, " the Jarman (or underprivileged area [UPA]) score, " 
and the Scottish deprivation (SCOTDEP or, Carstairs and Morris) score. ' 22 of 
these indices is composed of a different set of census small area statistics (table 
3.7), each of which has various statistical procedures performed on them to ensure 
equal weighting, and therefore an equal contribution to the index. 
Thunhurst has criticised composite scores for'e' 
"Throwing everything into a statistical melting pot and expecting to 
produce an answer. " 
Several other criticisms have been made regarding the criteria for selecting 
variables, the mathematical manipulations required to create an index, and their 
reliance on dated census information . 
32"26 Despite these comments the indicators 
have been increasingly used as markers of deprivation when social inequalities in 
health are under consideration. 
In assessing the value of each of these indices in explaining the relationship 
between deprivation and health, Morris and Carstairs concluded that although the 
scores correlated well with each other, the Townsend deprivation index and the 
Scottish Deprivation score performed better than the Jarman score. 32" This is not 
surprising in view of the fact that the Jarman score was originally developed to 
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identify factors likely to affect the workload of general practitioner's. The 
methodology employed to obtain the Jarman score has been criticised for its flawed 
approach 3x6,328,32' 
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3.4.2 Deprivation and child health 
Following publication of the Black report a plethora of published literature 
appeared demonstrating inequalities in health between those from poorer areas and 
those from more advantaged areas. Recent evidence suggests that this differential 
may be increasing. "'82,330,331 
Various explanations for the association between deprivation and adverse 
health outcomes have been proposed. The Black report broadly classified them 
into four schools of sociomedical thought: artefact, natural selection, 
behavioural/cultural and structural/materialist (table 3.8): 21 
Table 3.8: Summary of the Black reports explanations for health inequalities 
1. Artefacts of measurement - This suggests that health inequalities are not real 
but due to statistical and classification artefact. 
2. Social selection - This accepts the existence of inequalities, but 
suggests that health determines social position 
rather than vice versa. 
3. Behavioural/cultural - This is based on the premise that the observed 
health differences between social groups are 
accounted for by health-related behaviour. 
4. Material/structural - This explanation suggests that the differences 
seen between social groups occur as a result of 
the unequal distribution of resources in society. 
Researchers have not applied equal weight to each of these explanatory 
variables and have suggested that the first two explanations are of little importance 
in explaining the observed inequalities in health. =1,32~ 33 Social medicine research 
has been biased towards the behavioural/cultural explanation. "" It has however 
been argued that the material/structural view best explains the socioeconomic 
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gradients seen when examining issues of inequalities in health, " although it is 
recognised that it is difficult to separate behaviour from its social context "s 
3.4.2.1 Paediatric communicable diseases and deprivation 
An extensive body of knowledge has demonstrated that paediatric 
mortality21 and a number of measures of morbidity such as low birth weight, SO child 
abuse, " diabetes, "' sudden infant death syndrome" and accidents " are associated 
with socioeconomic inequalities. The health inequalities demonstrated by these 
measures appears to indicate that there are significant differences in health 
experience between children from poorer areas and those from more advantaged 
areas. 
Examination of the relationship between paediatric infectious diseases and 
deprivation has however not received as much attention in the published literature. 
When the available literature on communicable diseases are examined, in general 
there appears to be an unequal burden of communicable disease among children 
from poorer socioeconomic backgrounds or levels of deprivation. 
The definitive communicable disease of poverty is tuberculosis. Its 
association with socioeconomic disadvantage has been one of the factors used to 
explain its recent re-emergence as a major infectious cause of morbidity and 
mortality in both the UK and USA. "'18'37 Other reasons given for the increase in 
tuberculosis include its link with HIV/AIDS and increasing antibacterial 
resistance. ", " 
An ecological analysis of meningitis cases in the North East Thames region 
utilised the Townsend score to divide wards into three groups to carry out an 
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analysis of area of residence. " The study did not find an association between 
meningococcal or Haemophilus meningitis and deprivation. The researchers 
reported an increasing incidence of meningococcal meningitis from the least 
overcrowded wards to those classified as the most overcrowded. A similar pattern 
was not found for H influenzae meningitis. A case-control study of meningococcal 
disease suggested that households with 6 or more residents were a risk factor for 
disease in children aged less than 5 years, while cases in households where the 
head of household was in social class I/II were less likely to present with 
meningococcal disease. " 
A study carried out in Sheffield reported that children admitted with 
bronchiolitis were more likely to reside in areas of deprivation (as defined by the 
Townsend deprivation score) than controls. 26 This relationship was still present 
even after excluding children from homes which contained a smoker. In the Child 
Health and Education Study, Taylor and colleagues employed a composite index of 
SES and demonstrated social class gradients for lower respiratory tract infections 
and gastroenteritis in children aged up to five years. Disadvantaged children were 
reported to be at increased risk. " 
Helicobacterpylori is acquired at an early age and prevalence of the 
infection increases with age. Patel et al carried out a population-based 
longtitudinal study of children in Edinburgh from the age of 7 to 11 years. " They 
examined a number of socioeconomic factors and found that children from single 
parent families, overcrowded homes and those living in rented accommodation 
were at increased risk of Helicobacter pylori infection. 
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In England and Wales the fourth national study of general practice (GP) 
consultations rates used social class (as defined by occupation) as one of its 
measures of socioeconomic status. Significantly more children from (the `lower') 
social classes IV and V attended GP consultations for infectious and parasitic 
diseases than children whose parents were in social classes I and II' 
A study from Glasgow reported on the relationship between deprivation 
and hospital admission by postcode of district of residence for a number of 
individual infectious diseases (measles, whooping cough, gastroenteritis) and all 
infectious diseases combined" They found a strong and consistent relationship 
with deprivation for all the diseases examined. 
Dental decay (or dental caries) occurs as a result of bacterial action 
modified by sugar in the diet and dental hygiene. In 1993-94, almost 50% of 5 
year olds had dental decay in Great Britain. There is a body of evidence linking 
dental decay in children with material deprivation. Two ecological studies, one 
using the Jarman score3" and the other using the Townsend index92 have both 
shown that tooth decay (based on the decayed, missing and filled tooth (draft) 
index) in children is associated with deprivation. 
Lissauer et al carried out a prospective case-control study which looked at 
the influence of homelessness on the health of children in London. 2' The 
researchers found that homeless children were more likely to be admitted to 
hospital with infectious diseases than the control group 2' 
In a review of the literature on infectious disease in childhood and social 
disadvantage, Reading cited a number of studies which provided equivocal 
evidence of social differences in disease incidence (for example ear infections, 
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measles and pertussis). s However, it seems clear that inequalities do exist in 
relation to communicable diseases. The causative factors underlying the patterns 
observed are however disputed but centre around lifestyle or behavioural 
influences and structural or material influences. Although it is difficult to separate 
one from the other, the latter appear to exert a greater influence when moving from 
the individual level to the community level. 
3.4.2.2 Immunisation and deprivation 
Immunisation is a major public health activity, and the level of 
immunisation uptake can be used as a marker for the adequacy of health-care 
delivery or its utilisation. The main aim of immunisation is to provide 
immunological protection against a specific infection without exposing the 
recipient to the risk associated with natural infection. The procedure prevents 
death and disability, and is recognised as one of the most cost-effective medical 
strategies available. It not only provides protection for the individual but through 
the herd immune effect also provides protection for the community. 
Such is the importance of immunisation that when the WHO set its target of 
`Health For All 2000', it included amongst its goals the elimination of the major 
vaccine preventable diseases of childhood such as diphtheria, tetanus, measles, 
congenital rubella, tuberculosis and polio. "' To achieve this goal it set a target of 
90% immunisation among children aged less than two years of age by 1990. In 
1992, the UK government white paper `Health of the Nation' set immunisation 
targets of 95% for the health authorities. " 
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In the UK it is well documented that immunisation uptake rates exhibit 
inter- as well as intraregional variation, "" and that immunisation rates are lower 
than in several other industrialised countries. "' Recent years however, have seen a 
temporal association between improving uptake rates and several changes in 
immunisation policy. These changes include the introduction of immunisation 
targets in GP contracts, 341 the computerisation of child health records, lts the 
appointment of district immunisation coordinators, 341 and the change in the 
national immunisation schedule from 3,7 and 9 months of age for the 'triple 
vaccine' and oral polio vaccine (OPV) to an `accelerated' schedule of 2,3 and 4 
months of age342 
However, for a vaccine to be effective it must reach those it is intended for, 
and a number of factors have been associated with poor immunisation levels in 
children. Factors linked with poor immunisation uptake in the UK and other 
countries are complex and multifactorial and maybe linked to the provision and 
organisation of health services and parental and health professional behaviour and 
knowledge. 'o6aos, '10' 4"46 International research evidence further suggests that there 
is a relationship between the characteristics of the population served such as low 
social class, living in deprived areas and certain family or social characteristics, 
and low immunisation uptake. '06,109,163,347 50 
Evidence from a national study of factors influencing childhood 
immunisation uptake rates in England and Wales indicated that districts with high 
social deprivation (UPA) scores were associated with lower levels of immunisation 
uptake. 106 Deprived areas have also been associated with inadequate access to or 
poor utilisation of preventive health services. ""' In a case-control study matching 
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children from a'deprived' area for gender and age with children from an'affluent' 
area, Marsh and Channing reported that there was a poor uptake of preventive care 
by children from deprived backgrounds, and that these children had much lower 
immunisation rates, and later immunisation dates than their controls"' A study 
from Liverpool indicated that parents from socially deprived areas were less likely 
to provide consent for immunisation of their children. "' Lynch examined GP 
payments linked to immunisation rates in Glasgow. "' It was found that practices 
providing health services for populations in deprived areas were less likely to reach 
childhood immunisation targets than those in more affluent areas. A report from 
Northumberland demonstrated that although an overall increase in immunisation 
rates had occurred in recent years, there were still inequalities in uptake between 
deprived and affluent areas. " In some cases these differences were said to have 
increased thereby leaving children from deprived areas at increased risk from 
preventable infectious disease. 
Jarman et al reported that immunisation uptake was lower in urban areas 
and that immunisation uptake was strongly linked with social factors such as 
overcrowding, population density, single parent families, unemployment and 
ethnic minority status (New Commonwealth including Pakistan). "' Data on 
children from ethnic minority groups is however conflicting. A number of studies 
have described children from these groups as being at increased risk for poor 
immunisation uptake, "', '" while others have suggested that immunisation uptake 
in these populations is similar to, if not better than, that of the indigenous 
population. 354,3"' However, it should be noted that the majority of the published 
UK data on ethnic minority children and immunisation uptake refers to children of 
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South Asian origin. There is little information regarding immunisation uptake in 
children from other ethnic minority groups. 
Larger families are associated with several social attributes including 
residing in inner city or deprived areas, and ethnic minority status. Research in this 
area has identified children from large families as starting immunisation schedules 
late or being less likely to complete the recommended immunisation schedule 
when compared with children from smaller families. 116,108,163,348 
A number of families are highly mobile and change address several times in 
a year. There is some concern that children in these families may be at risk of not 
being vaccinated. There is, however, conflicting evidence as to whether moving 
between health districts during the immunisation period affects immunisation 
uptake. One recent report from Li and Taylor in one of the London districts, found 
that children who had moved into the district from outside were as adequately 
immunised as those resident in the district since birth's' Pearson et al in 
Liverpool reported contrasting results 35' In their study, children who moved into 
the city were less likely to be fully immunised than those children who had been 
resident in Liverpool since birth. Among other factors, these discordant results 
may reflect differences in information transfer between districts, whether or not 
these families register with primary care services, and their utilisation of 
community health services. 
Most of the literature reviewed appears to indicate that children from 
deprived areas, or families, are less likely to be up-to-date with their immunisations 
than their peers from more affluent areas. These children are also more likely to 
have a higher frequency of hospital admission. 103,347 In addition, the literature 
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suggests that children admitted to hospital are likely to be inadequately 
immunised 357,358 However, despite WHO advice that: 359 
"contact with the health services made for other reasons should be 
exploited for the purposes of immunisation" 
reports indicate that the immunisation status of hospitalised children remains 
unchanged on discharge from hospital. "" 
Population characteristics alone however do not fully account for the 
variation in vaccine uptake, and the accuracy of data on immunisation uptake has 
been questioned? ", " The structure and organisation of preventive services has 
also been examined as a factor in differential rates of immunisation. Factors 
associated with missed or delayed immunisation include immunisation location, 
level of professional knowledge, inconvenient opening hours and failure to receive 
appointment letters. 10'108.346,363,365 
3.5 DIAGNOSIS AND TREATMENT OF INVASIVE H 
INFLUENZAE DISEASE 
In addition to the risk factors outlined in the previous sections, there are 
other factors which may affect the morbidity and mortality associated with primary 
invasive H influenzae disease. Again, these factors are generally well documented 
for H influenzae meningitis, and less well for other manifestations of the organism. 
This part of the literature review will therefore mainly refer to approaches designed 
to decrease the morbidity and mortality associated with H influenzae meningitis. 
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3.5.1 Diagnostic methods 
H influenzae is a small gram-negative coccobacillus indigenous to humans 
and found mainly in the upper respiratory tract. " On gram-staining clinical 
specimens may appear to be pleomorphic and this variable morphology may lead 
to misinterpretation of stained smears, 14' The organism requires two factors (X and 
V) for growth in vitro. The X factor is a heat-stable, iron-containing protophyrin, 
whereas V factor is a heat-labile coenzyme supplied by nicotinamide adenine 
dinucleotide (NAD). 146'2ss These growth requirements distinguish H influenzae 
from other Haemophilus species. 
H influenzae are divided into capsulated and unencapsulated strains. 
Encapsulated strains are further sub-divided into serotypes a through to f 
depending on the antigenic specificity of their polysaccharide capsule. Type b is 
responsible for 90% of invasive disease and antibody to the type b capsule is the 
basis for rapid diagnostic tests as well as the current vaccines. "" 
Detection of H influenzae either by Gram stain or culture from a normally 
sterile fluid, such as CSF or blood, is the'gold' standard for the aetiological 
diagnosis of invasive H influenzae disease's, "s However, prior antibiotic 
treatment may decrease the probability of detecting the organism in up to 60% of 
patients with meningitis. 1' This figure may be higher in countries, such as Hong 
Kong and Thailand, where antibiotics are more freely available than they are in 
most Western countries. 239 Although antibiotic therapy prior to hospitalisation has 
been shown to reduce the frequency of positive Gram stains and bacterial cultures, 
it does not affect the yield of the organism or the biochemical characteristics of the 
CSF in bacterial meningitis366 
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As a result of the problems caused by prior antibiotic therapy, the difficulty 
in establishing the precise aetiology of syndromes such as pneumonia, and the 
importance of starting antibiotic treatment before culture results are known, 
specific immunological tests have been developed to rapidly establish the presence 
. 
36'a69 of type b capsular polysaccharide antigen 
Cross-reactivity with E. coli, S. pneumoniae, staphylococcus, 
meningococcus and other bacteria may also result in false positive test results. 
This is because these organisms possess surface structures similar to Hib antigen 
and therefore cross-react with Hib anti-serum. 
195,369,370 
Another problem is the detection of Hib antigen in urine and CSF following 
vaccination. Using latex agglutination tests, Goepp et al reported that antigenuria 
occurred in 41% of infants up to 30 days after receiving Hib conjugate vaccine. "' 
In another study, Hib antigen was detected in the CSF of a child despite negative 
serum and urinary antigen tests, as well as negative blood and CSF cultures twenty 
one days after receiving inununisation. 'n 
As a consequence of these problems, and their inability to identify 
antibiotic bacterial resistance, rapid antigen tests are not recommended for the 
routine diagnosis and management of invasive disease in general, and meningitis in 
particular. "' 
3.5.2 Antibiotic resistance 
Ampicillin has been the mainstay of treatment for invasive H influenzae for 
many years. However, in 1974 plasmid-mediated b-lactamase resistance to 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 88 
Chapter 3: Literature review 
ampicillin was first reported. "' Since then, increasing resistance to ampicillin and 
other antibiotics has been reported. 
This is dramatically illustrated by the rapid rise in ampicillin resistance 
found in one region of France. A ten year retrospective study reported that 4% of 
strains were ampicillin resistant in 1980.126 By 1989, this had increased to 55%. 
During the same time period, ampicillin resistance in Britain increased from 3% to 
16%. 12`, 141.142 A more recent report from the PHLS six region study indicates that 
from 1990/91 to 1993/94 the proportion of ampicillin resistant Hib strains 
increased from 16% to 26%. 140 This increase may however have occurred as a 
result of increased testing and awareness following the introduction of Hib 
conjugate vaccine. In Europe, the highest incidence has been reported from Spain, 
where 60% of isolates were found to be ampicillin resistant. "" In the USA, two 
nationwide studies reported that in 1986 approximately 32% of H influenzae 
isolates were resistant to ampicillin. 
'ZS'374 
Occasional reports documenting chloramphenicol resistance have appeared 
in the literature. Campos et al have reported that 66% of invasive Hib isolates in 
Spain are resistant to chloramphenicol. 'Z' Contrastingly, strains resistant to 
chloramphenicol are rarely encountered in other parts of Europe. In Britain, 
Anderson et al found 2% of H influenzae strains to be chloramphenicol resistant in 
the early 1990's, 249 while in France"' and Sweden=" 4% and I% (respectively) of 
strains were resistant to chloramphenicol. In the USA, a study in which 1025 
isolates were tested reported that only 1 (0.1%) was chloramphenicol resistant 30 
A recent five year study carried out in Hong Kong where the community use of 
antibiotics without prescription is a recognised clinical problem, found that 23% of 
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isolates were chloramphenicol resistant in addition to 26% being ampicillin 
resistant and 16% demonstrating resistance to both antibiotics. " Strains resistant 
to both ampicillin and chloramphenicol are also a major problem in Spain where 
57% of Hib isolates are resistant to both antibiotics. "" 
The emergence of strains resistant to both drugs complicates the treatment 
of H influenzae meningitis, especially in places where ampicillin and 
chloramphenicol are still commonly used as initial empiric therapy. Fortunately, 
this does not appear to be a dilemma in many countries yet, although recent reports 
from England and Wales indicate that up to 2% of Hib strains are resistant to both 
antibiotics. "' 249 
Antibiotic prescribing patterns in hospital and the community may 
influence the observed pattern of antibiotic resistance, as may inter-community 
transmission of resistant strains. Different methodologies, such as mode of 
collection of specimens, and the testing of isolates from sterile and non-sterile sites 
may also account in part for the different rates of resistance found in various 
countries. 
3.5.3 Antibiotic therapy 
Empiric treatment of meningitis in children beyond the neonatal period has 
traditionally been instituted with penicillin or ampicillin, and chloramphenicol. 
Once the organism has been positively identified as H influenzae and its antibiotic 
susceptibility is known, then treatment may be changed where appropriate. 
The combination of a penicillin and chloramphenicol is both cheap and 
effective, and is used in many parts of the world for bacterial meningitis in the 
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post-neonatal period. The regimen, however, has several drawbacks including, 
increasing bacterial resistance to either or both of these drugs (see section 3.5.2), 
the interaction of chloramphenicol with other drugs, the variation in drug 
metabolism between individuals, as well as its potential toxicity"5'36 It is now 
recommended that third-generation cephalosporins are used for the treatment of H 
influenzae meningitis 3's, 3" Despite these recommendations, ampicillin and 
chloramphenicol may remain the drugs of choice in the treatment of invasive Hib 
disease especially in countries with limited resources, in areas where there are 
issues of cost-containment, and where paediatricians and microbiologists are 
reluctant to change their prescribing practice. 
Prospective randomised controlled trials of cephalosporins have shown that 
they are efficacious when used to treat invasive H influenzae type diseases, 
including meningitis. 378-380 They penetrate well into the CSF, achieve rapid 
sterilisation, are active against strains resistant to penicillins and chloramphenicol, 
and have few toxic side effects. Furthermore, resistance to these drugs remains 
uncommon. However, in comparative trials with traditional therapy for H 
influenzae meningitis, they have not been shown to be superior to ampicillin and 
chloramphenicol, and do not appear to significantly reduce mortality and 
neurological sequelae. 
381483 
The duration of antibiotic therapy for meningitis is generally gauged upon 
the response of the child to treatment and a7 to 10 day course is traditionally 
recommended"s Recent research in a number of different centres has examined 
seven day courses of antibiotic therapy in children with uncomplicated H 
influenzae meningitis. """, ", "' The results have been encouraging, reporting no 
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significant differences in terms of morbidity, treatment failures and sequelae when 
compared to children treated with longer courses of antibiotics. The studies have 
however suffered from small numbers and the use of differing drug and dosage 
schedules. This makes it difficult to reach any firm conclusions as to the benefits 
of shorter courses of treatment. The introduction of Hib conjugate vaccines means 
that further evidence to support these results is unlikely. 
3.5.4 Dexamethasone therapy 
Despite the availability of newer antibiotics and advances in the diagnosis 
and management of H influenzae meningitis and other invasive Hib diseases, H 
influenzae meningitis is still associated with significant morbidity and mortality in 
children. Much of this has been attributed to the inflammatory response within the 
CNS. 
Animal models have shown that the lysis of bacteria by antibiotics induces 
the release of cytokines such as tumour necrosis factor (TNF) and interleukin-1 
beta (IL-1 13). 3863$' These in turn activate the inflammatory response which may 
lead to undesirable changes such as cerebral oedema, increased intracranial 
pressure (ICP) and disturbances in cerebral blood flow. The administration of 
dexamethasone has been shown to reduce or prevent the production of cytokines 
and thereby decrease the inflammatory response both in vitro and in vivo. """' 
A number of clinical trials in children with bacterial meningitis suggest that 
when dexamethasone is given before or together with the first dose of parenteral 
antibiotic, abnormal CSF parameters, fever and the concentrations of CSF 
cytokines improve significantly earlier than in those children given placebo. 219-221 
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These trials also suggested that sensorineural hearing loss, and other neurological 
sequelae were more likely to be reduced in those who received dexamethasone. =" 
221,392 Adverse side effects appeared to be minimal and were mainly related to 
gastrointestinal bleeding. 21, zzo 
Two meta-analytical studies using slightly different methodologies, and 
published out six years apart, examined the evidence for the routine use of 
dexamethasone in the treatment of bacterial meningitis. """' Both reached the 
same conclusion, that there was insufficient evidence to recommend routine use of 
corticosteroids in the treatment of acute bacterial meningitis. They also found that 
the available evidence indicated that steroids did not significantly reduce the risk of 
morbidity or mortality in children with acute bacterial meningitis. "' 394 
There have been several criticisms of the dexamethasone studies. It has 
been pointed out that most of the initial studies were carried out by the same group 
of researchers, that the number of patients enrolled in the studies were small and 
that differing doses of corticosteroids were given. Furthermore, as the majority of 
children had H influenzae meningitis, the results were not generalisable to other 
types of bacterial meningitis. 
129,393495 
Nevertheless, on the basis of the initial results, in 1990, the American 
Academy of Pediatrics recommended that dexamethasone therapy be considered in 
children two months of age or older with proven or suspected bacterial 
meningitis 396 The recommended regimen was 0.15 mg/kg every 6 hours for 4 
days. They also recommended that the initial dose of dexamethasone be given 
with the initial dose of antibiotic, and that haemoglobin concentration and the 
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examination of stool for occult blood be performed regularly during 
dexamethasone administration. 396 
A questionnaire survey of directors of paediatric infectious disease training 
in the USA and Canada was carried out in 1992. Responses were received from 69 
of 79 (87%) questionnaires sent out. Of these 50% said that they "always" or 
"sometimes" used dexamethasone for the treatment of bacterial meningitis. "' 
Comparable data for the UK on the use of dexamethasone by paediatricians is 
unavailable. 
The British Paediatric Immunology and Infectious Disease's Group, in a 
review of the published literature on dexamethasone and meningitis, believed that 
the introduction of H influenzae vaccines in the UK would significantly reduce the 
incidence of H inf uenzae meningitis, and that this would therefore render any 
debate over the issue less meaningful. 129 They concluded that research priorities 
should be directed towards determining the effect of dexamethasone on the course 
and outcome on other forms of bacterial meningitis, especially meningococcal. 
3.6 PREVENTION OF INVASIVE H INFL UENZAE DISEASE 
3.6.1 Chemoprophylaxis 
Colonisation with Hib may not be eradicated or may recur after antibiotic 
therapy has been completed in a child with invasive Hib disease. Recolonisation 
and persistence of the organism are ways by which this may occur. This may be 
prevented by the use of chemoprophylaxis, which is used to prevent secondary 
transmission of meningitis following the occurrence of an index case. "' 
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Rifampicin is the current drug of choice for the eradication of 
nasopharyngeal carriage of H influenzae and the prevention of secondary cases of 
invasive H influenzae disease. 398 Studies have shown that a dose of 20mg/kg/day 
(maximum 600mg/dose) of this antibiotic given orally once daily for 4 days is 
effective in eradicating nasopharyngeal carriage of H influenzae"'402 It is 
generally safe, but has several side effects including red coloration of sputum, 
urine and tears, itching and gastrointestinal upset. " 
Despite its effectiveness, instances of prophylactic failure have been 
reported. Several possible explanations have been advanced for this including the 
emergence of rifampicin resistant H influenzae strains, failure of the drug to 
eliminate Hib from the nasopharynx and recolonisation with the organism 
following rifampicin prophylaxis"9'404'1 Other problems associated with 
chemoprophylaxis include defining contacts, delayed contact tracing, ensuring 
simultaneous administration of chemoprophylaxis to all contacts and failure of 
compliance. aos, 4o6 
Prophylaxis for invasive Hib disease in the UK has been recommended for 
all index cases, all family members who are close contacts and other close contacts 
with children aged less than four years of age who are unimmunised or 
incompletely immunised with Hib vaccine `03 Furthermore, in order to reduce the 
likelihood of recolonisation all contacts should be treated simultaneously. These 
are similar to guidelines for chemoprophylaxis in the USA. 407 
The development and introduction of the conjugate Hib vaccines into 
routine immunisation programmes has probably made the issue of 
chemoprophylaxis less contentious. However, because the majority of secondary 
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cases occur within a few days of the index case, and because it takes I to 2 weeks 
for antibody concentrations to become protective following administration of Hib 
vaccine, "' immunisation alone would not prevent disease occurrence during the 
period of greatest risk. 409'1'0 Additionally, treatment of invasive H influenzae 
disease does not eliminate carriage of the organism in the nasopharynx of the index 
case. 195,411 Following hospital discharge index cases still harbour bacteria and may 
be a potential source of recolonisation in household contacts. Thus, 
chemoprophylaxis is required by both index cases and contacts. 
3.6.2 Hib vaccines 
The Hib bacteria contains a polysaccharide PRP capsule which determines 
its virulence and invasiveness. "' Antibodies to this capsular polysaccharide 
provide immunity to invasive disease by Hib, and by 5 years of age most children 
have protective antibody levels. "= This immunity is thought to develop from a 
number of sources including asymptomatic carriage and following cross-reactivity 
with various gastrointestinal bacteria which have similar polysaccharide capsules 
to that of Hib. "= Maternally acquired antibodies as well as antibodies obtained 
through breastfeeding provide protection in the first few months of life. 
146,284,294 
Therefore, invasive disease primarily affects children aged between 2 months and 5 
years. 
The identification of the key role played by the polysaccharide capsule of 
Hib in the pathogenesis of invasive disease by this organism has been instrumental 
in providing one of the most exciting advances in paediatrics, the development of 
conjugate vaccines to prevent Hib disease. This technology is now being applied 
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to the development of a number of other conjugate vaccines against group B 
meningitis, pneumococcal infections, malaria and Pseudomonas aeruginosa. 413 
The new Hib conjugate vaccines are more immunogenic and efficacious in 
young children than the initial Hib polysaccharide vaccine, and therefore have a 
greater potential to significantly reduce the incidence of severe Hib disease. 
167,414416 
The reason for the greater protective efficacy afforded by the conjugate vaccines 
over the polysaccharide vaccine lies in the type of humoral immune response 
elicited. 
In general, protein antigens evoke a T-cell dependent antibody response. ": 
This involves the activation of T-helper lymphocytes, which then stimulate 
antibody production by B-lymphocytes. "' T-cell induced immunity also results in 
the manufacture of B-memory cells, which provide the basis for significantly 
increased antibody production when the host is challenged by the same antigen at a 
later date (booster response). "' The carrier protein is also said to enhance the 
immune response. 146 
In common with other polysaccharide vaccines (for example 
meningococcal and polyvalent pneumococcal), the bacterial capsular 
polysaccharide Hib vaccine is poorly immunogenic in infants"' The antigen 
elicits a T-cell independent immune response by acting directly on B-cells to 
induce the synthesis of humoral antibodies. """ The T-helper lymphocytes are 
bypassed, and therefore the T-cell independent inunune response is not associated 
with the production of appreciable numbers of B-memory cells, or significantly 
increased levels of protective antibodies in response to further exposure to the 
antigen, either by natural exposure or further vaccination. "x°12 T-cell independent 
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antigens are also associated with limited or no antibody response in children below 
the age of 18 months, and these are the children most at risk of morbidity and 
mortality. 146,412 
The following section will examine the immunogenicity and protective 
efficacy of the different varieties of Hib vaccine. 
3.6.2.1 Polysaccharide vaccine 
Polyribosyl ribitol phosphate (PRP) vaccine 
Now mainly of historical interest, PRP vaccine was a T-cell independent 
immunogen which induced a poor immunologic response, was highly age 
dependent and failed to respond to booster doses. It was the first Hib vaccine to be 
licensed in the USA in 1985 following trials in Finland which reported an 
estimated protective efficacy of 90% (95% CI=56% to 96%) but only in children 
aged more than 18 months. 146,418 
Protective levels of antibody with this vaccine are said to be reached when 
anti-PRP antibody concentration is 1.0 µg/ml. 419 However, children aged less than 
18 months failed to achieve this with the polysaccharide vaccine. The exact 
concentration of antibody required to confer protection against invasive Hib 
disease is unknown. Long-term protection is however reported to be associated 
with anti-PRP antibody concentration levels of 1.0 µg/ml, "' while levels of z 
0.15pg/ml are regarded as protective if obtained in unimmunised people. "' 
In the USA, post-licensure case-control studies provided a wide variety of 
results, together with reports of vaccine failures. One multi-centre study reported 
high levels of protective efficacy in their trial, 88% (95% CI=74% to 96%). °20 
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Osterholm et al were originally part of the same multi-centre trial but 
reported markedly different results. They found that PRP vaccine had a protective 
efficacy of -55% (95% CI= -238% to 29%). "o Their results suggested that there 
was an increased risk of disease following vaccination. Although several 
explanations have been proposed, these widely conflicting results remain 
unexplained. The development of conjugate vaccines has now made this issue 
academic. 
3.6.2.2 Conjugate vaccines 
The limited immunogenicity of PRP vaccine in young infants, and the 
variable levels of protective efficacy reported from clinical trials provided the 
impetus for the development of the next generation of vaccines, the conjugate 
vaccines. 
These vaccines are produced by covalent linkage (conjugation) of PRP to a 
protein carrier molecule. "" This increases the immunogenicity of the vaccine as it 
elicits a T-cell dependent immune response, and results in improved 
immunogenicity. "2 Consequently, there is increased and prolonged antibody 
synthesis, and the production of a booster response. The vaccines have been 
shown to be highly effective in young infants and children with only minor adverse 
effects reported. These include local erythema, tenderness, irritability and 
fever. 421'422 
At the time of writing there are 4 conjugate Hib vaccines and although all 
are similar in some respects, they differ in several others. Their differences include 
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the type of carrier protein used, length of the polysaccharide chain (see table 3.9), 
and level of protective efficacy. 
PRP-diphtheria toxoid conjugate (PRP-D) vaccine 
This vaccine links diphtheria toxoid as the protein carrier to a medium- 
sized length of PRP polysaccharide. '"-23 Immune responses using this vaccine are 
demonstrably better than those seen after immunisation with plain PRP 
polysaccharide vaccine, and an increased response is seen following a second or 
third booster dose'", "', "' Although most children developed high antibody levels, 
the immune response in children 2 to 6 months of age was found to be poor, even 
after three doses. ""' While children aged 9 to 15 months responded less well to the 
vaccine, older children achieved high concentrations of anti-PRP antibody even 
after a single dose. 408"' 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 100 
G 
r, 
3 
0) 
u 
ä 
M 
a 
.b U 
ri 
aý 
a 
Q b 
cu w H 
aý 
U 
w 
b 
U 
cd 
O 
w aý 
U 
U 
Q 
U 
O 
w Lýr 
N 
U 
U 
cd 
bO 
O 
U 
xaa Q 
0 
b 
y 
Q, 
N C3 
ý 
ý" Fly' 
Ü 
NRy. 
0 
ý- 3 0 
OHA bbO ayi 
=L =L 
13 0. p 
pýO 
ÖÖÖ 
ö333 
r- 
Uo 
U 
Ok 
t) U Ei -0 0- 
-; ý 2 Ei Ei -0 
w a+ )U 
aýi V GQ Y 
e. ao 
Ä21C7 BH 
v 
ýaa 
a 
b 
U 
y 
b 
0 
cad 
y 
eý 
aý 
.9 n , ri 
:ru 
Co 
Uy 
.E U 
bil 
N 
äO 
Q 
Chapter 3: Literature review 
In Finland, over 100 000 children received PRP-D vaccine at 3,4,6 and 14 
months of age. The estimated protective efficacy of the vaccine was 89% (95% 
CI=70% to 96%) after 3 doses, and 100% (95% CI=82% to 100%) following the 
fourth booster dose. 436 An efficacy study conducted in the USA by Greenberg et al 
also found the vaccine to be protective. 408 They reported a protective efficacy of 
88% (95% CI=42% to 97%) in children aged 18-59 months of age. 
However, an efficacy trial conducted amongst a group of Native Alaskan 
infants, who are a high risk group, provided conflicting results! " Thirteen of 32 
episodes of invasive disease occurred in children who had been immunised, with 
eight of these having received the full course of three vaccinations at 2,4 and 6 
months of age. Vaccine efficacy in this group of children was estimated to be 35% 
(95% CI= -57 to 73%). The reasons for this difference are yet to be clearly 
defined, but it has been proposed that a higher incidence or earlier development of 
Hib disease in this population, or other undefined factors, may be responsible. 412'423 
Hinfluenzae type b oligosaccharide conjugate (HbOC) vaccine 
HbOC is a PRP oligosaccharide conjugate vaccine whose carrier protein is 
a non-toxic mutant diphtheria toxin which is covalently linked to several short 
oligosaccharide chains of PRP. 24''`2' A three dose course of the vaccine has been 
demonstrated to provide protective concentrations of antibody for a minimum 
period of a year in most young children, with reports in some series of protective 
levels lasting 2-4 years 428,429 
Black et al reporting from Northern California estimated vaccine efficacy 
to be 84% (95% CI=59% to 94%) when infants were vaccinated at 3,5 and 7 
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months of age. "" In this study, only three vaccine failures were identified over a1 
-3 year follow-up period. All of these occurred in children in the period following 
the first vaccine, but prior to the second vaccine. Further evaluation of this group 
of children found protective levels of antibody in 97% one month after the final 
dose of HbOC. This had dropped to 71 % one year after completing the 3 dose 
course, however a fourth dose of vaccine given at 18 months of age produced a 
significant booster response. 
Tudor-Williams et al evaluated HbOC vaccine in a group of British 
infants. "" The vaccine was given in one of two doses, either 2 pg or 10 µg, at 3,5 
and 9 months of age. When reviewed one month after completing the course, 
regardless of the dose administered, 98% of those immunised had protective levels 
of antibody. No further follow-up of these children was conducted. 
An efficacy trial in a group of Native American children also used a three 
dose series, but the children were immunised at 2,4 and 6 months of age and doses 
ranged from 6.5 µg to 15 µg. 429 Evaluation of antibody levels 2 months after the 
first dose found no difference between control and placebo groups. However, 
following second and third doses of the vaccine a booster response was observed, 
and one month after the final dose over 90% of the children had protective 
concentrations of antibody. An observed decline in antibody levels in the months 
following administration of the fmal dose resulted in the authors recommending a 
booster dose at 15-18 months of age. 
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PRP outer membrane protein conjugate (PRP-OMP) vaccine 
This vaccine has medium sized lengths of PRP polysaccharide linked to its 
protein carrier which are outer membrane protein vesicles of a strain of group B 
Neisseria meningitidis. zaa, au PRP-OMP is highly immunogenic and in contrast to 
other Hib conjugate vaccines, a dramatic antibody response is seen in response to 
the first dose, even in infants as young as 2 months of age. 41' Unlike other 
conjugate vaccines a significant booster response is not seen following a second 
dose, and antibody levels decrease significantly in the year following 
immunisation. "' 
Santosham et al evaluated the efficacy of this conjugate vaccine in a group 
of Native American infants who were immunised at 2 and 4 months of age. " 
Using an intention to treat analysis they estimated that the protective efficacy in 
children receiving one or two doses was 95% (95% CI=72% to 99%). A decline in 
antibody levels was seen in the 3-12 month period following the second 
vaccination in the 2 dose regimen, and the authors recommended that a booster 
dose should be given at 12 months of age. Other reports have also recommended 
that a booster dose be given at 12-15 months of age. 431'432 
PRP tetanus toxoid conjugate (PRP-T) vaccine 
Large polysaccharide polymers linked to a tetanus toxoid protein carrier are 
used to produce the PRP-T conjugate vaccine. 1114,423 The vaccine is highly 
immunogenic at all ages, "" and has been reported to be immunogenic in children 
with sickle cell disease and malignancy. 416 
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In 1991 Booy et al reported from Oxford that when PRP-T was 
administered at 2,3 and 4 months of age, concentrations of more than 1.0 µg/m1 
were seen in 91% of children who had received the vaccine one month after the 
third dose. 43 The authors estimated that the protective efficacy of the vaccine was 
95% (95% CI=75% to 100%). Only one vaccine failure was identified in 
immunised children compared to 18 vaccine failures in control children followed 
for 20 months. These results were achieved without the use of a booster dose in 
the second year. 
Recent reports from South America and Africa indicate that PRP-T 
conjugate vaccine is equally immunogenic in young children from developing 
countries. Lagos et al reported an estimated vaccine efficacy of 92% (95% 
CI=65% to 100%) in Chilean children who completed a3 dose schedule at 2,4 and 
6 months. 4' Mulholland et al conducted a double-blind randomised trial in The 
Gambia. 4' Children received PRP-T conjugate vaccine at 2,3 and 4 months. The 
estimated vaccine efficacy in this group of children was 95% (95% CI=67% to 
100%). 
3.6.2.3 Combined vaccines 
A combined vaccine is one which contains two or more vaccines 
administered in a single injection, DTP and MMR are examples of such vaccines 
which are already currently employed 8'4°0 They have demonstrated that combined 
vaccines are acceptable to both health professionals and parents, and can be as safe 
and as effective in preventing disease as their component vaccines. 
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Clinical evaluation of new combination vaccines containing Hib conjugate 
vaccine, such as Hib-DTP, Hib-DTP-IPV and Hib-DTP-HBV-IPV have been 
conducted or will take place. With more and more parenteral vaccines (for 
example acellular pertussis, varicella, meningococcal, pneumococcal and 
respiratory syncitial virus vaccine) on the horizon, the reasons for combining a 
number of these vaccines into a single injection becomes attractive. 
8, "38,139, «1-4" The 
infant and parent will not only have fewer visits and fewer injections, but from the 
public health perspective, a reduction in the number of inoculations would reduce 
the cost of administration, be more practical and contribute to improved vaccine 
uptake. , 447,448 
The administration of Hib conjugate vaccines together with other childhood 
immunisations has been shown to be both safe and effective. Begg and colleagues 
compared the safety and immunogenicity of giving combined PRP-T/DTP and 
HbOC/DTP vaccines with giving the combinations separately at different sites. 
They analysed data from children recruited to previous trials and immunised using 
the standard UK immunisation schedule (at 2,3 and 4 months of age). "' The 
results obtained indicated that protective levels of anti-PRP antibody were attained 
with both types of combined Hib conjugate vaccines and that no significant 
differences in post-vaccination titres were seen between the four different groups. 
They also reported that the combined vaccine did not result in increased adverse 
reactions. Using a randomised controlled trial approach, Jones et al reported 
similar results for a study conducted in a different part of the UK. "' 
Results from these studies and several others worldwide indicate that there 
is a reduction in the anti-PRP antibody response as well as tetanus and pertussis 
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antitoxin responses in combined vaccines containing PRP-T or PRP-D and 
DTP 4 , 435, «4 *46 Reasons for these reduced responses are not known but it has been 
proposed that it may be due to carrier suppression. "' The clinical significance of 
the reduced response to combined vaccines is yet to be determined. 
3.7 PUBLIC HEALTH IMPACT OF Hib CONJUGATE 
VACCINES 
The literature indicates that the use of Hib conjugate vaccines has been 
followed by a rapid decline in morbidity and mortality due to invasive Hib 
infections in all countries where they are used. The final section in this chapter 
will review the published literature on the impact Hib conjugate vaccine has had on 
invasive Hib infections and examine the factors associated with vaccine failures. 
3.7.1 Effect of Hib conjugate vaccine on disease incidence 
Hib conjugate vaccines were incorporated into the primary immunisation 
schedule of the UK and Republic of Ireland in October 1992. Three doses of PRP- 
T conjugate vaccine were to be given at one month intervals starting from the age 
of two months. `50'45' It was also recommended that children aged up to 48 months 
be included in a catch-up programme, which was scheduled to last one year. 
Children aged less than 12 months were to receive 3 doses of the PRP-T conjugate 
vaccine, while those aged between 12 and 48 months would receive a single dose 
of the HbOC conjugate vaccine. In children aged 12 months, coverage of greater 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMI R 1990-1994 107 
Chapter 3: Literature review 
than 90% had been achieved by November 1993.452 Following conclusion of the 
vaccine programme, only PRP-T conjugate vaccine was recommended for use in 
the UK. 
In the PHLS six region laboratory-based study, Hargreaves and colleagues 
assessed the change in incidence of invasive H influenzae disease among children 
aged less than 5 years. "' They reported that incidence rates fell from 26.0 to 2.0 
per 100 000 children between 1990/91 and 1993/94. This represented a 92% 
decrease in incidence during the period of the study. Urwin et al also reported a 
reduction in the incidence of H influenzae meningitis in children aged less than 5 
years in the North East Thames region, from 22.0 per 100 000 in 1991 to 3 per 100 
000 in 1993, the year following the introduction of Hib conjugate vaccine. "' 
In the Republic of Ireland, a similar dramatic decline in incidence was also 
observed. A 90% reduction in disease incidence was seen with approximately 75% 
immunisation coverage. 453 Reports from other European countries indicate that 
comparable reductions in the incidence of invasive Hib disease have occurred 
following the introduction of Hib conjugate vaccines. 
136,454,45 
Vaccination with Hib conjugate vaccines has also resulted in large 
decreases in the incidence of Hib infections in the USA, with reductions of 
between 82% to 95% reported in children aged less than 5 years, 
134,135,217,456.460 Data 
from Canada, "' Australia138 and The Gambia"' also demonstrate an association 
between the decline in the incidence of invasive Hib disease and the introduction of 
Hib conjugate vaccines. 
Notwithstanding the temporal association between introduction of the 
vaccine and the decline in cases of invasive H influenzae disease among young 
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children, it is possible that other factors may be responsible. Indeed, the incidence 
of invasive Hib disease has been shown to vary both seasonally and 
interannually. 138,279'292 The results of a time-series analyses carried out in Australia 
suggest that these factors cannot account for the dramatic decline observed. "' 
Furthermore, the vaccination effect has been seen consistently in each country 
where Hib conjugate vaccine has been introduced. This evidence provides further 
support that the introduction of the vaccine was responsible for the rapid reduction 
in the incidence of invasive Hib disease. 
The decline in incidence seen following the introduction of the vaccine has 
been observed not only in immunised children but also in unimmunised 
children. 
134,135,287,460 This phenomenon, known as the herd immune effect, occurs as 
a result of the presence of immune individuals in the population providing indirect 
protection to non-immune individuals. "' It has been suggested that Hib conjugate 
vaccines reduce nasopharyngeal carriage of Hib among vaccinated children and 
that this provides some protection for unvaccinated children by reducing 
transmission of the organism or delaying its acquisition. """" This then leads to 
greater than expected reductions in the incidence of invasive Hib disease. 
Man is the only host for H influenzae type b and consequently the 
worldwide use of Hib conjugate vaccines has the potential to eliminate the 
pathogen and its resultant diseases. However, not all countries currently employ 
Hib conjugate vaccines. For example, in the WHO European region, only 14 of 47 
(30%) member countries (as of 1995) include Hib in their immunisation 
programmes, 464 These countries are mainly from Northern Europe and they have 
different immunisation programmes and schedules. With the increased movement 
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across international boundaries and the likelihood of the transfer of the medical 
care of susceptible children, knowledge regarding the interchangeability of Hib 
conjugate vaccines is essential. Currently available data from studies conducted in 
the United States46"a6' and the United Kingdom4" suggest that PRP-T and PRP- 
OMP; PRP-OMP and HbOC; PRP-T and HbOC; and PRP-OMP and PRP-D can 
be interchanged with each other without compromising safety, immunogenicity or 
efficacy. It has been demonstrated that giving different combinations of Hib 
conjugate vaccines may produce a better immune response than if a single Hib 
conjugate vaccine had been used for all three vaccinations. "", ' Small numbers of 
children recruited for the studies, the use of different immunisation schedules, the 
exploration of only a few of the possible schedules and the lack of data on long- 
term protection and the interchangeability of combined vaccines limits any 
conclusions which may be drawn. 
Despite these and other concerns, such as the cost of conjugate vaccines, "' 
472 and debate as to whether Hib conjugate vaccines should be introduced into the 
EPI (Expanded Programme on Immunisation) programme,, " the future elimination 
of Hib remains a possibility. The WHO and the Children's Vaccine Initiative 
(CVI) have recommended that Hib conjugate vaccines be included in infant 
immunisation programmes, and are currently considering how best to incorporate 
these vaccines into the EPI programme. "' 
3.7.2 Hib conjugate vaccine failures 
Despite the success of Hib conjugate vaccines, vaccine failures have 
occurred and the reasons for this remain ambiguous. Holmes and Granoff 
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reviewed published serologic, immunologic and genetic data of children who 
developed culture-proven invasive Hib disease 14 or more days after immunisation 
with Hib conjugate vaccine. "' Their study only looked at children aged 15 months 
or more at the time of immunisation. They found that some of these children had a 
deficiency of IgG2 and/or IgM, and were thought to represent delayed maturation 
of the immune system. These results were however only seen in 40% of vaccine 
failures, the reasons for the remainder remain unclear. 
In the UK Booy et al have recently reported the findings of a national 
BPSU study into Hib conjugate vaccine failures from 1992-1995. "6 They reported 
89 vaccine failures, of these they identified 43 true vaccine failures (TVF) and 46 
apparent vaccine failures (AVF). A true vaccine failure was defined as invasive 
Hib disease occurring more than 2 weeks after a single dose of vaccine (PRP-T or 
HbOC) given to an infant of more than 1 year or more than 1 week after at least 
two doses had been given (at least I month apart) to a child younger than 1 year. 476 
The majority of their TVF cases were either due to meningitis (26 of 43,60%) or 
epiglottitis (10 of 43,23%). 
Frasch et al reported Hib conjugate vaccine failures following 
immunisation with PRP-D in 26 children in the United States over a one year 
period. "' All of these children were aged less than 5 years and meningitis was the 
most common diagnosis (11 of 18,61%), there was only one case of epiglottitis. 
An Australian report on one year's experience with Hib conjugate vaccine usage, 
also found a lack of epiglottitis cases in the 9 vaccine failures identified following 
immunisation with one or more doses of either PRP-T, PRP-D, HbOC or PRP- 
OMP. 478 Among their 9 cases were 5 cases of meningitis and 1 case of epiglottitis. 
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There were no reported vaccine failures following immunisation with PRP-T 
conjugate vaccine. Vadheim et al reported on 29 vaccine failures following 
immunisation with one or more doses of HbOC or PRP-OMP conjugate vaccines 
over a two year period. "' They found that 21 of these cases manifested as 
meningitis and none as epiglottitis. 
The lack of epiglottitis cases seen in most series may be attributed to the 
herd immune effect with vaccinated younger children protecting unvaccinated 
older children. In the UK series the diagnostic distribution has changed with 
proportionally more cases of epiglottitis identified"` It is however difficult to 
draw any conclusions from this series with respect to children as ages were not 
given. 
3.8 Summary of chapter 3 
This review of the literature has shown that the current British surveillance 
systems reliance on voluntary reporting of cases of H inj7uenzae meningitis leads 
to underreporting of the disease. Reliance on routine data sources may therefore 
underestimate the clinical, public health and economic impact of Hib disease. 
Disease incidence and risk factors vary between and within countries, but 
are highest in `developing' countries and among the native populations of the 
United States, Canada, Australia and Israel. This may reflect differing study 
methodologies or clinical practices, access to healthcare, socioeconomic factors or 
other influences. 
Deprivation has an important effect on health, and the most deprived appear 
to suffer relatively more from ill-health than the more affluent members of the 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 112 
Chapter 3: Literature review 
population. Children are one of the most at risk groups, and there is a plethora of 
British data which has examined the issue of deprivation in relation to 
immunisation uptake. Given that prior to the introduction of Hib conjugate 
vaccines in the UK that H influenzae was one of the leading causes of meningitis in 
young children, it is surprising that there is little data on its relationship with 
deprivation. Furthermore, data is lacking on the incidence of the disease among 
the ethnic minority population in the UK. 
Hib conjugate vaccines have resulted in a dramatic reduction in the 
incidence of disease in all countries where they have been introduced. Consequent 
to their success conjugate vaccines are being developed for a number of other 
diseases and the WHO is planning to incorporate Hib conjugate vaccines into the 
EPI programme. Thus eradication of this disease is potentially possible, however 
vaccine failures have been identified and the long-term effectiveness and safety of 
these vaccines is yet to be determined. This means that continued surveillance to 
identify at risk populations remains important. 
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METHODOLOGY 
In October 1992, a descriptive study of deprivation and other 
socioeconomic risk factors associated with invasive H influenzae disease in the 
West Midlands Health Region (WMHR) was undertaken as Hib conjugate vaccine 
was introduced into the UK primary immunisation schedule. 
To identify cases a comprehensive surveillance system was established by 
the researcher which involved retrospective and prospective identification of cases 
and was planned to involve all hospital laboratories and consultants in 
communicable disease control (CsCDC) within the region. 
The surveillance effort was directed at identifying all children aged less 
than 5 years with invasive H influenzae during a four year period. This would 
provide a comprehensive register of cases of invasive H influenzae infections 
which could be used to determine disease incidence, provide data for 
epidemiological research, and measure the impact of Hib conjugate vaccine. 
This chapter provides an overview of the conduct of the study from the 
initial literature search through to methods of data collection and analysis. 
4.1 SYSTEMATIC SEARCH OF THE LITERATURE 
The literature search was carried out with the aim of identifying, retrieving 
and critically reviewing the available published literature reporting original data or 
reviews describing the association between invasive H influenzae disease and 
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markers of poor socioeconomic circumstance. At the same time, a similar search 
was conducted for the demographic, epidemiologic, environmental and public 
health issues surrounding invasive H influenzae disease in children aged 0-59 
months. 
In order to conduct a comprehensive literature search, several keywords 
(table 4.1) were used: 
Table 4.1: Keywords used in the systematic search of the literature for invasive 
Haemophilus influenzae disease 
Antibiotic resistance Infectious diseases 
Cellulitis Meningitis 
Chemoprophylaxis Neonatal sepsis 
Conjugate vaccines Osteomyelitis 
Communicable diseases Pneumonia 
Co-primary disease Race 
Deprivation Registers 
Dexamethasone Risk factors 
Epidemiology Secondary disease 
Epiglottitis Sensorineural hearing loss 
Ethnic group Septic arthritis 
Haemophilus influenzae Septicaemia 
Health inequalities Socioeconomic status 
Immunisation Vaccines 
A number of computerised databases were consulted and these were: 
MEDLINE°'9: This database contains citations to the world-wide 
literature on biomedicine, including research, clinical practice, 
management and policy. It is produced by the National Library of 
Medicine in the United States and over 70 per cent of the 
references are from English language source materials. The 
literature was searched for articles published in English on H 
influenzae in children from 1966-1997. 
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ASSIA (Applied Social Science Index and Abstracts)480: 
References to and abstracts of articles in more than 300 academic 
journals in the applied and social sciences from 1987 are contained 
in this database. There were 79 references to infectious diseases 
and 96 for communicable diseases. When combined with 
deprivation (430 references), only one citation was found. 
Combining infectious diseases with risk factors (2,435 citations) 
produced 7 references. When infectious diseases and 
communicable diseases were each linked with health inequalities 
and socioeconomic status, no citations were found. 
ASLIB (Association of Special Libraries and Information 
Bureaux) INDEX TO THESES`': This database provides 
details of theses accepted by universities in Great Britain and 
Ireland from 1970. Using H influenzae as the keyword 21 theses 
were identified from 1975 to 1996 at the MSc, MD and PhD 
levels. The most recent of these was submitted in 1993, however 
all were laboratory-based and none examined the epidemiology of 
invasive H influenzae diseases. 
Citations thought to be appropriate were retrieved and reviewed. The 
reference lists of articles obtained by this method were then examined and 
additional appropriate literature identified. The scope of the search for literature 
was further widened by requesting colleagues who had published work in the areas 
of epidemiology, social medicine or communicable diseases to identify published 
or unpublished work on health inequalities and invasive H influenzae. 
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4.2 STUDY DESIGN 
Social inequalities in health are difficult to study and increasingly 
researchers are using "small area" census-based socioeconomic characteristics of 
residential areas to address the problem of inadequate socioeconomic information 
in individual health records. ", ", 65 Studies which use this geographic approach are 
called ecological studies. In these studies the unit of analysis is an aggregate of 
individuals within a defined geographic location. "' An "ecological fallacy" occurs 
when inappropriate conclusions are made on the basis of ecological data. "' This is 
because an association observed between variables at the group level is not 
necessarily representative of any particular individual or of all individuals in that 
group. 
There are also problems in carrying out individual-level analyses as access 
to individual-level data is required. This access may be denied on the grounds of 
confidentiality. Furthermore, it has been argued that individual-level analysis may 
be less appropriate for transmissible infectious disease epidemiology in which 
infection risk depends on the prevalence of disease in a community. 483,484 
Ecological analyses are thought to be more appropriate for identifying 
community level determinants of infectious disease rates and for studying the 
distribution of infectious diseases in a population. "' Transmission of infection 
involves direct and indirect contact between individuals and groups. Analysis of 
individuals is necessary but insufficient on its own to define communicable disease 
distribution in a population. 08a, 
186 
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It has been stated that the prime justification for the ecological approach is 
to study health in an environmental context. 486 The aim is to understand how the 
environment affects the health of persons and groups through a number of factors. 
It is believed that measures of individual attributes cannot account for these 
processes. Families, communities, cultures and other social, political and 
economic phenomena may affect health in ways not explicable by studies that 
focus exclusively on individuals. ""' 
Susser has stated that ecological studies are obligate when they are the only 
choice available either because of the question asked (as in testing differences 
between groups and discovering group effects), or because of a concern with 
dependent happenings (as in transactions involving more than one individual), or 
merely because of the lack of individual data. '" All of these reasons are relevant to 
this study. 
This study is therefore a descriptive ecological cross-sectional study with 
cases of invasive H influenzae disease as the numerator and 1991 census 
population data as the denominator. 
It is designed to examine the relationship between invasive H influenzae 
disease and material deprivation in the WMHR between 1 October 1990 and 30 
September 1994. 
In addition to analysing the relationship between disease and deprivation, 
the study describes the epidemiology of invasive H influenzae disease in children 
aged less than 5 years in the WMHR in the two year period before (October 1990 - 
September 1992), and immediately following (October 1992 - September 1994), 
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the introduction of Hib conjugate vaccines into the primary immunisation schedule 
of the United Kingdom. 
Although hypotheses are not being tested in this study, the data collected 
should provide information for the development of hypotheses and pointers for 
further research. 
The study was originally designed as a case-control study which would also 
have investigated the role of stressful life events in the onset of invasive H 
influenzae disease in children. Despite designing, testing and piloting a 
questionnaire, the original study design was discarded because of a number of 
reasons. These included insufficient funding, the length of time taken to obtain 
permission from the various research ethics committees and the increased 
probability of recall bias, especially on the part of control parents due to the long 
time-lag in gathering data. It was also anticipated that the introduction of Hib 
conjugate vaccine would greatly reduce the numbers in the post-conjugate vaccine 
period making a case-control study unfeasible. 
4.2.1 Why invasive H influenzae disease ? 
Initially, both invasive meningococcal and pneumococcal diseases were 
considered as alternatives. However, because of anticipated problems with disease 
definition and the imminent introduction of an effective vaccine for invasive Hib 
disease, it was decided to select invasive H influenzae diseases over the other two. 
Some other factors which favoured the selection of invasive H influenzae 
diseases for this study were the defined susceptible population (children aged less 
than 5 years), and the opportunity to determine the epidemiology of both 
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meningitic and non-meningitic diseases. Furthermore, previous British studies had 
not reported environmental risk factors for invasive H influenzae disease. Most of 
them concentrated on other epidemiological aspects. In addition, this study could 
provide a model for the accurate determination of baseline incidence rates and 
other epidemiological changes which may be associated with the introduction of 
pneumococcal, meningococcal or other vaccines. 
The WMHR was selected because of the researcher's academic base, and 
its fortuitous exclusion from the PHLS six region study of invasive H influenzae 
disease, which was carried out during the same time period as this study. 
4.3 ETHICAL CONSIDERATIONS 
This will be considered in two parts, ethics committees and the issue of 
confidentiality. 
4.3.1 Ethics committees 
In the NHS ethical issues relating to medical research are the responsibility 
of district and hospital research ethics committees. Their purpose is to maintain 
high ethical standards in the conduct of medical research. ""' Permission to access 
the medical records of children identified as eligible for inclusion in the study was 
sought from the research ethics committees in each of the 20 districts prior to 
commencing the study. 
Letters were sent to chairpersons, or secretaries, in each of the districts 
requesting permission to carry out the study. Application forms were received, 
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completed and returned together with the protocol and any other documents which 
were requested. Several ethics committees invited the researcher to explain the 
purpose of the study, answer questions about the protocol, and to clarify aspects of 
the data collecting instruments and draft letters. Permission was eventually 
obtained from all of the districts, but took almost a year. 
4.3.2 Confidentiality and anonymity 
All correspondence, data entry and data storage were carried out at the 
University of Warwick, which is registered under the Data Protection Act 1984. 
Once the child's medical notes had been traced and data extracted from 
them onto a proforma, the child was given a non-unique code number using a 
modification of the Soundex Code' (see section 4.7.2 for more details). 
The data obtained were entered onto a computer directly from the proforma 
and stored on the hard disk, backup copies were made on floppy disks. The 
computer was situated in a room with a number lock. A password was needed to 
access the data on the computer, and this was known only to the researcher. The 
floppy disks were kept under lock and key in a separate room. 
At the end of the study, any data which could be used to identify the child 
or their family will be destroyed. Results of the study will be provided in 
aggregated form whereby it will not be possible to identify individual children or 
their families. 
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4.4 STUDY AREA 
This study was carried out in the WMHR from October 1990 to September 
1994. The WMHR comprised 20 health districts in 1991489 (figure 4.1), and these 
have been retained for the analysis of data. Table 4.2 illustrates how the present 
(1997) 13 health authorities arose following changes made to district boundaries 
over the years. 
The WMHR occupies a central geographic location within England, 
covering an area of 13,004 square kilometres, and has a population density of 406 
persons per square kilometre (compared to 240 per square kilometre for the UK). "o 
Nearly 9% of households in the West Midlands contain 5 or more people, the 
largest proportion in any of the English regions. '" 
The region contains England's second largest city, Birmingham, as well as 
cities and towns such as Coventry, Stoke-on-Trent, Wolverhampton, Stafford and 
Walsall. Residents of the region live within a wide range of socioeconomic 
conditions, from densely populated deprived inner-city areas to affluent residential 
districts and sparsely populated rural areas. A number of regional socioeconomic 
indicators are shown in table 4.3. 
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Table 4.3: Selected socioeconomic variables*: WMHR compared to England and the 
United Kingdom 
WMHR England UK 
Proportion of workforce unemployed (spring 1993) 11.7 10.3 10.3 
Proportion of claimants unemployed for over 3 and 8.6 7.4 7.4 
up to 5 years (1994) 
Total population change (1981-1992) 1.8% 3.3% 2.9% 
Proportion of male employees earning under £200 26.0 22.4 23.4 
gross per week (1993) 
Redundancy rates per 1,000 employees (1992) 16.1 15.6 15.11 
Day nursery places per 1,000 population aged <5 40.4 35.7 32.8 
years (1992) 
Household disposable income (£ per head, 1991) 93.5 101.0 100.0 
Proportion of population in ethnic minority group 8.2 6.2 5.5t 
(1991) 
Proportion of population aged <5 years (1991) 6.9 6.7 6.7 
Proportion of household income from social security 15.1 12.4 13.1 
benefits (1992) 
Average gross weekly income per household (£, 304.2 350.5 342.9 
1992) 
Lone parent households with dependent children as a 10.1 8.9 9.1t 
proportion of all families (1991-92) 
Household car ownership (1992): no car 29% 31% 33%t 
one car 47% 45% 44%t 
two or more 24% 24% 23%t 
Proportion of dwellings owner-occupied (1991) 68 69 68 
Social class of economically active (1993): 
professional (class I) 4.6% 5.4% 5.4% 
unskilled (class V) 6.1% 5.6% 5.8% 
Adapted from reference 490 
t Data relates to Great Britain and not the United Kingdom 
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There are 10,903 enumeration districts in the WMHR and they are 
distributed amongst the Health Authorities as shown in table 4.4. Almost half 
(47%) of all EDs in the region may be classified as deprived and great variation in 
the distribution by health authority can be seen. A higher proportion of deprived 
EDs are seen in urban/inner city areas such as Birmingham, Wolverhampton and 
Sandwell, whereas mainly rural areas tend to have fewer deprived EDs, for 
instance, Hereford and South Warwickshire. The WMHR contains some of the 
most deprived (Sandwell and Birmingham) as well as some of the most affluent 
districts (Solihull, North Worcestershire, Warwickshire and South Staffordshire) in 
England 491 
Table 4.4: Health Authorities in the W1V1HR ranked by proportion of enumeration 
districts classified as deprived by the Townsend material deprivation score using 1991 
census data 
Health Authority' Number of Number % 
enumeration classified as classified as 
districts deprived' deprived' 
West Birmingham 413 322 78.0 
Sandwell 562 433 77.0 
East Birmingham 389 282 72.5 
Wolverhampton 498 359 72.1 
South Birmingham 829 566 68.3 
Walsall 472 306 64.8 
Coventry 601 337 56.1 
North Staffordshire 939 453 48.2 
Dudley 601 279 46.4 
North Birmingham 318 138 43.4 
North East Warwickshire 588 210 35.7 
Bromsgrove & Redditch 307 103 33.6 
Shropshire 970 298 30.7 
South East Staffordshire 542 165 30.4 
Solihull 380 115 30.3 
Mid Staffordshire 637 188 29.5 
Kidderminster 219 61 27.9 
Hereford 489 120 24.5 
Worcester 602 142 23.6 
South Warwickshire 547 123 22.5 
Total 10 903 5 000 45.9 
Data refers to Health Authorities and enumeration districts as at October 1992 
t This refers to enumeration districts with a Townsend deprivation score of greater than zero 
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The West Midlands population of approximately 5 million is unevenly 
distributed, with approximately 50% of the population living in the urban 
conurbation of the West Midlands Metropolitan County (WMMC). 490 This has 
2,927 people per square kilometre and is the second most populous county in 
England and Wales after Greater London. '" In contrast, other areas of the WMHR, 
such as South Shropshire and Leominster (with 38 and 43 people per square 
kilometre respectively) are amongst the least populated areas in the country. "" 
Data from the 1991 Census shows that although the population of the 
region is predominantly white, it is ethnically diverse, with one in 12 people 
belonging to an ethnic minority group (only the South East has a higher 
proportion). '" A high proportion of these are from the South Asian (people from 
India, Pakistan and Bangladesh) ethnic group (table 4.5). 
Table 4.5: Population characteristics of the WMHR compared to England and Wales 
(1991) 
England & WaleS492 wMHR 9 193 
(all ages) (all ages) (0-4 years) 
Total persons* 49 860 000 5 150 000 350 000 
Ethnic group (%) 
White 94.1 91.8 86.2 
South Asian 2.9 5.4 8.6 
Black 1.8 2.0 3.2 
Others 1.2 0.8 2.0 
* to the nearest thousand 
Adapted from Owen.. 
Adapted from the West Midlands Regional Information Unit"' 
An estimated 350,000 children aged 0-4 years of age are resident in the 
region, '" and in 1992 it was estimated that the West Midlands regional annual live 
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birth rate of 66 per 1,000 women in all age groups was amongst the highest in the 
"0 country. 
The regional immunisation uptake rates were comparable to those seen 
nationally. COVER (cover of vaccination evaluated rapidly) surveillance data 
indicated that in November 1993 uptake of diphtheria and pertussis immunisations 
in children aged 12 months, was 94% and 92% respectively in the WMHR, while 
measles coverage was 92% for the same period in children aged 24 months. 'ao Hib 
uptake was reported for the first time in November 1993 by the COVER scheme 340 
The uptake of the newly introduced vaccine was also reported to be high, with 
overall coverage in the UK regions reaching 90% (range 86% to 95%) for 3 doses 
in children aged 12 months. In the WMHR the estimated average regional 
immunisation coverage for this period was 91% (79% to 97%). 340 
Variation in the provision of acute paediatric care exists within the region. 
When the study commenced there were twenty two hospitals providing acute 
paediatric care, with the majority having hospital-based laboratories. All districts 
with the exception of Solihull, had at least one hospital providing acute paediatric 
care within it's boundaries. Children presenting at Solihull Hospital were usually 
referred to the nearby Birmingham Heartlands hospital. 
Children with uncomplicated meningitis and systemic diseases are usually 
managed in the hospital of admission. Children with complications, or those 
requiring diagnostic techniques which are unavailable at the admitting hospital 
may be referred to one of two centres, either Birmingham Children's Hospital or 
North Staffordshire Hospital. 
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4.5 OPERATIONAL DEFINITIONS 
Systemic H influenzae disease primarily affects young children, with up to 
71% of cases seen in children aged 24 months or less in European countries. 
"' 209,231 
Furthermore, the literature indicates that after the age of 5 years, the incidence of H 
influenzae disease decreases dramatically. 112,232,275 The study was therefore 
restricted to collecting data on children from the age of 0 to 59 months. 
Previous research has shown that where serotyping is performed, nearly all 
cases of invasive H influenzae disease in young children are due to organisms of 
serotype b, 
121,126,233,270 Serotyping, however is not routinely performed by many 
laboratories in the region, nor are all specimens sent to the Haemophilus reference 
laboratory for typing and antibiotic sensitivity testing. The case definition was 
therefore not restricted to serotype b or those cases where serotyping had been 
carried out. 
4.5.1 CASE DEFINITION 
4.5.1.1 Primary invasive H inf uenzae disease 
This study will consider primary cases of invasive H influenzae disease, 
and these are defined as an illness in which H influenzae was isolated from either 
CSF or blood culture in children who are not known to have had direct exposure to 
another person with an invasive H influenzae infection! "-"a If onset of illness 
occurs in children from the same household or day-care facility within 24 hours of 
an index case, these will be defined as co-primary cases. '/' 
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Secondary cases of invasive H influenzae disease have been defined as 
those in which disease occurs 1 to 30 days following exposure to a primary case in 
the same household or day-care facility. '" In the UK secondary cases are 
uncommon, 141,142,197 in North America and Europe they account for less than 2% of 
invasive H influenzae disease. ' As the number of cases of secondary disease are 
expected to be small and because of the importance of defining risk factors for 
primary invasive H influenzae disease, children with secondary disease will be 
excluded from the study. 
It was assumed that invasive H influenzae infections were serious diseases 
which would require hospitalisation. Children with H influenzae were eligible for 
inclusion in the study if there was clinical and laboratory evidence of infection, and 
if they fulfilled all of the following criteria: 
- aged less than 5 years at the time of admission 
- admitted to a hospital within the West Midlands Health Region 
- date of onset between 1 October 1990 and 30 September 1994 
The date of hospital admission was used as a proxy for the date of disease 
onset. Children who died prior to admission were included if a post-mortem 
examination was conducted in a hospital within the region, and if post-mortem 
isolates yielded H influenzae, and the recorded date of death was within the time- 
frame of the study. Children discharged and readmitted within a 30 day period 
were only counted once. 
Children initially admitted to a hospital within the region, and then 
transferred outside the region were included in the study if cultures obtained prior 
to transfer had subsequently proved to be positive. 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 130 
Chapter 4: Methodology 
Excluded from the study were: 
- children from the region admitted to hospitals outside the region 
- diagnoses based solely on isolation of H influenzae antigen 
- patients in whom the organism had been isolated from a non-sterile site 
- children whose cultures were taken outside the study period 
- secondary cases of invasive H influenzae disease 
- any medical notes not obtained before June 1st 1995 
The database containing all cases of invasive H influenzae disease eligible 
for this study was known as the West Midlands H influenzae case register 
(HICARE). 
4.5.2 CLINICAL FEATURES 
4.5.2.1 Spectrum of disease 
Whenever possible the primary site of infection was identified, but it was 
recognised that a number of children would not have an identifiable focus, and that 
others might have more than one possible diagnosis. In addition, it is 
acknowledged that retrospective ascertainment from medical records makes a 
definitive diagnosis difficult in some children. 
Table 4.6 contains the definitions used for this study of the most commonly 
encountered disease syndromes. All other diagnoses were based on a positive 
blood culture together with clinical signs and symptoms compatible with a specific 
disease syndrome. 
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Table 4.6: Definition of clinical syndromes used for the identification and hierarchical 
classification of cases of invasive Haemophilus influenzae disease on the HICARE 
register: WMHR 1990-1994 
Clinical syndrome HICARE definition 
Meningitis Clinical findings compatible with a diagnosis of meningitis 
together with one or more of the following: H influenzae isolated 
from the CSF, or characteristic cellular and/or biochemical 
changes in the CSF together with a positive blood culture 
Epiglottitis Diagnosed on the basis of a positive blood culture, with relevant 
clinical history and clinical features. 
Pneumonia Defined by a positive blood culture together with positive clinical 
chest findings, radiological signs, or both. 
Cellulitis A positive blood culture together with localised acute 
inflammation of the skin. 
Septic arthritis Pain and swelling around a joint together with culture of 
Haemophilus influenzae from venous blood. 
Osteomyelitis Localised bone tenderness, together with local inflammation and a 
blood culture which grows Haemophilus influenzae. 
Bacteraemia A positive blood culture without focal signs. 
Where more than one invasive H influenzae disease entity was present in an 
individual, a hierarchical order of disease was established following the method of 
Broadhurst et al. "' In order for each case to be counted only once, a diagnosis of 
meningitis took precedence over any other diagnoses, next was epiglottitis and so 
forth (see table 4.6). 
4.5.2.2 Hearing loss and other sequelae 
This was assessed from the hospital records and was based on routine 
paediatric follow-up as indicated in the medical notes. No attempt was made to 
contact community paediatricians to determine the results of developmental or 
hearing tests. 
A diagnosis of SNHL was accepted only if the results of a hearing test, or a 
letter from an audiologist, Senior Clinical Medical Officer (SCMO) or other person 
responsible for carrying out hearing tests were present in the medical notes. 
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Other neurological sequelae were defined as neurological dysfunction 
secondary to invasive H influenzae disease if they were recorded in the medical 
notes and present at discharge, or identified during follow-up. 
It is acknowledged that sequelae, especially long-term sequelae such as 
behavioural problems and intellectual disorders, cannot be accurately determined 
from a retrospective perusal of medical notes. 
4.5.2.3 Clinical and laboratory definitions 
The various definitions used are shown below in table 4.7. 
Table 4.7: Definitions used for abstracting data from case notes of invasive Haemophilus 
influenzae disease: HICARE, WMHR 1990-1994 
HICARE definition 
Antibiotic resistance As documented in the medical notes or laboratory records. 
Antibiotic therapy The initial parenteral antibiotic(s) received by the child on 
admission to hospital were recorded. 
Chemoprophylaxis Documented evidence that the case child, or any contacts, had 
been prescribed chemoprophylaxis was sought from the 
medical notes. 
Chloramphenicol Children with Haemophilus influenzae meningitis in whom at 
monitoring least two recorded plasma chloramphenicol measurement 
were found in their medical notes. 
Dexamethasone Medical notes were examined to determine whether parenteral 
dexamethasone had been given following admission for 
Haemophilus influenzae meningitis. Children were divided 
into two groups, those who received dexamethasone and those 
who did not receive dexamethasone. 
Duration of illness Children were divided into three groups according to length of 
duration of illness before admission to hospital as ascertained 
from the case notes. These were short duration (5.24 hours), 
intermediate (>24 hours but <48 hours), and long (>48 hours). 
Where the sample size was small, these were collapsed into 
two groups. 
Pre-admission antibiotics This was defined as documented evidence that the child had 
received oral or parenteral antibiotics within one week of 
admission to hospital for Haemophilus influenzae meningitis. 
Serotype As documented in the notes or laboratory records. 
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4.5.3 INDIVIDUAL RISK FACTORS 
4.5.3.1 Age 
Age on admission was defined as the number of completed months at 
which the child was admitted to hospital for an episode of invasive H influenzae 
disease. This was obtained by subtracting the date of birth from the date of 
admission. For many analyses the ages were classified into 5 groups, namely 0-11 
months; 12-23 months; 24-35 months; 36-47 months and 48-59 months. Other 
groups were used where appropriate to provide comparisons with other studies. 
4.5.3.2 Gender 
This was specified as male or female. 
4.5.3.3 Ethnic group 
As this study is retrospective, it is difficult to determine the ethnicity of 
cases. The children were therefore placed into one of two groups using their 
surname and forenames. One group was defined as South Asian (that is, children 
deemed to originate from the Indian sub-continent countries of India, Bangladesh 
and Pakistan) and the other as non-South Asian. This method of defining ethnicity 
retrospectively has been used previously by several researchers, 3sa, 3sý, a9s and the 
categories used in this study are compatible with 1991 census data. 496 
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4.5.3.4 Low birthweight 
This was defined as a birthweight of less than 2500 grams. 300 Where 
birthweight had been recorded in pounds and ounces it was converted to grams 
using the formula 2.2 pounds = 1,000 grams. 
4.5.3.5 Nutritional status 
Weight on admission for each child was evaluated using Child Growth 
Foundation weight charts appropriate for the gender of the child. 
497'498 Children 
found to be below the 3' centile for age were classified as being underweight for 
age acv 
4.5.3.6 Anaemia 
The WHO has recommended that a haemoglobin (Hb) concentration of less 
than 11 g/dl be used to identify anaemia in children aged between 6 months to 6 
years. '"' This was the definition used in this study. 
4.5.3.7 Chronic illness 
Following the method of Fogarty et al, children with illnesses which had an 
allergic component (e. g. asthma and eczema), and those with illnesses associated 
with reduced immunity (e. g. leukaemia and Downs syndrome) were considered to 
have a chronic illness. 2° 
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4.5.4 FAMILY AND COMMUNITY RISK FACTORS 
4.5.4.1 Day-care attendance 
This was defined as any child care arrangement documented in the medical 
notes which indicated that the child was cared for inside or outside the home by a 
non-parent. The retrospective nature of the study precluded any consideration of 
the number of children cared for or the number of hours the child attended. 
4.5.5 ENVIRONMENTAL RISK FACTORS 
4.5.5.1 Immunisation status 
Medical records were examined to determine the immunisation status of all 
the cases. Age-appropriate uptake was calculated according to the expected 
completion of the immunisation schedule (table 4.8). 
Table 4.8: Recommended UK primary immunisation schedule for infants and 
children 
Age Vaccine 
2 months 1st dose Diphtheria, Tetanus, Pertussis (DTP) vaccine 
1st dose H influenzae type b conjugate (Hib) vaccine 
1st dose Oral Polio Vaccine (OPV) 
3 months 2nd dose DTPIHib/OPV 
4 months 3rd dose DTP/Hib/OPV 
12-15 months 1st dose Measles, Mumps, Rubella (MMR) vaccine 
A child was considered to have been completely immunised if they had 
received their three scheduled primary doses by the age of six months, and 
MMR/measles by 15 months of age. If at the time of hospital admission the child 
had not received the appropriate number of immunisations more than one month 
after the due date, the child was considered to be incompletely immunised for age. 
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A child was considered to have received a vaccine if specific 
immunisations had been noted in their records, or if their immunisation status had 
been documented as "up-to-date". Where immunisation status was not documented 
in the notes the child was excluded from this part of the data analysis. 
Only children identified in the post-Hib conjugate vaccine era had their 
immunisation status verified in order to determine primary immunisation status, as 
well as, Hib immunisation status. This was achieved by contacting the appropriate 
district immunisation co-ordinator or public health physician. The information 
obtained was then utilised to determine which children could be regarded as 
'vaccine failures' following the British Paediatric Surveillance Unit (BPSU) 
definition, and the accuracy of hospital recorded primary immunisation histories 
compared to that found on the child health computers. 
Vaccine failures 
The BPSU have classified vaccine failures into two groups, true vaccine 
failures and apparent vaccine failures. Invasive Hib disease occurring in a child 
following three doses of vaccine is defined as a true vaccine failure. 476 True 
vaccine failures are also said to occur if invasive Hib disease is seen more than one 
week after two doses of vaccine are given to a child aged up to 12 months; or if 
Hib disease occurs in a child aged more than 12 months two weeks or more after 
receiving a single dose of vaccine. Apparent vaccine failures also occur following 
vaccination but present before protection can be expected to develop. Therefore, 
children aged less than 12 months who develop invasive disease after a single 
vaccination, or within a week of receiving a second vaccination, are termed 
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apparent vaccine failures. 476 Children aged over 12 months of age who present 
with invasive disease within two weeks of a single dose of vaccine, are also termed 
apparent vaccine failures. 
4.5.5.2 Urban/rural areas 
In order to determine the `urbanity' or `rurality' of areas, the districts 
comprising the WMHR were divided into two groups. Those which make up the 
WMMC were considered to be 'mainly urban' areas, while all other districts were 
classified as'mainly rural' areas. The districts comprising the WMMC are 
Coventry, Dudley, Solihull, Sandwell, Walsall, Wolverhampton and the 
Birmingham districts (see figure 4.1). It is recognised that this represents a crude 
classification and that within a district classified as 'mainly rural' a substantial 
percentage of the population may live in areas which could be classified as urban, 
and vice versa. For instance, North Staffordshire is one of the districts which has 
been placed in the 'mainly rural' category yet contains Stoke-on-Trent, a 
conurbation with a population of more than 250,000. 
4.5.5.3 Socioeconomic census variables 
The relationship between invasive H influenzae disease and a number of 
census variables was explored using univariate analysis to identify possible 
associations between incidence rates for invasive H influenzae disease and different 
levels of deprivation and social and economic disadvantage. The census variables 
selected for analysis are listed and defined in table 4.9. 
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Table 4.9: Sociodemographic 1991 census variables selected for the analysis of invasive 
H inf uenzae disease, Wivil R 1990-1994 
Socioeconomic Definition 
variable 
All movers Proportion of residents with a different address one year before 
the census 
Child density Density of children aged <5 years per km2 
Children <5 years Proportion of the total population less than 5 years of age 
Deprivation Townsend material deprivation score 
Local movers Proportion of residents with a different address one year before 
the census who moved between districts but within counties 
Lone parent Proportion of lone parent households 
No car* Proportion of households without a car 
Not owner- Proportion of households not owner-occupied 
occupied* 
Overcrowded Proportion of all households with more than one person per room 
households* 
Unemployed* Proportion of economically active people who are unemployed 
Components of Townsend material deprivation score 
They were selected as independent variables as a number of them are 
recognised markers of socioeconomic disadvantage or deprivation. 23,74 Previous 
epidemiologic studies have also shown the majority to be either risk factors for 
invasive H influenzae disease or to be associated with poor immunisation 
uptake. 106'1u, ias. 151' e, sso, 357 
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4.6 CASE ASCERTAINMENT 
Surveillance has been defined as the systematic collection, collation, and 
analysis of data and dissemination of the results so that appropriate control 
measures can be taken. S0' In communicable diseases this information is used to 
monitor disease trends, identify outbreaks or epidemics and evaluate control and 
prevention programmes S01 
In the UK there are three main sources of surveillance data on 
communicable diseases, ""' including invasive H influenzae disease. Firstly there 
is the statutory notification system. In this system the attending clinician has a 
statutory duty to notify the `proper officer' of the local authority (usually a 
consultant in communicable disease control) of suspected or confirmed cases of 
certain infectious diseases, including H influenzae meningitis. "' These 
notifications are then collated at the regional and national level by the Office of 
National Statistics ([ONS] formerly Office of Populations Census and Surveys 
[OPCS]). '69 This source of data is however known to suffer from underreporting 
and a number of other drawbacks. '", "" = 
Initially, notifications for H influenzae meningitis and other causes of 
bacterial meningitis (apart from meningococcal meningitis) were concealed within 
the category of'other bacterial causes of meningitis'. Since 1982 however H 
influenzae meningitis and other forms of bacterial meningitis, have been identified 
separately. S02 Other manifestations of invasive H influenzae are however not 
notifiable diseases. 
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A second source of data is the PHLS, CDSC laboratory reporting system 
for microbiologically confirmed infections! " This system, which will include 
reports on both meningitic, as well as non-meningitic forms of invasive H 
influenzae disease is however subject to selection bias with regard to the taking of 
samples, variability in reporting by laboratories and limited demographic data on 
cases. 503,504 
The third system is the Royal College of General Practitioners (RCGP) 
`spotter practice' scheme. 
169,501 The main limitations of this system are that 
coverage is `patchy' and the system is mainly targeted at diseases, such as 
chickenpox, scabies and influenza, which are not notifiable. "' 
In addition, these routine sources of communicable disease surveillance 
may be supplemented by hospital discharges and death notifications. Hospital 
discharge diagnoses are however subject to coding errors, and in one published 
audit 20% of case notes retrieved were inappropriate for the study. "' With regard 
to death certificates, there is wide variation in the accuracy with which they are 
filled out. 503 Furthermore, it has been reported that the case notes of patients who 
have died in hospital are more likely to be missing than those of other patients S°6 
Taking these into consideration it was decided not to employ either of these 
sources of information for the study. 
For the purposes of this study statutory notifications and laboratory reports 
will be used as the foundation for the construction of a register of invasive H 
influenzae cases in children aged less than 5 years who meet the case definition for 
inclusion in the study. Cases will also be identified from a number of other sources 
(see section 4.6.1). 
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4.6.1 Compilation of disease register 
Invasive H influenzae meningitis produces a potentially life-threatening 
disease in children and is a statutorily notifiable disease, yet a number of UK 
studies have demonstrated that notification and reporting of this form of meningitis 
is more incomplete than notification for meningococcal meningitis. 114,145,173 
In order to ensure that case identification for meningitic and non-meningitic 
disease was as comprehensive and complete as possible, several overlapping 
surveillance systems were used (figure 4.2) to assemble a disease register. 
Figure 4.2: Sources of case identification for invasive Haemophilus 
influenzae disease in the WNM, 1990-1994 
Regional Pis 
Laboratories CDSC 
Haemophilus 
Reference 
Laboratory 
HICARE 
OVG/ 
ooý BPSU* CsCDC 
*OVGBPSU (Oxford Vaccine Group/British Paediatric Surveillance Unit) 
The co-operation of the PHLS, CDSC, regional laboratories, consultants in 
communicable disease control and immunisation co-ordinators within the WMHR, 
the OVGBPSU and Haemophilus reference laboratory in identifying cases and 
providing data was sought. For the purposes of this study, a laboratory or an 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 142 
Chapter 4: Methodology 
individual was considered to have participated in the study if they provided one or 
more of the following pieces of information: 
- the name, date of birth or other demographic information related to 
cases 
- indicated that no cases had been identified during the study period 
- allowed examination of laboratory records 
- provided access to medical records 
4.6.1.1 PHLS, CDSC 
As part of the national surveillance of communicable diseases, laboratories 
in the West Midlands region voluntarily report isolates of H influenzae, and other 
infectious diseases, to the PHLS, CDSC London. Computerised line listings from 
the PHLS, obtained with the co-operation of the regional epidemiologist, provided 
the primary source of retrospective data for this research. Late reporting of cases 
by laboratories is known to occur, and to account for this data was requested for 
laboratory reports from October 1990 to December 1994. 
4.6.1.2 Regional PHL and NHS laboratories 
The major local source of cases were the records of all hospital 
microbiology or pathology laboratories in the region. Laboratory directors were 
asked to provide information on all children aged under 5 years with positive 
cultures of H influenzae who had specimens sent to their laboratory. At the time 
the study was conducted, several laboratories lacked computer resources and, either 
provided manual reports or, were visited by the researcher who reviewed the 
laboratory records in order to identify cases. Thirteen (62%) of the twenty one 
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laboratories in the region provided data which was either retrospective and/or 
prospective in nature. 
4.6.1.3 Consultants in communicable disease control 
The third major source of cases were CsCDC. There were eighteen CsCDC 
in the region when the study commenced, eleven (61 %) supplied information 
regarding cases notified to them during the study period. 
4.6.1.4 BPSU/OVG 
The Oxford Vaccine Group have been conducting a study on Hib conjugate 
vaccine failures in the Hib vaccine era on behalf of the BPSU. Sources of data for 
the BPSU study include over 90% of paediatricians, as well as microbiologists and 
public health physicians. The OVG provided the researcher with a listing of cases 
reported to them who were eligible for inclusion in this study. 
4.6.1.5 Haemophilus reference laboratory 
The Haemophilus reference laboratory at Oxford, which provides 
identification, serotyping and sensitivity testing for H influenzae, was also 
contacted via the OVG. They were asked to provide a listing of isolates sent to 
them from the region during the study period. This was used to ascertain specimen 
dates, serotypes and antibiotic sensitivities. 
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4.6.1.6 Consultant paediatricians 
All consultant paediatricians working in hospitals in the West Midlands and 
listed in the British Paediatric Association (BPA) yearbook for 1992-93 were also 
contacted. 5 ' They were informed of the study and asked for permission to 
examine the medical notes of children who had been under their care during the 
study period. In cases where laboratory directors had not provided access to their 
laboratory records to confirm laboratory diagnosis and provide further information 
where required, consultant paediatricians were contacted and provided with all 
available information in order to obtain the child's case notes. 
4.6.1.7 Immunisation co-ordinators 
All the district immunisation co-ordinators within the region co-operated in 
providing information on children in their district. Each immunisation co- 
ordinator was sent a list of the cases believed to be from their district, and asked to 
provide the researcher with their immunisation histories. 
Using the information obtained from all these sources, the West Midlands 
HICARE database was constructed. All sources were cross-referenced using first 
and second names, together with date of birth and postcode of home address to 
ensure maximum case ascertainment without duplication. When case identification 
was complete the total number of case children identified by each system was 
known, 
Since this study does not involve sampling, the usual consideration of 
sample size determination does not apply. It is however expected that the study 
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will provide one of the largest and most comprehensive case series of invasive 
Haemophilus disease in Britain. 
4.7 DATA COLLECTION 
4.7.1 Access to hospital notes 
Once cases were identified, letters containing a brief description of the 
study were sent to the consultant paediatrician responsible for the care of the child 
asking them for permission to look at the child's medical notes. When this was 
obtained, letters were then sent to managers of medical records libraries in all the 
hospitals informing them of the study, providing them with all the available details 
for each child, and asking them to locate the medical notes of children identified as 
cases. Ideally this information would include all or some of the following: the 
child's full name; gender; address at the time of admission, or last known address; 
date of birth, or age; date of admission, or date of specimen; and hospital number. 
In several instances, especially where information was obtained from the PHLS, 
CDSC listing, much of this information was missing. Where the identifying 
information was deemed insufficient by the medical records librarian, consultant 
paediatricians were asked to supplement the available information by searching 
their admission records. 
Once the consultant paediatricians had given their consent for the 
researcher to look at the case notes, either by directly informing the researcher or 
through the medical records librarian, a suitable date was arranged with the 
librarian for the researcher to visit the hospital to look at the case notes. Many of 
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the hospitals collated the records, and invited the researcher to extract the required 
data on the hospital premises. In cases where only one or two case notes had been 
identified, some hospitals posted the medical notes to the researcher, and these 
were reviewed and returned as quickly as possible by registered post. 
Any child who was eligible for the study but whose notes could not be 
located by the 1' June 1995 was excluded from the study. 
4.7.2 Research instrument 
A data collection form or proforma (appendix 1) was constructed by the 
researcher following the initial proposal and review of the literature. The 
information to be obtained using this instrument was discussed with the 
researcher's supervisor, chair of the advisory committee and the regional 
epidemiologist. Agreement was reached as to which factors should be looked at. 
The form was piloted using the medical notes of twelve children who had 
been admitted to one of the hospitals in the region with invasive Haemophilus 
influenzae disease prior to 1 October 1990. This resulted in minor changes to the 
form. 
The information collected for each case included the identifying hospital 
laboratory, confirmation of the diagnosis, date of birth, gender, name, postcode, 
clinical presentation, management, antibiotic therapy, laboratory results, outcome 
and immunisation status. After completing the proforma it was checked for errors 
and omissions, and when deemed complete, dated and given a serial number. 
The serial number was obtained by coding the child's name using a 
modification of the Soundex code'" The Soundex code is a simple system 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 147 
Chapter 4: Methodology 
developed for the confidential reporting of AIDS/HIV cases which produces a non- 
unique three digit numeric code from a surname. In this study it was used in 
combination with the last two digits of the child's year of birth and forename and 
family name initials. These preceded the three digit code derived from the 
surname. 
Any events or data required for this study which were not present in the 
notes were treated as missing data. 
4.8 DATA ENTRY 
Epi InfoS08 was used to create a computerised version of the form. The 
researcher entered data directly onto the computer from the proforma, and apart 
from the child's identification number, most entries were pre-coded and numeric. 
All data was maintained on computer, and Microsoft Access for windows, 
Microsoft Excel for windows and SPSSS09 were used for database maintenance and 
manipulation. 
Systematic errors were periodically checked for by printing frequency 
tables for each variable, and going back to the proforma where necessary to 
corroborate data. When data entry for all forms was complete, a sample of 20% of 
proformas were checked in order to minimise errors. Serial numbers of fifty two 
cases were selected randomly using numbers generated by Epi Info version 6. The 
computer-held data on each of these cases was then compared with that on the 
original proforma. Thirty three errors were identified and corrected. 
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4.9 DATA ANALYSIS 
4.9.1 Sources of denominator data 
The period of study (1990-94) spanned the 1991 census, therefore the 1991 
population distributions and census data were thought to be appropriate for the 
calculation of rates and other demographic data. The population of 0-4 year olds 
was available at the ED level, and these were aggregated and used as denominator 
data for the calculation of disease rates for districts, deprivation and other 
socioeconomic variables derived from the census. The population counts for EDs 
from the 1991 Census were downloaded from the computerised Small Areas 
Statistics package (SAS) database held by MIDAS (Manchester Information 
Databases and Associated Services, University of Manchester). Aggregating the 
EDs revealed that there were 351,037 children aged 0-4 years in the WMHR. 
Census variables, and therefore Townsend scores, were available for 10,774 
of 10,903 (99%) EDs in the WMHR which contained 350,999 children aged 0-4 
years. Data were therefore unavailable for 129 EDs which contained 38 children 
aged 0-4 years. These children were excluded from the denominator in all analyses 
involving census variables, but included in any other analyses. This difference 
may be attributed to measures to protect confidentiality especially in the case of 
small populations. -"" The variations identified in the denominator data were 
deemed too small to affect the overall results obtained. 
District, age, gender and ethnic-specific incidence rates were among those 
calculated, and reported as cases per 100 000 children under 5 years of age. 
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Children from outside the region (identifiable by postcode and district of residence) 
were excluded from certain geographic and socioeconomic analyses. 
4.9.2 Statistical analyses 
Cases with data missing for a particular variable were excluded from the 
analysis for that variable. As a consequence, missing data for certain variables 
occurred and numbers therefore varied slightly. 
All percentages were rounded to the nearest whole number, while all 
probability values were expressed to two significant figures. All statistical tests 
were carried out using Epi-Info version 6. 
The x2 test with Yates' continuity correction, or Fisher's (two-tailed) exact 
test (where sample sizes were less than 5) were used to test for differences between 
categories using 2x2 tables., "' Statistical significance was determined using 
probability (p) values, and odds ratios with Cornfield 95% confidence intervals. 
Where Cornfield estimates were deemed to be inaccurate using Epi Info version 6 
'statcalc' software, Epi Info version 6 'epitable' was used. Student's t test for 
independent samples was used to compare two means, while one-way analysis of 
variance was used to test the equality of several means. " ' 
The x2 test for trend was used to test for significant increase or decrease in 
trend across categories of deprivation or other socioeconomic variable. -" 
Differences of <0.05 were considered to be significant, and <0.01 highly 
significant. "' Odds ratios greater than I were indicative of a positive 
association. "" 
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Confidence intervals for rates were derived from published tables of 
confidence intervals for Poisson counts at the 95% level 512 
Evaluation of the strength of agreement between different sources of 
immunisation history in the post-Hib conjugate vaccine era was reported using the 
overall proportion of agreement and the kappa (K) statistic. For the latter, the 
strength of agreement was determined using an adaptation of the categories 
suggested by Landis and Koch (table 4.10). '" 
Table 4.10: Interpreting strength of agreement of kappa statistic 
K value Strength of agreement 
<0.40 poor to fair agreement 
0.40 to 0.60 moderate agreement 
0.60 to 0.80 substantial agreement 
0.80 to 1.00 almost perfect agreement 
4.9.3 Socioeconomic analyses 
Geographic Information Systems (GIS) are computerised systems for 
automating, storing, retrieving, manipulating, displaying and analysing mapped 
information. 69 '72 A GIS includes spatial data in the form of maps and descriptive 
information in the form of relational databases associated with the mapped 
features. '" The GIS technique can be used to associate spatial distributions of 
epidemiologic and environmental variables n, 51 515 
In this study the GIS used was ArcView (Environmental Systems Research 
Institute (ESRI), Redlands, California), this was based at the Cancer Intelligence 
Unit (CIU), University of Birmingham and was used to match the postcode at the 
time of admission to an ED for each case by computerised cross-referencing. 
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Computerised data on the socioeconomic characteristics of each ED were 
obtained from the 1991 census SAS database, held by the CIU, University of 
Birmingham. These were then collated and linked to data on cases from the 
HICARE register. Figure 4.3 illustrates how the different databases were linked 
via postcodes to obtain the district of residence as well as the Townsend material 
deprivation score and other socioeconomic data applicable to the corresponding 
ED. 
The enumeration district is the smallest geographical unit for which census 
information is available (containing between 150-250 households), and is the 
geographic unit of analysis for this study. Justification for using EDs were 
concerns that the use of aggregated data from larger area units such as wards and 
postcode sectors would lead to aggregation bias and provide less socially 
homogenous populations than those found in EDs " 
Once the EDs were obtained they were allocated a score on the Townsend 
material deprivation index. The Townsend deprivation score is generated by 
carrying out mathematical transformations on four census variables, these are the 
proportions of the total resident population of each ED who are, unemployed 
adults, live in households with more than one person per room, do not have access 
to a car and are not owner-occupiers. Townsend used these as markers for lack of 
material resources (unemployment), wealth (owner-occupancy), income (car 
ownership) and living conditions (overcrowding). ' 
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Log transformation is carried out on the unemployment and overcrowding 
variables to reduce their skew. Each variable is then standardised by converting it 
to a Z-score and it is the sum of these standardised scores which provides the 
Townsend deprivation score. 23 Increasingly positive scores indicate greater 
deprivation. 
Apart from the Townsend score the medical literature contains a number of 
other indices which aim to measure deprivation and there is debate about which is 
the most appropriate to use in analysing the relationship between health and 
deprivation. The most prominent of these indices are those developed by Jarman"" 
and Carstairs and Morris. 27 
The Jarman index was initially designed to measure the workload of 
general practitioners. The scoring system used to identify underprivileged areas 
was generated from the subjective views of general practitioners of their patients 
social characteristics which they believed increased their workload. "', "' In 
practice, however it rapidly gained currency as an indicator of deprivation, 517 and 
has also been used to identify areas for the allocation of deprivation payments to 
general practitioners 326, s'7 This index has been criticised for its selection of 
variables, lack of validation and inappropriate usage. 26'328'329'517 
Amongst its 8 variables the Jarman score includes children under 5 years of 
age, ethnicity and single parenthood. These demographic factors make it less 
effective as a measure of material deprivation because they are not indicators of 
material deprivation per se and people or families in these categories are not 
equally deprived 23 
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Similarly, the use of social or occupational class in the construction of the 
Carstairs and Morris score is also thought to have disadvantages. Social classes 
contain groups of occupations with appreciable economic heterogeneity, and 
research has shown that there is greater intra-class variation than inter-class 
variation in income. 318 Although poor access to material resources may be related 
to membership of low social class, Townsend has stated that inclusion of this factor 
as a variable in an index of deprivation would not permit analysis of the 
relationship between deprivation, health and social class. ' 
The inclusion of social class in the Carstairs and Morris index and certain 
demographic factors in the Jarman index impair the ability of these indices to 
assess all aspects of material deprivation. Taking the above into consideration, it 
was believed that the Townsend material deprivation score would provide the best 
means of exploring the relationship between health and material deprivation. 
The Townsend deprivation scores for EDs used in this study were provided 
by the Cancer Intelligence Unit (CIU). The EDs were ranked in ascending order, 
according to these scores, and divided into three groups (tertiles) containing 
approximately equal numbers of EDs, thereby grouping together areas of similar 
socioeconomic status (table 4.11). 
Table 4.11: Townsend deprivation tertiles for the WMHR 
Deprivation category Population Townsend deprivation score 
1 (low deprivation) 98,825 -8.50 to -2.10 
2 (medium deprivation) 101,012 -2.00 to +1.70 
3 (high deprivation)) 151,162 +1.80 to +8.80 
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The deprivation map (figure 4.4) of the WMHR indicates where the three 
different categories of material deprivation may be found in the region. Incidence 
rates were calculated for each of these different levels of deprivation and 
differences in observed rates compared using x2 for trend. 
The four variables used to construct the Townsend deprivation score, along 
with other selected census indicators of deprivation (see section 4.5.5.3), were 
analysed in a similar manner. 
A scatter diagram was used to determine the closeness of the association 
between district immunisation uptake rates for Hib conjugate vaccine and the 
district Townsend deprivation score. 
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RESULTS 
Despite rigorous attempts to do so, it was not possible to collect data on all 
variables for all children. It is therefore inevitable that sample sizes for certain 
sub-analyses will vary. Because of the small number of cases identified in the non- 
meningitic group, especially in the second period of the study, only a limited 
analysis has been carried out using this sub-group. Nevertheless, this chapter 
presents a series of analyses which examines variations in the incidence of disease 
for the risk factors specified in chapter 4. Details of diagnostic categories, and 
selected clinical and laboratory aspects are also presented. Each section of the 
chapter ends with a summary of the key results obtained. 
5.1 INCIDENCE OF INVASIVE HINFLUENZAE DISEASE 
5.1.1 Case identification and comparison of surveillance systems 
Using multiple sources of case ascertainment over a four year period from 
October 1990 to September 1994,258 cases of invasive H influenzae disease were 
identified who fulfilled the case definition and were included on the HICARE 
disease register. Of these, 199 were identified in the pre-Hib conjugate vaccine era 
(October 1990-September 1992), and 59 in the post- Hib conjugate vaccine era 
(October 1992-September 1994). H influenzae meningitis was the most common 
disease entity each year, and accounted for 172 of 258 (67%) cases. Epiglottitis 
(32 of 258,12%) was the second most common disease identified during the study 
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period. Pneumonia, septicaemia and cellulitis were the other major syndromes 
seen. The clinical spectrum of disease observed in the WMHR is dealt with in 
more detail in section 5.5.1. 
Table 5.1 shows the estimated incidence rates for all cases of invasive H 
influenzae disease and H influenzae meningitis during each year of the study. The 
incidence of all invasive H influenzae disease and H inf uenzae meningitis showed 
a statistically significant decrease in both of the post-conjugate vaccine years from 
the pre-conjugate vaccine years. In addition, the incidence of disease seen in the 
second post-conjugate vaccine year of the study was statistically significantly 
lower than that of the first (confidence intervals did not cross). 
Table 5.1: Incidence of invasive Haemophilus influenzae disease and Haemophilus 
influenzae meningitis by study year, WMHR 1990-1994 
Invasive HI disease 1-HT meningitis 
Study year Cases Incidence rate Cases Incidence rate 
(95% CI) (95% CI) 
October 1990-September 1991 
October 1991-September 1992 
October 1992-September 1993 
October 1993-September 1994 
Four yearly incidence rate 
97 27.6 (22.4-33.7) 
102 29.1 (23.7-35.3) 
53 15.1 (11.3-19.7) 
6 1.7 (0.6-3.7) 
258 18.4 (15.7-20.2) 
64 18.2 (14.0-23.3) 
72 20.5 (16.0-25.8) 
31 8.8 (6.0-12.5) 
5 1.4 (0.5-3.3) 
172 12.3 (10.5-14.2) 
' Incidence per 100 000 children <5 years of age 
t Haemophilus influenzae 
Figures in bold indicate incidence rates significantly different from that of the previous year 
A comparison of all cases identified by the case register with those reported 
to the CDSC and other surveillance systems is summarised in table 5.2. The table 
shows that 19% of cases on the register were not reported to the CDSC. 
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Underreporting to the CDSC varied with time and other parameters. 
Fifteen per cent of cases identified by HICARE were not reported to the CDSC in 
the period prior to the introduction of the vaccine. This proportion more than 
doubled in the period following introduction of the vaccine to 36%. 
When comparing reports of meningitis and non-meningitic disease during 
the two study periods, a similar picture is seen. In the pre-vaccine era 
underreporting of 14% and 16% occurred for meningitis and non-meningitic 
diseases respectively, while in the post-vaccine period 31% of meningitis cases and 
42% of non-meningitic HICARE cases were not reported to the CDSC. There was 
also apparent variation in the reporting of cases according to age. It was found that 
in children aged less than 2 years, approximately 24% of cases were not reported to 
the CDSC. This was almost four times more than the estimated 7% underreporting 
in children 2 years of age or older. There were no differences in reporting by 
gender or ethnic group. 
Incidence rates based on reports to CDSC for the pre- and post-vaccine 
periods were found to be 24.2 (95% CI=20.7 to 28.1) per 100 000 children less 
than 5 years old and 5.4 (95% CI= 3.8 to 7.4) 100 000 respectively. The 
corresponding figures obtained utilising data for the West Midlands from the 
HICARE register were 28.3 (95% CI=24.5 to 32.6) 100 000 and 8.4 (95%=CI 6.4 
to 10.8) 100 000 respectively. These incidence rates were 17% and 56% above 
those obtained using CDSC data in the pre- and post-Hib conjugate vaccine eras 
respectively. 
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5.1.2 Exclusions from HICARE 
Initially 310 potential cases were identified, however, 52 (17%) of these 
children were excluded from the West Midlands HICARE register. Lack of 
traceable medical notes meant that 25 children, who apparently met the case 
definition, were excluded from the study (table 5.3) as it could not be determined 
whether their diagnosis had been laboratory confirmed. These children had similar 
characteristics to those included on the HICARE register. 
Table 5.3: Cases of invasive Haemophilus influenzae disease excluded from 
HICARE due to lack of traceable medical records by study period and 
demographic characteristics, WMHR 1990-1994. 
Pre-Hib Post-Hib Total 
conjugate vaccine conjugate 
(n=19) vaccine (n=6) 
Diagnosis: 
meningitis 7 3 10 
other 5 3 8 
unknown 7 0 7 
Mortality 6 2 8 
Age group (months) 
0-11 7 2 9 
12-23 6 3 9 
24-35 1 0 1 
36-47 3 0 3 
48-59 1 0 1 
unknown 1 1 2 
Gender: 
boys 11 2 13 
girls 7 3 10 
unknown 1 1 2 
Ethnic group 
Non-South Asian 16 5 21 
South Asian 314 
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Eight of the 25 (32%) children died. Two other children were not included 
on the register because their medical notes were not made available to the 
researcher before the deadline for data collection. 
Of the remaining 27 cases, ten children had no evidence of a positive blood 
culture in their medical records, and their details are shown in table 5.4. 
Two children were found to have non-H influenzae disorders. One was 
diagnosed with undescended testes, while another was a case of bacterial 
meningitis caused by another organism. Of the remaining 15 children, eight who 
had no record of sample dates when reported to CDSC were subsequently found to 
have had specimens taken outside the study period, another seven, who had no 
documented date of birth or age when first reported to CDSC, were found to be 
more than 59 months of age at the time of hospital admission. 
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5.1.3 The impact of Hib conjugate vaccine 
Figure 5.1 shows the dramatic reduction in the number of cases of invasive 
H inf uenzae following the introduction of Hib conjugate vaccine in the fourth 
quarter of 1992. 
A more detailed six monthly examination of this data is shown in table 5.5. 
The incidence of disease can be seen to fluctuate up to the introduction of Hib 
conjugate vaccine in October 1992. There was little change in the first six months 
after the vaccines introduction, then a precipitous decrease in the observed 
incidence rate was seen from April 1993 onwards. The incidence of disease in this 
period was significantly different from that in the preceding 6 months. 
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Table 5.5: Six-monthly incidence of invasive Haemophilus influenzae 
disease in the WMHR, 1990-1994 
Time period Cases Incidence 
rate 
95% Cl 
October 1990 - March 1991 52 14.8 11.1-19.4 
April 1991 - September 1991 44 12.5 9.1-16.8 
October 1991 - March 1992 60 17.1 13.0-22.0 
April 1992 - September 1992 43 12.2 8.9-16.5 
October 1992 - March 1993 47 13.4 9.8-17.8 
April 1993 - September 1993 7 2.0 0.8-4.1 
October 1993 - March 1994 2 0.6 0.1-2.1 
April 1994 - September 1994 3 0.9 0.2-2.5 
Incidence per 100 000 children <5 years of age 
Figures in bold indicate incidence rates significantly different from that of the previous period 
5.1.4 KEY POINTS FROM SECTION 5.1 
were 199 cases pre-Hib conjugate vaccine period and 59 
cases identified in the post-Hib conjugate vaccine period. 
0 Underreporting to CDSC increased from 15% in the pre-conjugate vaccine era 
to 36% n the post-conjugate vaccine period. 
0 Variation in reporting according to age was observed, 24% of cases aged less 
than 24 months of age were not reported to CDSC compared with 7% in those 
older than 24 months. 
Q Incidence rates obtained from HICARE register data were 17% and 56% above 
those obtained using CDSC data in the pre- and post-conjugate vaccine periods 
respectively. 
Q Seventeen per cent of cases identified were ineligible for inclusion on the 
HICARE register for reasons which included lack of case notes and insufficient 
diagnostic information. 
0A significant decrease in disease incidence was seen 6 months after the vaccine 
was introduced. 
Q Introduction of Hib conjugate vaccine resulted in a precipitous decrease in the 
incidence of invasive H influenzae diseases. The most dramatic reduction was 
seen 6 months after the vaccine was introduced. 
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5.2 INDIVIDUAL RISK FACTORS 
5.2.1 Age 
The age distribution of cases of H influenzae meningitis, epiglottitis and 
other invasive diseases is shown in table 5.6. This shows that there was a 
significant association between the type of invasive H influenzae disease and age 
of presentation. Children aged 0-11 accounted for most cases of meningitis and 
non-epiglottic invasive disease, whereas epiglottitis was seen more commonly in 
older children. Age differences related to specific disease syndromes are discussed 
in greater detail in section 5.5. 
Table 5.6: Distribution of cases of invasive H influenzae disease in the WMHR 
by age group and disease entity, 1990-1994 
Age group Meningitis Epiglottitis Other disease Total 
(months) 
0-11 74 1 26 101 
12-23 58 12 17 87 
24-35 20 10 5 35 
36-47 11 7 1 19 
48-59 9 2 5 16 
Total 172 32 54 258 
x2 = 33.86; df = 8; p<0.0001 
During the four years of the study, more than half (152 of 258,59%) of all 
cases were aged less than 18 months, 39% (101 of 258) were under 12 months of 
age, 13% (34 of 258) were aged less than 6 months of age and 5% were under 3 
months of age. More detailed examination of this data for those aged less than 3 
months indicates that they accounted for 7% (13 of 199) of cases in the pre- 
conjugate vaccine period and 9% (5 of 59) of cases in the post-conjugate vaccine 
era. 
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Figure 5.2 compares the proportional age distribution of cases of invasive H 
influenzae disease during the two time periods. Prior to the introduction of Hib 
conjugate vaccine in the WMHR, children aged 6-11 months were at greatest risk. 
They accounted for 30% of cases during this period and 14% in the post-vaccine 
era (OR=2.69,95% CI=1.14 to 6.55; p=0.021). Following introduction of the 
vaccine, children over 12 months of age accounted for a slightly larger proportion 
of cases with those aged 24-35 being at proportionately increased risk (OR=2.64, 
95% CI=1.16 to 5.94; p=0.017). 
5.2.2 Gender 
The ratio of boys: girls was similar (1.1: 1) for the duration of the study. 
This slight preponderance of boys was mainly due to the large number of cases 
identified in boys in the first year of the study (boy: girl ratio of 1.3: 1). Table 5.7 
indicates that following the introduction of Hib conjugate vaccine the incidence 
rates for both boys and girls were similar. The incidence of disease fell 
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significantly in girls in both post-conjugate vaccine years. In boys, a significant 
decrease was not seen until the second year. 
Table 5.7: Incidence of invasive Haemophilus influenzae disease in the WMHR by 
gender and study year, 1990-1994 
Boys Girls 
Study year Cases Incidence rate Cases Incidence rate 
(95% Cl) (95% CI) 
October 1990-September 1991 55 29.5 (23.0-39.8) 42 23.9 (17.7-33.2) 
October 1991-September 1992 48 25.8 (19.7-35.3) 54 30.7 (23.7-41.2) 
October 1992-September 1993 27 14.5 (9.8-21.8) 26 14.8 (9.9-22.3) 
October 1993-September 1994 3 1.6 (0.33-4.88) 3 1.7 (0.4-5.1) 
' Incidence per 100 000 children <5 years of age 
Figures in bold indicate incidence rates significantly different from that of the previous year 
Evaluation of the major disease syndromes by gender (table 5.8) 
demonstrated that overall, there was a significant difference between the 
occurrence of disease syndromes amongst boys and girls. 
Table 5.8: Distribution of cases of invasive Haemophilus influenzae disease 
in the WMHR by gender and diagnostic category, 1990-1994 
Diagnostic category 
Meningitis Epiglottitis Other Total 
Boys 82 23 28 133 
Girls 90 9 26 125 
x2= 6.33; df=2; p=0.042 
This may be due to the greater number of boys with epiglottitis than girls, 
the overall gender ratio for this disease was 2.6: 1. This difference was statistically 
significant (OR=2.69,95% CI=1.13 to 6.60; p=0.023) when gender was used to 
compare epiglottitis with all the other disease syndromes. 
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More girls were identified with meningitis than boys in both periods of the 
study (boy: girl ratio 0.9: 1). This observation showed a trend towards increased 
risk for girls but just failed to reach conventional levels of statistical significance 
(OR= 1.65,95% CI=0.95 to 2.88; p=0.079) when meningitis was compared with all 
other disease syndromes. 
5.2.3 Ethnic group 
Only children resident in the region were used in this analysis. Overall 22 
(9%) of 244 cases who were resident in the region were classified as being of 
South Asian origin (SA) origin (see section 4.5.3.3 for definition). The proportions 
obtained were similar to the demographic distribution of these groups in the 
paediatric population of the WMHR. Although the proportion of SA children 
affected increased from 8% (15 of 190) in the pre-vaccine era to 13% (7 of 54) in 
the post-vaccine period, this increase was not statistically significant (OR=1.74, 
95% CI=0.60 to 4.93, p=0.28). 
With the exception of the year prior to the introduction of the vaccine, 
incidence rates for children of SA origin were consistently, but not significantly, 
higher than those for children of non-South Asian (NSA) origin (table 5.9). A 
significant reduction in the incidence of disease in NSA children was seen in 
1992/93 following the introduction of the vaccine.. A correspondingly significant 
fall was not demonstrated for SA children. 
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Table 5.9: Incidence of invasive Haemophilus influenzae disease by study year and 
ethnic group, WMHR 1990-1994 
Non-South Asian South Asian 
Study year Cases Incidence rate Cases Incidence rate 
(95% CI) (95% CI) 
October 1990-September 1991 85 25.7 (20.5-31.8) 9 28.6 (13.0-54.4) 
October 1991-September 1992 90 27.2 (21.9-33.4) 6 19.1 (7.0-41.7) 
October 1992-September 1993 42 12.7 (9.2-17.2) 6 19.1 (7.0-41.7) 
October 1993-September 1994 5 1.5 (0.5-3.5) 1 3.2 (0.1-17.8) 
Incidence per 100 000 children <5 years of age 
Figures in bold indicate incidence rates significantly different from that of the previous year 
Meningitis was responsible for 68% (15 of 22) of cases in SA children, and 
septicaemia (3 of 22) was the second most common disease entity. A similar 
proportion of meningitis cases were seen in NSA children (150 of 222,68%), with 
the most common non-meningitic disease in this group of children being 
epiglottitis, which accounted for 28 of 222 (13%) cases. Only one case of 
epiglottitis was seen in a child of SA origin throughout the four year study period. 
This difference was not statistically significant (OR=0.38,95% CI=0.05 to 2.76, 
p=0.50). 
Table 5.10 shows the incidence rates for meningitis and non-meningitic 
diseases by gender and ethnic group. Although not statistically significant, both 
SA and NSA girls had a higher incidence of meningitis than boys from their 
respective ethnic groups. 
Table 5.10: Incidence (95% Cl) of invasive H inf uenaae disease in the WMHR by 
gender, ethnic group and disease category, 1990-1994 
South Asian Non- South Asian 
Boys Girls Boys Girls 
Meningitis 9.3 (3.4-20.4) 14.6 (6.7-27.8) 11.0 (8.7-14.0) 12.6 (10.0-15.7) 
Non-meningitic 4.7 (0.9-13.7) 6.5 (1.8-16.6) 7.2 (5.2-9.3) 4.8 (3.1-6.7) 
' Incidence per 100 000 children <5 years of age 
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In general, the age distribution of SA children differed from that of NSA 
children (figure 5.3). The majority of cases in SA children (14 of 22, or 64%) 
occurred in children less than 12 months old, compared to 38% (84 of 222) in NSA 
children (OR=2.88,95% CI=1.07 to 7.86; p=0.033). The mean age at onset for 
SA children was 13.1 months (median 10.0 months) and ranged from 1 to 37 
months, compared with an average age of 19.0 months in children of NSA origin 
(median 15.0 months, range 0 to 59 months). 
Figure 5.3: Cumulative frequency graph of the age distribution 
of invasive Haemophilus influenzae disease in the WMHR, by 
ethnic group 1990-1994 
10 
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Children of SA origin were also more likely to present for admission 48 
hours or more after the onset of symptoms than NSA children (OR=2.72, CI=1.01 
to 7.24: p=0.046). 
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5.2.4 Birthweight 
Low birthweight was defined as a weight of less than 2500g at birth. At the 
time of hospital admission, the birthweight of 164 children had been recorded, and 
18 (11%) were classified as having a low birthweight. In this group of children the 
birthweight ranged from 1020g to 2470g (mean 1860g, median 2050g). 
Disease entities identified in children who had a LBW were meningitis 
(11), pneumonia (2), septicaemia (2) and neonatal sepsis (3). Three cases were 
observed in children of SA origin and all were girls. There were 15 children from 
the NSA population, eight boys and seven girls. 
Cases with a history of LBW had a mean age of 12.6 months (median 8.5 
months, range 0-39 months) compared to 19.0 months (median 15.0 months, range 
0-59 months) for children with a birthweight equal to or greater than 2500g. The 
difference between the mean age of disease onset in those of LBW and normal 
birthweight almost reached conventional levels of significance (p=0.058) 
Twelve of 127 (9%) children seen during the pre-vaccine period had been 
of LBW compared to 6 of 37 (16%) in the post-vaccine era. (OR=0.54,95% 
CI=0.19 to 1.55; p=0.24). There was no overall association between LBW and 
deprivation (OR=0.41,95% CI=0.04 to 2.10; p=0.34), however LBW children 
were more likely to come from single parent families (OR=4.01,95% CI=1.11 to 
12.95; p=0.017). 
Children who had been born with a LBW were not found to be at greater 
risk when examined for complications at follow-up (OR=1.87,95% CI=0.39 to 
8.88; p=0.34). They were however more likely to die following their episode of 
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invasive H influenzae disease than those of normal birthweight (OR=9.24,95% 
CI=1.29 to 51.98; p=0.013). 
Ten of 18 isolates were serotyped in this group of children and all were 
serotype b. Antibiotic resistance was seen in 5 of 17 (24%) isolates, three of which 
were CSF cultures and two blood cultures. 
5.2.5 Nutritional status 
The nutritional status of cases was determined by plotting the weight on 
admission on a `Child Growth Foundation' growth chart. Children below the 3`' 
weight centile for age were classified as being underweight for age. 
Only previously healthy children aged more than 1 month were included in 
this analysis, therefore neonates and children with predisposing conditions, such as 
Down's syndrome or congenital heart disease, were excluded. 
Of the 241 cases eligible for the analysis, 228 (95%) had a documented 
weight at the time of admission, and 18 (8%) of these were underweight. There 
were 11 of 178 (6%) in the pre-conjugate vaccine period compared to 7 of 50 
(14%) in the post-vaccine era. This difference failed to reach conventional levels 
of significance (OR=2.47,95% CI=0.81 to 7.42; p=0.080). The most common 
disease encountered in this group of children was meningitis (14 of 18), there were 
no cases of epiglottitis. 
Significant differences were found between children who were underweight 
for age and those within the normal weight range. Underweight children were 
more likely to have a history of previous hospital admissions (OR=16.07,95% 
CI=4.22 to 62.32; p<0.0001). They were also more likely to have been ill for more 
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than 24 hours prior to admission (OR=6.24,95% CI=1.39 to 27.98; p=0.0090), and 
to have been LBW babies (OR=9.71,95% CI=2.32 to 40.09; p=0.0015). 
Children who were underweight on admission spent a mean of 11.3 days in 
hospital compared to 9.8 days for those not classified as underweight. This 
difference did not reach conventional levels of statistical significance. A highly 
significant association was however found between being underweight on 
admission and coming from a highly deprived area (OR=undefined, p=0.0083). 
Outcome was known in 225 of the 228 cases whose weight was known. 
Only one death occurred in this group of children and this was seen in a child who 
was underweight. 
Significant associations were not found for several other variables such as 
disease entity, ethnicity, gender and family size and structure. 
5.2.6 Anaemia 
Following the WHO recommendation that a haemoglobin concentration of 
less than 11 g/dl be taken as indicative of anaemia in children aged between 6 
months and 6 years, 72 of 207 (3 5%) cases of invasive Hinfluenzae disease aged 6 
months or more were classed as anaemic. A smaller proportion of children were 
found to be anaemic in the second period of the study compared to the first (29% 
[10 of 44] vs 38% [62 of 163]). This difference was not statistically significant 
(OR=2.09,95% CI=0.90 to 4.91, p=0.087). 
Meningitis was the most common disease entity in this group of children 
accounting for 72% (52 of 72) of cases. Epiglottitis (6 cases, 8%), and septicaemia 
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(5 cases, 7%) were the next most common. The remaining diagnoses were 
pneumonia (3 cases, 4%), cellulitis (3) and septic arthritis (1). 
The mean age of children with anaemia was 16.1 months (median 14.5 
months, range 6-52 months), while those with normal haemoglobin levels had an 
average age of 23.6 months (median 20.0, range 6-59). The difference in the mean 
age of these two groups was statistically significant (p=0.0013). Children with 
anaemia were more likely to be the youngest child in the family (OR=4.63,95% 
CI=1.62 to 16.17; p=0.003). 
Significantly more children with anaemia were ill for 24 hours or more 
before admission than other children (OR=2.56,95% CI=1.31 to 5.05, p=0.018), 
and spent an average of 12 days in hospital compared to 8.3 days for those with 
normal haemoglobin levels. This difference was statistically significant 
(p=0.0027). 
Children with anaemia were also more likely to have complications at 
follow-up (OR=3.69, CI=1.05 to 14.51; p=0.022), although when hearing loss 
alone was examined a significant association was not found. 
Significant associations were not found for several other factors such as 
deprivation, ethnicity, gender, and mortality. 
5.2.7 Chronic illness 
Table 5.11 shows that a history of chronic illness for a variety of conditions 
was recorded for 25 of 254 (10%) children on the register. Several of these 
children had more than one long-term illness. 
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Table 5.11: Chronic illness identified in 25 cases of invasive Haemophilus 
influenzae disease in the WMHR, 1990-1994 
Chronic illness Number of children affected 
Asthma 9 
Eczema 9 
Congenital heart disease 3 
Down's syndrome 3 
Drug allergies 3 
Others 6 
Total 33 
A number of children had more than one chronic condition 
The proportion of children with a documented chronic illness rose from 9% 
(18 of 196) in the pre-vaccine period to 12% (7 of 58) in the post-vaccine period. 
The increase did not reach conventional levels of significance (OR= 1.41,95% 
CI=0.50 to 3.88: p=0.63). 
Among this group of children there were 14 cases of meningitis, 3 cases 
each of epiglottitis and pneumonia, and 2 of cellulitis. One case each of 
septicaemia, septic arthritis and bacterial endocarditis were also seen. 
Twenty-three children were of NSA origin, 14 were boys and 9 girls. Only 
two children were of SA origin, one of each gender. No association was found 
between deprivation and chronic disease. 
The mean age of these children was 17.4 months (median 13.0 months, 
range 3-58 months) compared to an average age of 18.7 months (median 15.0 
months, range 0-59 months) in children who did not have a chronic illness. This 
difference did not reach conventional levels of significance (p=0.897). 
One death occurred in this group of children, a case of meningitis in a SA 
infant who had Down's syndrome together with congenital heart disease. 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 177 
Chapter 5: Results 
5.2.8 KEY POINTS FROM SECTION 5.2 
Q Overall, almost 60% of cases identified were aged less than 18 months of age. 
QA significant shift was seen in the age of those proportionately most at risk 
from 6-11 months of age in the pre-conjugate vaccine period to 24-3 5 months of 
age in the post-vaccine period. 
Q Similar numbers of boys and girls were affected in the four years studied. 
0 Boys were significantly more at risk for epiglottitis, however more girls were 
identified with meningitis in both periods of the study. 
Q The proportion of SA children affected increased from 8% in the pre-conjugate 
vaccine period to 13% in the post-conjugate vaccine period. 
USA girls had the highest rates of H influenzae meningitis. 
Q Significantly more cases of invasive H influenzae disease were seen in SA 
children at less than 12 months than in NSA children. 
Q Children of SA origin were more likely to present to hospital late. 
QA LBW was documented for 9% of cases in the pre-conjugate vaccine era 
compared to 16% in the post-conjugate vaccine period. 
El LBW babies were associated with single parent families and increased risk of 
mortality. 
Q Before Hib conjugate vaccine was introduced 6% of cases were underweight for 
age on admission, this increased to 14% of cases in the second period of the study. 
El Significant associations were seen between being underweight and a history of 
LBW, previous hospital admissions and living in an area of high deprivation. 
Q More than one-third (35%) of cases were anaemic on admission. 
Q Children with anaemia were significantly younger when admitted, spent longer 
in hospital and were more at risk of neurological complications at follow-up. 
O Chronic illness on admission was identified in 10% of cases over the duration 
of the study. 
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5.3 FAMILY AND COMMUNITY RISK FACTORS 
5.3.1 Family size and structure 
Information on family size and structure were available for 254 of the 
children. There were 200 children with one or more siblings at the time of 
admission, and 157 of 194 (81 %) of these children had one or more siblings 
younger than 5 years of age. Significantly more cases of meningitis occurred in 
children who had two or more siblings aged less than 5 years (0R=4.62,95% 
CI=1.28 to 25.11; p=0.019). 
In cases with siblings, meningitis was responsible for the majority of cases 
(131 of 200,65%) with epiglottitis (22 of 200,11%) the next most common 
invasive disease. 
In this study, the number of siblings ranged from 1 to 7 (mode=l), and the 
mean number of siblings in these families was 1.7. Children from SA families had 
an average of 2.7 siblings, whereas NSA children had a mean of 1.6 siblings. This 
difference was highly significant (p = 0.00023). 
There were 54 of 254 (21%) children who were reported to be singletons, 
and 52 (96%) of these were NSA children. The most common invasive disease in 
singletons was meningitis (37 of 54,69%), followed by epiglottitis (9 or 17%). 
The mean age among this group of children was 20.6 months (median 18 months, 
range 0-59 months) compared to 17.9 months (median 13 months, range 0-59 
months) in children with siblings. This difference was not statistically significant 
(p=0.20). 
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There was one instance of co-primary disease. Two siblings aged 22 
months and 7 months were admitted to hospital in the pre-vaccine era, both had 
septicaemia. The younger sibling was the index case and was admitted to hospital 
24 hours before the older child. Both children recovered without any apparent 
problems. No secondary cases were identified in this case series. 
5.3.2 Lone parent families 
Only 234 case notes had parental details from which it was possible to 
identify 32 (14%) children as having a single parent. The proportion of children 
from lone parent families was similar in both study periods, 14% in the pre-vaccine 
period and 13% in the second period of the study. 
As with many of the other variables examined, meningitis was the most 
common diagnosis, and accounted for 20 of 32 (63%) cases. 
All the children identified from lone parent families were of NSA origin. 
(OR = undefined, p=0.05 1). Deprivation was not significantly associated with 
coming from a lone parent family. 
5.3.3 Daycare attendance 
Excluding children aged less than one month of age, various forms of 
daycare were documented in the medical records of 39 of 252 (16%) children at the 
time of admission. Most children attended nursery/primary school (17 of 39, 
44%), while other forms of daycare were playgroup/playschool (8), mother and 
toddler groups (7), and childminders (7). 
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Cases attending any type of daycare were aged between 2 to 59 months, 
and had an average age of 26.1 months (median 23.0 months) compared to a mean 
of 17.6 months (median 13.0 months, range 2-58 months) in children who were not 
attending any form of daycare. Comparison of the mean ages of the two groups 
revealed a significant difference (p=0.00012) 
The main disease entity in children attending daycare was meningitis (24 of 
39,62%), with epiglottitis (7 or 18%) being the next most common. Other 
diseases encountered were cellulitis (4), septic arthritis (2), pneumonia and 
empyema (1 case each). There were no deaths or long term complications in 
children attending daycare. 
Girls accounted for nearly two-thirds of children receiving day care (24 of 
39,62%). Daycare attendance was however uncommon in children of SA origin, 
only one child of SA origin was identified in this group. It was also uncommon for 
children of lone parents to attend daycare (3 of 32,9%). 
Children attending daycare were less likely to have siblings (OR=0.41,95% 
CI=O. 18 to 0.92; p=0.028) than those not attending daycare. 
Cases attending daycare accounted for 32 of 199 (16%) cases in the pre- 
vaccine era, and 7 of 59 (12%) cases in the post-vaccine era. This difference was 
not statistically significant (OR=0.70,95% CI=0.29 to 1.69; p=0.34). None of the 
children identified in the post-vaccine period who attended daycare had received 
Hib conjugate vaccine. 
During the survey, two cases of invasive disease were identified in children 
who had attended the same nursery. Information on one of these children is limited 
as the child (the index case) died within 24 hours of admission and the medical 
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notes could not be located. Both children were admitted to the same hospital, the 
second child being admitted 46 days after the index case, and both had blood 
specimens identified as Hib biotype I. More detailed typing was however not 
available. 
5.3.4 KEY POINTS FROM SECTION 5.3 
LI Significantly more cases of meningitis were seen in children with 2 or more 
siblings aged less than 5 years. 
Q Children from SA families had a mean of 2.7 siblings compared to 1.6 for NSA 
children. 
Q There was only one instance of co-primary disease in this series and no 
secondary cases were identified. 
Q From 1990-94 14% of cases were identified as coming from lone-parent 
families. 
Q No association was seen between deprivation and coming from a lone parent 
family. 
Q Daycare attendance was documented for 16% of cases in the pre-conjugate 
vaccine period and 12% in the post-conjugate vaccine era. 
Q Cases attending daycare were significantly younger than those who were not, 
and significantly less likely to have siblings. 
Q Daycare was uncommon amongst children of NSA origin. 
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5.4 ENVIRONMENTAL RISK FACTORS 
5.4.1 Immunisation status 
5.4.1.1 In the pre-Bib conjugate vaccine era 
The primary immunisation history documented in the hospital notes at the 
time of admission was used to evaluate the immunisation status of the 199 children 
hospitalised prior to the introduction of Hib conjugate vaccine. 
Children were placed in one of two categories according to their 
immunisation history. They were classified as having received either (i) an age- 
appropriate course of primary immunisation, or (ii) having received an incomplete 
course of primary immunisation, this category included those who had not received 
any immunisations. Eight children aged less than 2 months, and 24 children for 
whom immunisation data had not been recorded were excluded from the analysis. 
Immunisation histories had been documented in the medical records of 167 
(84%) children. Of these, 31 (19%) had either been incompletely immunised or 
not immunised at all. Seven of these children had not received any immunisations 
prior to admission, while fourteen of the remaining children needed one or more 
doses of DTP/DT. Nine required MMR alone, and one child was overdue for both 
DTP/DT and MMR. 
When the two categories were compared, attending daycare, being 
underweight, having a history of chronic illness or LBW, anaemia on admission or 
living in a mainly urban or mainly rural area did not appear to influence 
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immunisation uptake. Age was not significantly related to uptake however, 
immunisation uptake improved with increasing age (table 5.12). 
Table 5.12: Primary immunisation status of children with invasive Haemophilus 
influenzae disease in the pre-Hib conjugate vaccine period in the WMHR, 1990- 
1992 
Age group (months) Total 
0-11 12-23 24-35 36-47 48-59 
Age-appropriate 48 53 13 10 12 136 
Incomplete/none 17 9 3 2 0 31 
Total 65 62 16 12 12 167 
The mean age of cases with age-appropriate primary immunisation status 
compared to the other cases was 19.7 months (median 15.0 months, range 2-59 
months) and 14.9 months (median 11.0 months, range 3-43 months) respectively. 
The difference between these two groups was not statistically significant (p=0.12). 
Overall, only 12 of 19 (63%) children from lone-parent families, compared 
to 110 of 132 (83%) children from other families were up to date with their 
immunisations. This result almost reached conventional levels of significance 
(OR=0.34,95% CI=O. 11 to 1.09; p=0.057). 
South Asian children were more likely to be overdue for their 
immunisations than NSA children (OR=3.54,95% Cl= 1.04 to 12.03; p=0.048), 
while children who had three or more siblings were less likely to be adequately 
immunised than cases from smaller families (OR=0.22,95% CI=0.06 to 0.72; 
p=0.0067). 
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5.4.1.2 In the post-Hib conjugate vaccine era 
The Hib immunisation status of the 59 children presenting in the post- 
vaccine era was determined primarily by contacting the appropriate immunisation 
co-ordinator. Where the information was not available from this source, either 
because the child was not a resident of the region or had moved, the immunisation 
history documented in the hospital records at the time of admission was used. 
Excluded from the following analysis are six children. Three were aged 
less than two months at the time of the study, and therefore not eligible for 
immunisation at the time of admission. Three other children were from outside the 
region and had no documented immunisation history. 
There were 44 of 53 (83%) children who did not receive Hib immunisation 
in the two year period immediately following introduction of the vaccine. Of these 
25% (11 of 44) were less than 12 months of age and 70% (31 of 44) between 12 
and 47 months of age. The mean age of children who did not receive Hib 
immunisation was 21.4 months (median 18.5 months, range 3-59 months). When 
compared with the average age of children who had received the vaccine (mean 
13.8 months, median 12.0 months, range 3-38 months), a statistically significant 
difference was not found (p=0.11). 
Analysis of the Hib immunisation status of those children who had not been 
immunised before admission indicated that over one third (15 of 44,34%) did not 
receive Hib conjugate vaccine following discharge. Those children who were 
immunised, received the first dose of vaccine on average 109.6 days (median 76 
days, range 3-441 days) following discharge from hospital. None of the children 
received the vaccine while in hospital. 
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Overall 33 of 44 (75%) children who had not received Hib conjugate 
vaccine prior to admission, had age-appropriate immunisation status for the other 
vaccines in the primary immunisation schedule. Only two of these children were 
over 48 months of age, and would not have been targeted by the `catch-up 
programme'. Excluding them would have reduced the unimmunised proportion to 
70%. 
Factors which did not appear to significantly influence Hib conjugate 
vaccine uptake included ethnic group, family size and structure, attending daycare, 
having a history of chronic illness or LBW, or living in an urban or rural area. 
When the primary immunisation data obtained from the immunisation co- 
ordinators (excluding Hib immunisation) for children resident in the region 
admitted to hospital in the post-vaccine period were compared with the information 
initially recorded in the medical notes, similar results were obtained (table 5.13). 
Agreement between verified and documented immunisation data was seen in 37 of 
42 (88%) cases. Using the kappa measure of agreement, a kappa value of 0.55 
(one-tailed p-value=0.0002) was obtained. The Landis and Koch classification 
indicates that this represents moderate agreement between the two sources. 
Table 5.13: Comparison of the primary immunisation status of children with 
invasive Haemophilus influenzae disease in the WMHR obtained from two 
independent sources in the post-Hib conjugate vaccine period, 1992-1994 
Immunisation status Immunisation status documented in the Total 
obtained from the medical notes at the time of admission 
immunisation co-ordinator 
Age-appropriate Incomplete/none 
Age-appropriate 33 3 36 
Incomplete/none 246 
Total 35 7 42 
Kappa = 0.55; p=<0.001 
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District immunisation uptake scores for Hib conjugate vaccine first became 
available in November 1993 . 
34' Figure 5.4 shows a negative correlation between 
district immunisation uptake rate and the district Townsend deprivation score. The 
correlation was found to be highly significant (r2 =43%, n= 18; p <0.005). 
Figure 5.4: District* Hib immunisation uptake rates (Nov. 
1993) related to district deprivation scores, WMIIR 1992 
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* In November 1993 there were only 18 districts; Bromsgrove & Redditch and Kidderminster had 
merged to form North Worcester; and South Warwickshire and North East Warwickshire had 
merged to become Warwickshire (see table 4.2) 
The immunisation records of individual children were examined by 
deprivation tertile in the post-Hib conjugate vaccine era. A significant association 
was not found at this level (x2 for linear trend =0.092, p=0.76). 
5.4.1.3 Hib conjugate vaccine failures 
During the two year post-Hib conjugate vaccine period studied, nine 
vaccine failures were identified using the BPSU case definition. Table 5.14 shows 
selected characteristics of the 9 children identified, most of whom received only 
one dose of vaccine. There were three true vaccine failures, two occurred after 3 
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doses of vaccine and one after a single dose. Five apparent vaccine failures were 
also identified, as well as one non-vaccine failure. 
Excluding the non-vaccine failure, the other vaccine failures accounted for 
15% (8 of 53) cases seen during 1992/94. Five of the vaccine failures (including 
one true vaccine failure) occurred in the first year following the introduction of Hib 
conjugate vaccine, and three (including two true vaccine failures), in the second 
year. All the vaccine failures occurred in different health authorities. 
One of the children classified as an apparent vaccine failure died. This 
three month old girl of SA origin had received a single dose of vaccine ten days 
previously, and died within a few hours of hospital admission. The other four 
apparent vaccine failures, as well as the three true vaccine failures, and the child 
who was a non-vaccine failure all survived. 
Ethnic group, lone parent, family size and structure, having a history of 
chronic illness or LBW, living in a deprived area, anaemia or being underweight 
for age did not appear to influence the occurrence of Hib conjugate vaccine failure. 
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5.4.1.4 KEY POINTS FROM SUB-SECTION 5.4.1 
Q In the pre-Hib conjugate vaccine era immunisation histories were available for 
84% of cases. 
Q Age-inappropriate immunisation histories were recorded for 19% of children in 
the pre-Hib conjugate vaccine period, the majority required one or more doses of 
DTP/DT. 
O Deprivation was not significantly associated with poor immunisation uptake at 
the individual level, but a significant association was observed at the district level. 
Q Children of SA origin and those with 3 or more siblings were significantly 
more likely to have inadequate immunisation histories. 
Q Proportionately fewer children from lone-parents were up to date with their 
immunisations than children from other families. 
Q In the post-conjugate vaccine period, 83% of cases had not received Hib 
conjugate vaccine before admission despite being upto-date with other vaccines. 
Q Following discharge, 34% did not receive Hib conjugate vaccine, and those 
who did waited an average of 110 days. None received the vaccine in hospital. 
Q There was significant agreement between documented immunisation histories 
and those obtained from immunisation co-ordinators. 
Q There were 9 vaccine failures, 3 of which were true vaccine failures, 5 apparent 
vaccine failures and 1 non-vaccine failure. Two of the true vaccine failures had 
received full courses of Hib conjugate vaccine. 
5.4.2 Socioeconomic factors 
Data for figures in this sub-section may be found in appendix 2 together 
with the cut-off points for each of the tertiles used. 
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5.4.2.1 Deprivation 
The database containing the postcodes obtained from the medical records of 
cases were linked to the West Midlands geographic database at the CIU using GIS 
software. This matched 236 of 258 (92%) postcodes to EDs in the region. 
Unmatched addresses were checked in the Royal Mail postal address book to 
verify the postcode. Using this technique a further 8 postcodes were matched to 
EDs giving an overall match of 95%. The remaining 14 (5%) postcodes could not 
be matched to EDs because the addresses given were outside the WMHR. 
Townsend deprivation scores for cases ranged from +8.8 (most deprived) to 
-6.5 (least deprived), compared to +8.8 to -8.5 for the region as a whole. The 
proportionate distribution of deprivation amongst children with invasive H 
influenzae disease is compared with that in the WMHR (figure 5.5). 
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Figure 5.5: Proportional distribution of Townsend deprivation 
scores for cases of Invasive Haemophilus influenzae disease in 
the WMHR, 1990-1994 
evr. rrrr7Iºrr. 1 
-9 4 -7 4643 -2 -1 012346676i 
Townsend deprivation score 
WMHR 
" --- HICARE 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 191 
Chapter 5: Results 
The figure shows that the distribution of ED deprivation scores within the 
region is skewed towards the more affluent end of the range, whereas the 
distribution amongst cases is skewed towards the more deprived end of the scale. 
In table 5.15 the incidence of invasive H influenzae disease is shown for 
each of the deprivation tertiles. Although the incidence for children living in 
affluent areas was lower than that of the other two groups, they did not differ 
significantly. 
Table 5.15: Annual incidence of invasive Haemophilus influenzae disease by 
Townsend deprivation tertile, WMHR 1990-1994 
Deprivation category Population Cases Incidence rate (95% CI) 
High 151,162 110 14.2 (10.7 -18.4) 
Medium 101,012 78 19.3 (15.3 - 24.1) 
Low 98,825 56 18.2 (15.0 - 21.9) 
Total 350 999 244 17.4 (15.0 - 19.4) 
Incidence per 100 000 children <5 years of age 
The incidence of disease for those children in affluent areas was then 
compared with that of the other two groups combined (table 5.16). A significantly 
reduced incidence of disease was then seen in children living in the more affluent 
areas (p=0.0046). 
Table 5.16: Analysis of the incidence of invasive Haemophilus influenzae disease 
by Townsend deprivation category, WMHR 1990-1994 
Area of deprivation OR (95% CI) p value 
High vs low 1.34 (0.96 - 1.87) 0.09 
Low vs medium/high 0.73 (0.54 - 0.99) 0.046 
In the pre-Hib conjugate vaccine era there was a 14% difference between 
the incidence rates for all cases of invasive H influenzae disease observed for 
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children aged less than 5 years in low (23.3 per 100 000 [95% CI=17.0-31.0]) 
compared to high (27.1 per 100 000 [95% CI=21.6 - 33.7]) areas of deprivation 
(figure 5.6). The incidence rates in the post-conjugate vaccine period were 5.1 per 
100 000 (95% CI=2.4 - 9.3) and 9.2 per 100 000 (95% CI=6.2 - 13.39) for low and 
high areas of deprivation respectively. This represented a 45% difference, and the 
test for linear trend failed to achieve conventional levels of significance. 
Figure 5.6 also shows a gradient in disease experience in each time period 
of the study when H influenzae meningitis cases were examined separately. 
Although neither gradient was significantly different, the gap in incidence between 
the most deprived and least deprived areas widened over the two time periods. 
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Chapter 5: Results 
In the pre-conjugate vaccine period the incidence of H influenzae 
meningitis in children living in areas of high deprivation was 48% higher than that 
of those from areas of low deprivation. In the post-vaccine era this had increased 
to 53%. 
Table 5.17 compares children from the most deprived EDs with children 
from the least deprived EDs for several demographic, social and clinical factors. 
Immunisation status, gender, age-group and clinical disease were similar for both 
groups of children. However, cases of invasive H influenzae disease living in areas 
of high deprivation seem to be more at risk for a number of factors than cases from 
the most affluent areas. 
When children with meningitis were analysed separately (not shown in 
table), several additional factors emerged. It was found that children with 
meningitis from the most deprived areas were more likely to be the youngest child 
in the family (OR=0.12,95% CI=0.01 to 0.96; p=0.032), and more likely to come 
from a family with two or more siblings (OR=undefined, p=0.0030) than children 
from the least deprived areas. 
A number of other factors did not reach conventional levels of significance 
but may be clinically relevant. Compared to cases from the least deprived areas, 
children from the most deprived areas who had been admitted with meningitis were 
asked to attend follow-up less often than their peers from the least deprived EDs 
(67/73 vs 39/39, OR=undefined, p=0.090). Of these, only 55 of 67 (82%) children 
from the most deprived areas were brought for follow-up compared to 36 of 39 
(92%) children from the least deprived group (OR=0.38,95% CI=0.10 to 1.45; 
p=0.24). 
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Table 5.17: Comparison of selected variables for cases of invasive Haemophilus 
influenzae disease by Townsend deprivation category, WMHR 1990-1994 
Variable High Low Odds ratio p value 
deprivation deprivation (95% Cl) 
(n=110) (n=56) 
Study period: 
1990-1992 82 46 0.63 (0.26-1.50) 0.35 
1992-1994 28 10 
Disease entity: 
meningitis 78 40 0.96 (0.44-2.07) 0.94 
non-meningitic 32 16 
Age group (months): 
0-11 49 23 1.13 (0.56-2.29) 0.84 
12-23 33 19 0.85 (0.40-1.78) 0.76 
24-35 13 8 0.81 (0.29-2.32) 0.85 
36-47 5 3 0.85 (0.16-5.68) 1.00 
48-59 10 3 1.78 (0.43-10.49) 0.55 
Gender: 
boys 58 26 1.29 (0.64-2.58) 0.55 
girls 52 30 
Ethnic group 
SA 17 1 10.16 (1.32-78.50) 0.0069 
NSA 93 55 
Large family (> 2 
siblings): 23/88 1/38 13.09 (1.70-100.93) 0.0012 
yes 65/88 37/38 
no 
Immunisation statust: 
age-appropriate 69/88 42/48 0.52 (0.16-1.50) 0.28 
incomplete/none 19/88 6/48 
Underweight for age: 
yes 12/99 1/52 7.03 (0.89-55.7) 0.035 
no 83/99 51/52 
Hearing test requested*: 
yes 56/72 30/37 0.82 (0.27-2.42) 0.86 
no 16/72 7/37 
Attended hearing test*: 
yes 39/56 27/30 0.25 (0.04-1.00) 0.057 
no 17/56 3/30 
Failed hearing test*: 
yes 7/36 0/24 undefined 0.035 
no 29/36 24/24 
' This analysis only includes cases of meningitis 
t 1990 - 1992 (primary immunisation status in the pre-Hib conjugate vaccine period) 
Figures in bold indicate a statistically significantly result 
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In addition, children from the most deprived areas who had meningitis had 
more neurological problems at follow-up compared to those from the least 
deprived EDs (10/77 vs 1/40, OR=5.82,95% CI=0.72 to 47.21; p=0.095), and were 
significantly more likely to have SNHL (OR=undefined; p=0.035). 
No deaths were identified in children from the least deprived areas, whereas 
a case fatality rate of 5.5% (6 of 110) was found in children from the most deprived 
areas. This difference did not reach conventional levels of significance 
(OR=undefined, p=0.097). 
5.4.2.2 Components of the Townsend deprivation score 
There were no obvious disease gradients seen for all invasive H influenzae 
disease when the components of the Townsend material deprivation score were 
examined individually in the two years before Hib conjugate vaccine was 
introduced (figure 5.7). In the post-vaccine period however, gradients from low to 
high areas of deprivation can be seen for all the variables with non-owner 
occupancy being significantly associated with disease risk. 
For meningitis cases a similar picture was observed in the pre-conjugate 
vaccine era with only lack of a car demonstrating a slight gradient. With the 
exception of one variable, overcrowding, figure 5.8 shows that all other 
components of the Townsend score demonstrated a consistent increase in incidence 
of disease with increasing deprivation. 
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Figure 5.7: Incidence rates for invasive H influenzae disease for components of the 
Townsend deprivation score in the WMHR, 1990-94 
Pre-Hib conjugate vaccine: 1990-92 Post-Hib conjugate vaccine: 1992-94 
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Figure 5.8: Incidence rates for Haemophilus influenzae meningitis for components of 
the Townsend deprivation score in the WMHR, 1990-94 
Pre-Hib conjugate vaccine: 1990-92 Post-Hib conjugate vaccine: 1992-94 
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5.4.2.3 Other socioeconomic variables 
For all invasive H influenzae diseases figure 5.9 shows that in the period 
prior to the introduction of Hib conjugate vaccine, population density was 
significantly associated with disease. However, the gradient was contrary to that 
seen previously, with increasing attack rates from high to low areas of population 
density. 
A similar trend, although not reaching conventional levels of significance is 
seen when the proportion of children in the population are examined. Local 
movers show a gradient in the opposite direction, whilst all movers and lone 
parents did not show any gradient. 
As with components of the Townsend deprivation score, there was a change 
in trend for all the census indicators following the introduction of Hib conjugate 
vaccine. Gradients are seen for most of the variables, except child population and 
lone parents. Population density and all movers demonstrated marked trends 
which were statistically significant. 
Haemophilus meningitis cases were analysed separately and gradients were 
seen for a number of variables (figure 5.10). The incidence of Haemophilus 
meningitis for child population and population density decreased with increasing 
deprivation and a significant trend was seen with population density in the pre- 
vaccine era. Other variables showed no trend in incidence during the same time 
period. 
For most of the indicators examined a disease gradient was seen (figure 
5.10) following the introduction of Hib conjugate vaccine. Both types of migration 
showed marked trends in incidence of disease from high to low and both were 
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statistically significant. Haemophilus meningitis rates for population density 
continued to increase from high to low areas of deprivation and just failed to reach 
conventional levels of significance in the second period of the study. The variables 
lone parent and child population showed no trend in incidence. 
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Figure 5.9: Incidence rates for invasive Haemophilus influenzae disease for selected 
census variables in the WMHR, in the pre-Hib conjugate vaccine period 1990-94 
Pre-Hib conjugate vaccine: 1990-92 Post-Hib conjugate vaccine: 1992-94 
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Figure 5.10: Incidence rates for Haemophilus influenzae meningitis for selected 
census variables in the WMHR, in the pre-Hib conjugate vaccine period, 1990-94 
Pre-Hib conjugate vaccine: 1990-92 Post-Hib conjugate vaccine: 1992-94 
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5.4.2.4 KEY POINTS FROM SUB-SECTION 5.4.2 
Q Using the GIS technique, 95% of postcodes were matched to enumeration 
districts. 
Q More cases of disease seen in the most deprived EDs. 
Q Children in areas of low deprivation were at significantly less risk compared to 
children from other areas. 
Q Living in areas of high deprivation was associated with a number of factors 
including being underweight on admission, being of SA origin and suffering 
SNHL. 
Q Fewer children with meningitis who lived in areas of high deprivation were 
asked to, or attended follow-up. 
Q Children with meningitis living in areas of high deprivation were significantly 
more likely to have SNHL. 
Q Difference in incidence of disease were seen between high and low areas of 
deprivation in both time periods. The difference increased from 18% in the pre- 
conjugate vaccine period to 48% in the post-vaccine era. 
Q Gradients were not seen for the four components of the Townsend material 
deprivation score before the introduction of Hib conjugate vaccine. In the post- 
vaccine era gradients which increased from low to high were seen for all 
components. 
Q Areas with a high proportion of non-owner occupiers was significantly 
associated with increased disease risk in the post-conjugate vaccine period. 
Q Population density was associated with disease risk but the gradient increased 
from high to low. 
Q High areas of migration was significantly associated with disease in the post- 
vaccine period. 
Q Most of the socioeconomic variables examined showed trends in the post- 
conjugate vaccine period. 
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5.4.3 Physical environment 
5.4.3.1 Geographic distribution 
District incidence rates 
The district or health authority (HA) of residence was determined using the 
postcode recorded at the time of admission to hospital. The average annual 
incidence rate of invasive H influenzae disease in children according to HA of 
residence is shown in table 5.18 and figure 5.11. The table shows that two districts 
had incidence rates significantly different from that of the WMHR during the pre- 
conjugate vaccine period. Significant differences can also be seen between the 
lowest, South Warwickshire and a number of other districts. 
Following the introduction of the vaccine, the majority of Health 
Authorities experienced a fall in the incidence of invasive H influenzae disease of 
between 42%-100%. One exception to this was Worcester HA with a 67% 
increase in its incidence rate in the two year period immediately following 
introduction of the vaccine. This may have been caused by an'outbreak' in 1993 
when four cases were identified over a3 month period shortly after the vaccine was 
introduced. These four cases were found to be clustered in time, with the first and 
second case separated by 35 days, the second and third by 15 days and the third 
and fourth by 4 days. 
Despite the rapid fall in disease incidence in the period after Hib conjugate 
vaccine was introduced, only 4 health authorities experienced significant 
reductions in the incidence of disease. These were West Birmingham, Solihull, 
Shropshire and Bromsgrove and Redditch. 
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Table 5.18: Disease specific annual incidence rates of invasive Haemophilus 
influenzae disease before and following the introduction of Hib conjugate vaccine 
in the WMHR, 1990-1994 
Health Authority Pre-Hib Post-Hib 
conjugate vaccine conjugate vaccine 
Cases Incidence rate Cases Incidence rate 
(95% CI) (95% CI) 
Bromsgrove & Redditch 
Hereford 
Coventry 
West Birmingham 
Solihull 
East Birmingham 
Mid Staffordshire 
Kidderminster 
North Birmingham 
North Staffordshire 
Shropshire 
South Birmingham 
Dudley 
Wolverhampton 
North East 
Warwickshire 
Walsall 
South East Staffordshire 
Sandwell 
Worcester 
South Warwickshire 
17 74.2 (43.2 - 118.7) 2 8.7 (0.9 - 31.4) 
10 49.2 (23.6 - 90.6) 1 4.9 (0.1 - 27.1) 
19 43.9 (26.3 - 68.6) 5 11.6 (3.7 - 27.0) 
14 40.0 (22.0 - 67.2) 1 2.9 (0.09 - 15.7) 
9 35.6 (16.2 - 67.7) 0 0.0 (0.0 - 14.6) 
12 35.1 (18.2-61.5) 2 5.9(0.6-21.1) 
13 32.2 (17.1 - 55.1) 7 17.4 (6.9 - 35.7) 
4 31.4(8.6-80.1) 0 0.0(0.0-29.1) 
6 30.1 (11.0-65.7) 2 10.0(1.0-36.1) 
15 24.9(14.0-41.0) 6 10.0(3.7-21.8) 
13 24.5 (13.0 - 41.8) 1 1.9 (0.06 - 10.4) 
14 23.8 (13.1 - 40.0) 9 15.3 (7.0 - 29.1) 
8 20.5 (9.0 - 40.4) 3 7.7 (1.5 - 22.5) 
7 20.4 (8.2 - 42.0) 1 2.9 (0.09 - 16.0) 
7 19.9 (8.0 - 41.0) 2 5.7 (0.06 - 20.5) 
6 16.9 (6.2 - 36.9) 1 2.8 (0.08 - 15.5) 
6 16.7 (6.1 - 36.5) 5 13.9 (4.5 - 32.6) 
6 14.8 (5.4 - 32.3) 1 2.5 (0.07 - 13.6) 
3 10.1 (2.0 - 29.5) 5 16.8 (5.4 - 39.3) 
1 3.9 (0.1 - 21.3) 0 0.0(0.0-14.3) 
WMHR 190 27.1 (23.3 - 31.2) 54 7.7 (5.8 - 10.0) 
Incidence per 100 000 children <5 years of age 
Figures in bold indicate incidence rates significantly different from that of the WMIIR 
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Figure 5.11: Incidence rates of Invasive Haemophilus influenzae 
disease in the WMHR by health authority of residence In the pre- 
and post-Hib conjugate vaccine periods 
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Urban/rural districts 
The definition of mainly urban and mainly rural districts has been given in 
section 4.5.5.2. The overall incidence rates for the mainly urban and mainly rural 
districts were similar, 17.5/100 000 and 17.2/100 000 respectively, over the four 
years of the study. Table 5.19 shows that in both years of the post-conjugate 
vaccine period the incidence of disease was slightly higher in the rural areas 
compared to the urban areas. 
Table 5.19: Incidence of invasive Haemophilus influenzae disease by geographic area 
and study year, WMHR 1990-1994 
Mainly urban Mainly rural 
Study year Cases Incidence rate Cases Incidence rate 
(95% CI) (95% CI) 
October 1990-September 1991 
October 1991-September 1992 
October 1992-September 1993 
October 1993-September 1994 
49 26.8 (19.8 - 35.4) 
52 28.4 (21.2 - 37.3) 
22 12.0 (7.5 - 18.2) 
3 1.6 (0.3 - 4.8) 
45 26.8 (19.5 - 35.8) 
44 26.2 (19.0 - 35.2) 
26 15.5 (10.1 - 22.7) 
3 1.8 (0.4 - 5.2) 
Incidence er 100 000 children <5 years of age 
Figures in bold indicate incidence rates significantly different from that of the previous year 
Compared to rural areas, in urban areas the incidence of disease was 
significantly lower in the first year after the vaccine was introduced. The rural 
areas did not experience a significant decrease until the second post-conjugate 
vaccine year. Comparable results were obtained when H inf uenzae meningitis was 
analysed separately (results not shown). 
Table 5.20 compares children from the WMMC (urban districts) with 
children from the districts classified as mainly rural, for several demographic, 
social and clinical factors. 
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Table 5.20: Comparison of selected variables for cases of invasive Haemophilus 
influenzae disease in the WIVIHR by geographic area of residence, 1990-1994 
Variable WMMC Other Odds ratio p value 
(n=126) districtst (95% CI) 
(n=118) 
Study period: 
1990-1992 101 89 1.32 (0.69-2.52) 0.46 
1992-1994 25 29 
Disease category: 
meningitis 79 86 0.63 (0.35-1.12) 0.12 
non-meningitic 47 32 
Ethnic group 
SA 21 1 23.40 (3.09-176.99) <0.0001 
NSA 105 117 
Deprivation category: 
high 79/94 31/72 6.97 (3.20-1537) <0.0001 
low 15/94 41/72 
Large family (> 2 siblings): 
yes 78/100 84/90 0.25 (0.10-0.66) 0.0056 
no 22/100 6/90 
Lone parent: 
yes 20 8 2.28 (0.90-5.95) 0.090 
no 101 92 
Immunisation statusl: 
age-appropriate 85/106 82/97 0.74 (0.34-1.63) 0.53 
incomplete/none 21/106 15/97 
Dexamethasone given: 
yes 51/78 38/83 2.24 (1.13-4.45) 0.019 
no 27/78 45/83 
Follow-up given: 
yes 90/118 98/114 0.52 (0.25-1.09) 0.086 
no 28/118 16/114 
Hearing test requestedl: 
yes 57/75 68/78 0.47 (0.18-1.17) 0.11 
no 18/75 10/78 
Attended hearing test1: 
yes 48/57 51/68 1.78 (0.67-4.81) 0.30 
no 9/57 17/68 
Failed hearing test1: 
yes 8 2 4.54 (0.91-22.75) 0.090 
no 37 42 
"mainly urban' districts 
t'mainly rural' districts 
= 1990 - 1992 (primary immunisation status in the pre-Hib conjugate vaccine period) 
I This analysis only includes cases of meningitis 
Figures in bold indicate a statistically significant result 
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Living in the WMMC was significantly associated with being of SA origin, 
coming from a large family and experiencing deprivation. There were no gender or 
age differences, nor were there differences seen when nutritional status, anaemia 
and chronic illness were compared in these children. 
5.4.3.2 Seasonal variation 
Cases of invasive H inf uenzac disease were seen throughout the year, but 
were more common in the colder months. The majority of cases (144 of 258,56%) 
were seen between October and February, which also accounted for the highest 
number of fatalities (5 of 8). 
A statistically significant association was seen when season of onset and 
ethnic group were examined. During the autumn months significantly fewer SA 
children were admitted to hospital than at other times of the year (OR=0.09,95% 
CI=0.01 to 0.66; p=0.0018). 
When the relationship between age of admission and season of onset was 
examined, children admitted during the summer months were significantly younger 
than those admitted during cooler months of the year (p=0.039). The children in 
the former group had a mean age of 14.2 months (median 11.5 months, range 0-36) 
compared to a mean age of 19.3 months (median 15.0, range 0-59 months). 
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Evaluation by disease entity (figures 5.12 and 5.13) showed the occurrence 
of bimodal patterns for both meningitis, which peaked in mid-autumn and late 
winter, and non-meningitic diseases which peaked in late autumn and mid-spring. 
5.4.3.4 KEY POINTS FROM SUB-SECTION 5.4.3 
U Wide differences in incidence rates were observed for the different health 
authorities in the WMHR in both the pre- and post-vaccine periods. 
a All districts except one, experienced a reduction in disease incidence in the 
post-vaccine period. 
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Q Significant reduction in disease incidence seen in the urban areas before the 
rural areas in the post-conjugate vaccine era. 
Q Clinically, a lower proportion of children from urban areas were asked to attend 
follow-up or had a hearing test requested compared to children from rural areas. 
Q Proportionately more children from urban areas had SNHL. 
Q The majority of cases were seen in the colder months of the year, and a bimodal 
pattern was observed. 
Q Significantly fewer SA children were admitted in the autumn months than at 
any other time of the year. 
5.5 CLINICAL FEATURES 
5.5.1 Spectrum of disease 
The distribution of disease entities was similar in both study periods with 
meningitis and epiglottitis responsible for the majority of cases (table 5.21). 
Seventeen (7% of 258) cases were identified as having more than one form 
of invasive H influenzae disease. There were nine with pneumonia and meningitis, 
five with pneumonia and epiglottitis. One other child had pneumonia and cellulitis 
in addition to their primary diagnosis of meningitis. Other cases were septic 
arthritis and osteomyelitis (1), epiglottitis and septic arthritis (1). 
The following section will discuss the different clinical manifestations of 
invasive H influenzae disease. 
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Chapter 5: Results 
5.5.1.1 Meningitis 
Meningitis was the most common disease entity each year and accounted 
for 172 of 258 (67%) cases. During the four year study period, the incidence of 
Haemophilus meningitis in children aged 0-4 years fell 92% from 17.7 cases per 
100 000 in the first year of the study to 1.38 cases per 100 000 in the final year of 
the study. 
The mean age at presentation for non-neonatal cases was 17.3 months 
(median 13.0, range 1-59 months). During the 1990/92 period, 46% (62 of 136) of 
cases were under 12 months of age, and the mean age at presentation was 17 
months (median 12, range 1-58 months). In the post-vaccine period the proportion 
aged 12 months or less fell to 36% (12 of 36), and the mean age increased to 18.2 
months (median 15.5, range 1-59). When the mean age of the groups were 
compared for the two periods of the study, the resultant probability value (p=0.618) 
was not statistically significant. 
Of 133 cases of meningitis fulfilling the case definition for anaemia used in 
this study, 52 (39%) were found to be anaemic on admission to hospital. For non- 
fatal cases of meningitis, the average length of hospital stay was 11.7 days (median 
11 days), and ranged between 0-76 days. One child, who was very ill on 
admission, spent less than 24 hours before being transferred to another hospital 
within the region. Further information on this case was not available as the 
medical notes were incomplete. The child who spent 76 days in hospital was a 
seven month old boy who was hypertonic on admission and had seizures within 24 
hours of admission. He developed a hydrocephalus which required a shunting 
procedure, and subsequently developed seizures and brain damage. 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 214 
Chapter 5: Results 
Ten (6%) children with meningitis had concomitant pneumonia. One of 
these children had meningitis and pneumonia together with cellulitis, and was one 
of five deaths due to meningitis in this series. Children with meningitis who had 
more than one recognised site of infection were affected mainly in the pre-vaccine 
era (8 of 10), and were young boys of NSA origin. No child was seen with 
concomitant meningitis and epiglottitis. 
Over a third (62 of 168,37%) of meningitis cases received antibiotics prior 
to admission. Those who received pre-admission antibiotics had a mean age of 
19.4 months (median 15.0 months, range 3-59 months), whereas those who did not 
had an average age of 15.7 months (median 11.5 months, range 0-59 months). 
This difference just failed to reach conventional levels of significance (p=0.076). 
There was a decrease in the number of children who received antibiotics before 
admission from 39% (52 of 134) in the first period of the study to 29% (10 of 34) 
in the post-conjugate vaccine period. This was not statistically significant 
(p=0.42). 
Children with meningitis were more likely to have received antibiotics prior 
to admission (OR=2.17,95% CI=1.13 to 4.17; p=0.018), and to be brought to 
hospital later (more than 24 hours following the onset of symptoms), than children 
with other types of invasive disease (OR=3.29,95% CI=1.84 to 5.93; p<0.0001). 
Resistance to ampicillin was encountered in 21 of 145 (15%) CSF isolates, 
and 20 of 107 (16%) blood specimens. 
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5.5.1.2 Epiglottitis 
Epiglottitis was the second most common disease identified during the 
study period. The incidence of disease decreased 55% from 3.1 per 100 000 cases 
in 1990-92 to 1.4 in 1992-94. This decrease was not statistically significant. 
The mean age at admission for epiglottitis was 28.9 months (median 27.5 
months, range 10-59 months), with 41% (13 of 32) of cases aged 24 months or 
less, compared to 17.2 months for meningitis (median 13.0 months, range 0-59 
months). The difference between the mean age in children with epiglottitis and 
those with meningitis was highly significant (p<0.0001). 
Children aged 24-59 months were more at risk from epiglottitis (OR=5.02, 
CI=2.18 to 11.64; p<0.0001), while children aged less than 12 months were 
significantly less likely to have epiglottitis than any other invasive disease 
(OR=undefined, p<0.0001). 
Analysis of the severity of this manifestation of invasive H influenzae 
disease indicated that cases of epiglottitis were more likely to be admitted within 
24 hours of the onset of symptoms than those with non-epiglottic disease 
(OR=6.78,95% CI=2.56 to 20.90; p<0.0001). Using intubation as a further 
measure of the severity of the disease in this series, 69% (22 of 32) of the cases 
were intubated. The average duration of intubation was 2 days (range 0-4 days). 
Respiratory arrest occurred in one child at the time of admission, the child was 
successfully resuscitated and suffered no long term sequelae. Eighteen (56%) 
children were admitted to ITU or its equivalent, for between I to 14 days (mean 
2.3, median 2 days). The mean and median length of hospital stay were 5 days 
(range 1-13 days), with 63% of cases spending 5 days or less in hospital. 
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Children with epiglottitis were less likely to receive chemoprophylaxis than 
children with other invasive disease during admission or on discharge (OR=0.36, 
95% CI=O. 14 to 0.89; p=0.024), and were also less likely to receive follow-up 
(OR=0.10,95% CI=0.04 to 0.23; p<0.0001). 
Six of 32 (19%) had associated invasive H influenzae disease. Pneumonia 
was present in 5 children, while the remaining child, originally admitted with 
septic arthritis of the knee had developed epiglottitis in hospital. 
There were no deaths in this group of children, and no documented 
sequelae at discharge or during follow-up. 
Epiglottitis was observed mainly in the colder months of the year with 20 
of 32 cases (63%) identified between October and February. 
Of the 32 cases of epiglottitis seen 18 (56%), were serotype b. None of the 
ten children hospitalised in the post-vaccine era had been immunised with Hib 
conjugate vaccine prior to admission. 
5.5.1.3 Cellulitis 
Cellulitis was the most common non-meningitic disease after epiglottitis. 
The most common site for cellulitis was the periorbital area which accounted for 8 
of 15 cases (53%). Other sites were the head and neck (4), and the lower (2) and 
upper limbs (1). Eight boys and 7 girls were affected and none had more than one 
site involved. 
This manifestation of invasive H influenzae disease affected children aged 
3-48 months (mean 14.3 months, median 10 months). The mean age of those with 
periorbital cellulitis differed from that of those with other areas affected. 
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Periorbital cellulitis was seen more often in children with a mean age of 16.4 
months (median 13.0 months, range 6-48 months), whereas children with other 
areas affected had a mean age of 12.5 months (median 9.5, range 3-21 months). 
This difference was not significant (p=0.50). 
The majority (9 of 15) of these children spent less than 5 days in hospital 
with the average length of stay being 4.5 days (median 4 days, range 3-8 days). 
5.5.1.4 Pneumonia 
Pneumonia on its own accounted for 5% (13 of 258) of all invasive disease 
in both the pre-vaccine and post-vaccine periods of the study. However the 
incidence rate fell by 71% in the two years following the introduction of the 
vaccine, from 1.4 per 100 000 to 0.4 in 1992/94. 
Pneumonia was the most frequent disease entity associated with other 
invasive H influenzae disease, and amongst 17 cases identified with more than one 
disease entity, pneumonia was diagnosed in 15 (88%). 
Children with pneumonia were mainly NSA (11 of 13) and boys (10 of 13). 
The two SA children with this disease entity were both girls. The mean age of 
children with this form of invasive H influenzae was 15.4 months (median 15 
months, range 2-3 8 months). 
Two of 13 children with pneumonia as the primary diagnosis died, and a 
further 2 deaths occurred in children who had Haemophilus meningitis and 
concomitant pneumonia. 
Only one of the 13 isolates was serotyped, and this was type b. Of the ten 
isolates with antibiotic sensitivity results, none were ampicillin resistant. 
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5.5.1.5 Septicaemia 
Twelve children in this series were noted to have positive blood cultures 
without an associated focal infection. 
The median age of children in this group was 15 months (mean 23 months, 
range 2-58 months). Most of the children affected were less than 2 years old (9 of 
12,75%), with three cases occurring in children aged 51,55 and 58 months. 
Equal numbers of boys and girls were affected, giving a gender ratio of 1: 1. 
The ratio for ethnic groups however was 3: 1, with 9 children of NSA origin 
affected. 
5.5.1.6 Septic arthritis 
There were 8 sites identified in 7 cases. One child had two joints involved 
simultaneously, the left elbow and right shoulder. In this series, the larger joints 
were mainly involved with the upper (two sites each for the shoulder and elbow 
joints), and lower (two sites each for the knee and hip joints) extremities equally 
affected. All children recovered without any apparent disability. 
An associated invasive Haemophilus infection was noted in one child who 
had osteomyelitis in addition to septic arthritis. 
Children with an average age of 18 months (median 11 months, range 10- 
32 months) were affected with the majority of cases (4 of 7) occurring before 12 
months of age. All cases were seen in children of NSA origin, and 5 girls were 
affected. 
Septic arthritis required an average length of hospital stay of 12.7 days 
(median 7 days, range 4-39 days). This was reduced to 8.3 days when the child 
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with the longest hospital stay was excluded from the analysis. This child had 
incision and drainage of the hip and open reduction of the femoral head. 
During hospitalisation five of the children had X-rays of the affected joints. 
Only one child had radiographic evidence of a bony abnormality. 
5.5.1.7 Osteomyelitis 
Osteomyelitis without an associated invasive H influenzae disease was seen 
in two children. One 12 month old boy had osteomyelitis of the humerus, while 
the second child, a 14 month old girl had osteomyelitis of the distal end of the 
tibia. Both children were of NSA origin. 
There was no X-ray evidence of osteomyelitis in either of these children, 
however, a radionuclide scan suggested the diagnosis in one child. Diagnosis in 
the second child appeared to be based on blood culture and clinical signs and 
symptoms. At discharge both were well and there were no apparent long term 
sequelae. 
5.5.1.8 Uncommon manifestations 
Two less common manifestations of invasive H influenzae disease were 
encountered in this study. One was a case of bacterial endocarditis in an 8 month 
old NSA girl with pre-existing congenital heart disease. The second was a case of 
empyema in a four year old girl of NSA origin. Both cases occurred in the pre- 
vaccine era and both recovered uneventfully. 
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5.5.1.9 Perinatal disease 
During the study period, 4 neonates with invasive H influenzae disease 
were seen. This represents 1.6% of all cases identified. There were 74,210 live 
births in the region during this period, giving an average annual incidence of 1.4 
cases per 100 000 live births (95% CI=0.37 to 3.45). 
Onset of illness occurred within 24 hours of life in all of these babies. 
Positive bacterial cultures were obtained from blood (four specimens) and CSF 
(one specimen). None of the isolates were serotyped. Three were diagnosed as 
neonatal septicaemia, and one as neonatal meningitis. 
Three of the neonates were premature, the youngest was 26 weeks and the 
others were delivered at 28 and 35 weeks. All three were also low birthweight 
babies being 1080g, 1020g and 2350g respectively. The baby born at 26 weeks 
was the only death in this group. 
Clinical details were available for three of the mothers. H influenaae was 
isolated from the placental and vaginal cultures of one mother. Another mother 
had premature rupture of the membranes, but all cultures were negative, while the 
third mother had no clinical signs of infection. Most of the mothers were young 
(three were 20 years old, and one was 22 years old) and lone parents with more 
than one child and resident in the most deprived EDs (3 of 4). 
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5.5.1.10 KEY POINTS FROM SUB-SECTION 5.5.1 
Q Meningitis accounted for the majority of cases in both the pre-conjugate and 
post-conjugate vaccine periods. 
Q Anaemia was identified in 39% of meningitis cases on admission. 
Q Children with meningitis were brought to hospital significantly later than 
children with other types of invasive disease. 
Q Antibiotics prior to admission were given to 37% of cases of meningitis. These 
children tended to be older than those who did not receive antibiotics. 
Q After meningitis, epiglottitis was the second most common disease entity. 
Q The incidence of epiglottitis fell by 79% in the 2 years following the 
introduction of Hib conjugate vaccine. 
Q Children with epiglottitis were significantly older than those with meningitis 
Q Pneumonia was the disease most frequently associated with other invasive 
diseases. 
Q Only 1 of 13 isolates from children with pneumonia were serotyped, and this 
was type b. 
Q Four cases of perinatal disease identified, all developed illness within 24 hours 
of birth. None of the isolates were serotyped, and positive cultures were only 
obtained from I of 4 mothers. 
Q All 4 mothers were young, lone-parents and the majority were resident in the 
most deprived areas. 
Q Other invasive diseases encountered were septic arthritis, osteomyelitis, 
cellulitis, bacterial endocarditis and empyema. 
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5.5.2 Morbidity and mortality 
5.5.2.1 Morbidity 
Morbidity was assessed indirectly by determining the length of hospital 
stay and the presence of documented sequelae at follow-up. 
Hospital stay 
The median duration of hospital admission for all invasive H influenzae 
disease were the same in both periods of the study, 9 days. For the different 
disease manifestations, the median length of hospital stay did not differ between 
those who were admitted in the pre-conjugate and post-conjugate vaccine periods. 
Children with meningitis had median lengths of hospital stay of 11 and 10 days in 
the pre-conjugate and post-conjugate periods respectively. The median length of 
hospital admission for epiglottitis was 5 days in both time periods. Cases with 
non-meningitic and non-epiglottic disease had median lengths of hospitalisation of 
5 and 6 days before and after the introduction of the conjugate vaccine 
respectively. 
Sequelae 
Follow-up and attendance for follow-up were evaluated by examining the 
medical records for evidence of the child being seen, either at the admitting 
hospital or another centre, at least once following discharge. Of the surviving 
meningitis cases, 153 of 161 (95%) were asked to return for follow-up aller 
discharge. A similar evaluation of the non-meningitic disease entities revealed that 
only 45 of 82 (55%) were requested to attend for follow-up. This difference was 
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statistically significant (OR=15.72,95% CI=6.39 to 40.00; p<0.0001). Similar 
proportions of meningitic and non-meningitic patients did not attend follow-up 
(12% and 13% respectively) 
Seventeen children who had at least one recorded follow-up after discharge 
from hospital presented with a variety of sequelae, and four of these had multiple 
problems (table 5.22). All children identified with complications at follow-up had 
meningitis, and excluding fatal cases of invasive disease, a significant association 
between meningitis and complications at follow-up was observed (OR=undefined, 
P<0.001). 
Table 5.22: Long-term sequelae in survivors of invasive Haemophilus 
influenzae meningitis resident in the WMHR and ranked by age, 1990-1994 
Case Age Sex Ethnic Long-term sequelae 
no. (months) group 
1 1 M SA Hydrocephalus; seizures 
2 3 F SA Hearing loss; developmental delay 
3 5 M NSA Hearing loss 
4 6 M NSA Hydrocephalus; developmental delay; 
seizures; hemiparesis 
5 7 F NSA Hearing loss 
6 7 M NSA Hearing loss 
7 7 M NSA Hydrocephalus; developmental delay; 
seizures 
8 8 M NSA Hydrocephalus 
9 8 M NSA Hearing loss 
10 9 M NSA Hearing loss 
11 16 M NSA Hearing loss 
12* 18 F NSA Hearing loss 
13 23 F NSA Hearing loss 
14 25 M NSA Seizures 
15 34 F NSA Hemiparesis 
16 52 F NSA Hearing loss 
17 52 F NSA Hearing loss 
* This child was resident outside the region 
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SNHL was the most common post-meningitic complication. Figure 5.14 
shows that of the 157 children resident in the WMHR who survived, only 124 
(79%) had a hearing test requested by the hospital prior to or at the time of 
discharge, and only 98 of these were seen at least once. 
Figure 5.14: Sensorineural hearing loss and Haemophilus influenzae meningitis in 
children resident in the WMHR, 1990-1994 
CASES 
Hearing 
Test 
Requested 
Attended 
Hearing 
Test 
Result of 
Hearing 
Test 
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Of the 98 children tested, nine children had equivocal results, either 
because of an upper respiratory tract infection (URTI) or being uncooperative at 
the time of testing. These tests were to be repeated but no definitive results were 
located in the medical notes at the time of data collection. 
In this series 10% (10 of 98) children were diagnosed as having SNHL 
following audiometry. One other child with SNHL was resident outside the region 
and excluded from the following analysis. The hearing deficit in these children 
was bilateral in 6 cases and unilateral in 4, with one child requiring cochlear 
implants, and one other bilateral hearing aids. Similar proportions of SA (1 of 9, 
11%) and NSA (9 of 80,11%) children were affected. 
The ten children resident in the region with SNHL were aged 3-52 months, 
with a mean age of 18.2 months (median 9.5 months) compared with an average 
age of 19.9 months (median 15.0 months, range 1-58 months) in those without 
hearing loss. Eight of 62 (13%) children aged less than 24 months of age had 
SNHL, while 2 of 27 (8%) aged 24 months or more failed their hearing test. This 
difference was not statistically significant (p=0.72). Equal numbers of boys and 
girls were affected. 
The proportion of children identified with SNHL decreased from 13% (9 of 
72) in the pre-Hib conjugate vaccine era to 6% (1 of 17) in the post-conjugate 
vaccine period. This reduction was not statistically significant (OR=0.44,95% 
CI=0.02 to 3.93; p=0.68). 
Children who had been ill for more than 48 hours before admission were 
found to be at greatest risk for SNHL (OR=6.49,95% CI=1.70 to 24.77; 
p<0.0064). 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 226 
Chapter 5: Results 
The mean length of admission for those with SNHL was 15.4 days (median 
12.0 days, range 8-54) compared to 11.3 days (median 11.0, range 4-76 days), for 
those who did not suffer any hearing loss. This difference failed to reach 
conventional levels of significance (p=0.16). 
5.5.2.2 Mortality 
Outcome was known in 254 cases, and there were 8 deaths, giving a case 
fatality ratio of 3%. Equal numbers of deaths were seen in boys and girls. Of the 8 
deaths, 4 of 197 (2%) occurred during the pre-vaccine period, and 4 of 57 (7%) in 
the post-vaccine era. This difference almost reached conventional levels of 
statistical significance (OR=3.64,95% CI=0.88 to 15.05; p=0.078). 
Five children with meningitis died, two others died following an episode of 
pneumonia and the remaining death occurred in a case of neonatal sepsis. Five 
deaths were known to have occurred suddenly with the child either being found 
dead at home or soon after admission. The three other fatalities received hospital 
treatment for one, two and five days. 
Of the deaths occurring in the post-vaccine era, only one. child had received 
Hib conjugate vaccine. This 3 month old child was immunised ten days prior to 
hospitalisation, and was therefore classed as an apparent vaccine failure. 
There were 6 of 232 (2%) children of NSA origin who died compared to 2 
of 22 (9%) SA children. This difference did not reach conventional levels of 
significance (OR=3.77,95% CI=0.71 to 19.90; p=0.15). 
The mean age at admission of children who died was 7.9 months (median 
3.0 months, range 0-29 months) with 6 of 8 deaths occurring in children aged 12 
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months or less. Those who survived were on average 18.9 months of age (median 
15.0, range 0-59) on admission. There was a significant difference between the 
mean age of survivors and those who died (p=0.027) 
5.5.2.3 KEY POINTS FROM SUB-SECTION 5.5.2 
El Significantly more cases of meningitis were asked to return for follow-up after 
discharge, compared to those with non-meningitic disease. 
Q SNHL was the most common post-meningitic complication. 
El Only 65% of children resident in the WMHR had at least one documented post- 
meningitic hearing test. 
O SNHL was identified in 10% of post-meningitic survivors. 
Q Hearing loss was significantly associated with delay in being brought to 
hospital. 
O Case fatality rate of 3% over the four years of the study, 2% in 1990-92 and 7% 
in 1992-94. 
Q Those who died were significantly younger than survivors, and the majority of 
deaths occurred suddenly at home. 
5.5.3 Antibiotic regimens 
Only the initial antibiotics prescribed on admission to children with 
meningitis were considered in this analysis. Dosage and duration of treatment with 
antibiotics were not examined. Table 5.23 shows the various antibiotics prescribed 
for children with H influenzae meningitis. 
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Table 5.23: Antibiotics prescribed either singly or as combined therapy for the 
initial treatment of Haemophilus influenzae meningitis before and following the 
introduction of Hib conjugate vaccine in the WMHR, 1990-1994 
Antibiotic Pre-Hib 
conjugate vaccine 
Post-Hib 
conjugate vaccine 
No. Total 
Ampicillin 28 
alone 3 - 3 
combined 22 3 25 
Chloramphenicol 118 
alone 6 2 8 
combined 98 12 110 
Penicillin 95 
alone - - - 
combined 81 14 95 
Cefotaxime 42 
alone 17 12 29 
combined 5 8 13 
Ceftazidime 6 
alone 1 1 2 
combined 4 - 4 
Cefuroxime 12 
alone 1 - 1 
combined 10 1 11 
Other antibiotics 7 
alone - 1 1 
combined 6 - 6 
All antibiotics 254 54 308 
The most common antibiotic prescribed in the pre-Hib conjugate vaccine 
era was chloramphenicol. Of the 254 antibiotics prescribed it was given either 
alone or combined with another antibiotic on 104 (41 %) occasions. In the second 
period of the study a total of 54 antibiotics were prescribed, and chloramphenicol 
accounted for only 14 (26%) of these prescriptions. This reduction almost reached 
conventional levels of significance (OR=0.50,95% CI=0.25 to 1.02; p=0.056). 
Eight children received chloramphenicol alone as initial antibiotic therapy. 
Drug assays were performed for only 3 of these cases. Overall, less than half (50 
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of 118,42%) of the children who were prescribed chloramphenicol had blood 
levels of the drug monitored. 
Chloramphenicol was the most prescribed antibiotic in all age groups. In 
those aged less than 12 months chloramphenicol was prescribed for 53 of 142 
(37%) cases of meningitis. However, less than half (47% of 53) of these had serum 
chloramphenicol levels measured at least twice. 
Antibiotic combinations used during the pre-Hib conjugate vaccine period 
were compared with those employed during the post-conjugate vaccine period. 
Compared with other combinations, chloramphenicol and penicillin were used 
significantly more for the treatment of meningitis in both study periods (OR=2.55, 
95% CI=1.05 to 6.35; p=0.038). 
Cefotaxime was the most prescribed cephalosporin both prior to and 
following the introduction of Hib conjugate vaccine. There was a significant 
increase in the number of cases prescribed this drug as initial antibiotic therapy, 
either alone or in combination with another antibiotic in the immediate post- 
vaccine era (OR=6.20,95% CI=3.07 to 12.05; p<0.0001). Overall there was a 
significant increase in the number of children who received a cephalosporin as part 
of initial antibiotic therapy in the post-vaccine period (OR=3.91,95% CI=2.05 to 
7.43; p<0.0001). 
No association was found between the antibiotics prescribed and mortality, 
SNHL or other sequelae of meningitis. 
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5.5.4 Dexamethasone therapy 
Dexamethasone is not recommended for the routine treatment of H 
influenzae meningitis in the UK, however, this study found that 93 of 168 (55%) 
children with meningitis received intravenous dexamethasone. Seventy one of 134 
(53%) in the pre-conjugate vaccine period and 22 of 34 (65%) in post-conjugate 
vaccine era. The dosage and duration of steroid therapy were not examined in this 
analysis. 
Table 5.24 compares the characteristics of children with Haemophilus 
meningitis who received dexamethasone during their hospital admission with those 
that did not. Both groups had similar demographic and clinical characteristics. 
Slightly more children who received dexamethasone (6 of 43,14%) were 
later found to have SNHL than those who did not (5 of 48,10%). 
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Table 5.24: Comparison of selected variables for cases of Haemophilus influenzae 
meningitis who received dexamethasone therapy with those not receiving 
dexamethasone in the WMHR, 1990-1994 
Variable Received 
DXM* 
(n=93) 
No 
DXM* 
(n=75) 
Odds ratio 
(95% Cl) 
p value 
Study period: 
1990-1992 71 63 0.61 (0.26-1.43) 0.30 
1992-1994 22 12 
Age group (months): 
0-11 41 32 1.06 (0.55-2.05) 0.98 
12-23 31 26 1.29 (0.66-2.53) 0.52 
24-35 12 7 1.44 (0.49-4.32) 0.63 
36-47 7 4 1.44 (0.35-6.99) 0.76 
48-59 2 6 0.25 (0.02-1.48) 0.14 
Sex: 
boys 45 36 1.02 (0.53-1.95) 0.92 
girls 48 39 
Ethnic group 
SA 10 4 2.14 (0.58-9.71) 0.36 
NSA 83 71 
Length of admission: 
mean 11.5 11.8 0.80 
7 days or more 86/93 58/75 3.73 (1.35-10.68) 0.0082 
10 days or more 58/93 43/75 1.23 (0.63-2.41) 0.61 
Readmitted: 
yes 1 4 0.19 (0.00-2.02) 0.17 
no 92 71 
Antibiotics before 
admission: 
yes 32/92 30/74 0.78 (0.39-1.55) 0.55 
no 60/92 44/74 
Sequelae: 
yes 11 6 1.56 (0.50-5.41) 0.55 
no 82 69 
Failed hearing test: 
yes 6/43 5/48 1.39 (0.32-6.26) 0.85 
no 37/43 43/48 
Died: 
yes 0/89 2 undefined 0.21 
no 89/89 73 
Dexamethasone 
Figures in bold indicate a statistically significant result 
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5.5.5 Prophylaxis 
It is recommended that prophylaxis for the prevention of secondary cases of 
invasive H influenzae disease be given to the index case prior to discharge, and to 
all household members where there is another child less than 4 years of age in the 
index household. 
During hospital admission or prior to discharge, rifampicin was prescribed 
for some or all contacts of 50 of 115 (43%) index children who had a sibling aged 
less than 4 years in their household. Chemoprophylaxis was also prescribed for 11 
of 28 (39%) children who were the only child in the family or did not have siblings 
aged less than 4 years. In only 36 of 115 (31%) cases were some or all contacts of 
children with siblings aged less than 4 years prescribed rifampicin. 
Contacts of index cases with meningitis who had siblings below four years 
of age were more likely to receive prophylaxis than those who had a non- 
meningitic disease (OR=6.29,95% CI=2.20 to 21.88; p=0.00022). 
Table 5.25 compares the data obtained for index cases who received 
rifampicin with those who did not. Several significant findings can be seen. 
Additional analyses revealed that amongst the group of children attending daycare, 
those who had meningitis were more likely to receive prophylaxis than those who 
had non-meningitic disease (OR=13.0,95% CI=2.01 to 135.83; p=0.0035). 
Although statistically there was no difference between NSA and SA cases 
receiving prophylaxis, contacts of SA children were more likely (OR=3.65,95% 
CI=1.32 to 10.16; p=0.0091) to be prescribed rifampicin than their NSA 
counterparts. 
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Table 5.25: Comparison of selected variables for cases of Haemophilus influenzae 
disease who were prescribed prophylaxis with those not prescribed prophylaxis in 
the WMHR, 1990-1994 
Variable PXS No Odds ratio p value 
prescribed PXS' (95% CI) 
(n=111) (n=135) 
Study period: 
1990-1992 82 110 0.64 (0.34-1.23) 0.20 
1992-1994 29 25 
Disease entity: 
meningitis 99 64 9.15 (4.40-19.38) <0.0001 
non-meningitic 12 71 
Age group (months): 
0-11 45 49 1.20 (0.69-2.07) 0.58 
12-23 37 48 0.91 (0.52-1.59) 0.82 
24-35 13 21 0.92 (0.32-1.60) 0.49 
36-47 9 9 1.24 (0.43-3.54) 0.85 
48-59 7 8 1.07 (0.34-3.38) 0.89 
Gender: 
girls 62 57 1.73 (1.01-2.97) 0.045 
boys 49 78 
Ethnic group 
SA 13 7 2.43 (0.86-7.02) 0.10 
NSA 98 128 
Large family (> 2 
siblings): 38/82 42/108 1.36 (0.73-2.53) 0.38 
yes 44/82 66/108 
no 
Siblings <4 years old: 
yes 50/61 65/82 1.19 (0.47-3.00) 0.85 
no 11/61 17/82 
Attended daycare 
yes 18 21 1.05 (0.50-2.20) 0.98 
no 93 114 
Length of admission: 
mean 12.0 9.3 0.021 
7 days or more 96/111 79/135 4.54 (2.29-9.10) <0.0001 
10 days or more 72/111 45/135 3.69 (2.10-6.50) <0.0001 
PXS for some/all contacts: 
yes 51 16 6.32 (3.19-12.67) <0.0001 
no 60 119 
Prophylaxis 
Figures in bold indicate a statistically significant result 
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When rifampicin prophylaxis was analysed against season of onset, 
significantly fewer cases of meningitis (OR=0.46,95% CI=0.24 to 0.91; p=0.036), 
and their contacts (OR=0.38,95% CI=0.18 to 0.81; p=0.017) received prophylaxis 
during the autumn months than at any other time of the year. 
In addition to these findings, examination of the prescriptions contained in 
the medical notes indicated that there was confusion as to the duration and dosage 
of rifampicin required. In several instances, the index child and their contacts 
received prophylaxis which was appropriate for meningococcal disease (2 days) 
rather than for H influenzae (4 days). 
5.5.5.1 KEY POINTS FROM SUB-SECTION 5.5.3 to 5.5.5 
Q Chloramphenicol was the single most commonly prescribed antibiotic. 
Q Only 42% of children who received chloramphenicol had assays performed. 
Q Penicillin and chloramphenicol were the first-line combination of choice in 
both study periods. 
Q There was a significant increase in use of cefotaxime in the second period of the 
study. 
Q Dexamethasone was prescribed for 55% of meningitis cases in the pre- 
conjugate vaccine period and 65% in the post-conjugate vaccine period. 
Q Rifampicin was prescribed for 31% of cases who had a sibling aged 4 years or 
less. 
Q Rifampicin chemoprophylaxis was prescribed for 39% of children who were 
singletons or did not have a sibling aged less than 4 years. 
Q Children with meningitis were more likely to receive prophylaxis than those 
who had non-meningitic disease. 
Q Significantly more girls received prophylaxis than boys. 
Q Contacts of SA children were significantly more likely to receive prophylaxis 
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than contacts of NSA children. 
Q Significantly more cases received prophylaxis if they were admitted for seven 
days or more. 
Q Significantly fewer cases of meningitis and their controls received prophylaxis 
in the autumn than at any other time of the year. 
Q There appeared to be confusion regarding the dosage and duration of 
chemoprophylaxis. 
5.6 BACTERIAL EPIDEMIOLOGY 
5.6.1 Diagnostic tests 
There were 172 children with a diagnosis of meningitis in this series. In 
160 cases, both CSF and blood samples were taken. The organism was isolated 
from both specimens in 124 (78%) cases, from CSF and not blood in 22 (14%) 
cases, and from blood and not CSF in 14 (9%) cases. Of the remaining 12 cases, 
two children who died suddenly at home had the organism isolated from post- 
mortem swabs of the meninges, six children had only CSF samples taken and four 
others had only blood samples taken. In addition, on gross examination 9 of 162 
(6%) CSF specimens were reported as clear. Despite this all nine CSF cultures 
yielded H influenzae. 
Of the 87 children who had non-meningitic diseases, 75 (86%) had blood 
cultures performed without a concomitant CSF culture, and eleven children had 
both blood and CSF specimens taken of which only the blood culture was positive. 
The remaining child died before blood or CSF specimens were taken. Diagnosis 
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was by a post-mortem swab of the trachea and bronchi, and a sample of lung 
parenchyma, all of which grew H influenzae. 
When the effect of pre-admission antibiotics on culture results was 
examined, a significant association between negative blood cultures and cases who 
had received antibiotics prior to admission was found (OR=3.47,95% CI=1.36 to 
8.94; p=0.0064). A similar association was not seen with CSF cultures. 
5.6.2 Serotype 
Serotyping results were available for 154 of 258 (60%) cases, of which 152 
(99%) were type b. There were two non-capsulate strains, and these accounted for 
less than 1% (1 of 114) and 3% (1 of 40) serotypes in the pre- and post-Hib 
conjugate vaccine periods respectively. Both were ampicillin resistant cases of 
meningitis. One occurred in a two month old boy in the pre-vaccine period, and 
the other in a boy of 13 months in the post-vaccine period, both were NSA and had 
uneventful hospital admission and follow-up. 
A slight increase in the number of isolates serotyped was noted when the 
two main study periods were compared. In the pre-Hib conjugate vaccine era, 114 
of 199 (57%) were serotyped, compared to 40 of 59 (68%) in the post-Hib 
conjugate vaccine era. 
5.6.3 Antibiotic resistance 
Ampicillin resistance was identified in 54 of 357 (15%) H influenzae 
specimens. All the isolates tested were sensitive to chloramphenicol and 
cephalosporins. There were 33 of 211 (16%) blood culture isolates which were 
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ampicillin resistant, and 21 of 146 (14%) CSF isolates resistant to ampicillin. 
Nineteen of the CSF specimens were serotyped and 17 (89%) of these were 
serotype b. Of the ampicillin resistant blood specimens, 22 were serotyped and 21 
(95%) of these were serotype b. 
In 16 of the 54 resistant cases, both blood and CSF isolates had been taken 
simultaneously. Eleven isolates exhibited ampicillin resistance in both specimens, 
4 had ampicillin resistant H influenzae in blood but not in the CSF, while one 
organism demonstrated ampicillin resistance in CSF but not in blood. 
Two of the children who died had isolates identified which were resistant to 
ampicillin. One was a blood specimen, the other CSF. However, there was not a 
statistically significant association between ampicillin resistance and death. Two 
other children whose outcome was unknown also had ampicillin resistant invasive 
organisms. 
Significantly more children with ampicillin resistant invasive H influenzae 
were found to suffer hearing loss as a sequelae (OR=4.04,95% CI=1.07-15.25; 
p=0.045). A similar association was not found for a number of other factors 
including age, gender, ethnic group, chronic illness, anaemia and poor nutritional 
status on admission. Children with a history of previous hospital admission as well 
as those who were discharged and readmitted following the index admission were 
also analysed. Both failed to produce statistically significant associations. 
Ampicillin resistance increased during the post-vaccine period of the study 
for each type of specimen. Venous blood isolates exhibited resistance to ampicillin 
in 15% (24 of 163) of cases in the pre-vaccine period. This increased to 19% (9 of 
48) in the post-vaccine period (OR=1.34,95% CI=0.53 to 3.33; p=0.65). CSF 
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isolates demonstrated a more marked increase from 13% (15 of 116) to 20% (6 of 
30) during the same time periods (OR=1.68,95% CI=0.59 to 4.79; p=0.49). 
Neither of these increases were statistically significant. 
5.6.4 KEY POINTS FROM SECTION 5.6 
was seen between negative blood cultures and cases 
who had received antibiotics before admission. 
Q Serotyping results were available for 60% of cases, almost all were type b. 
Q More isolates were serotyped in the post-conjugate vaccine period (68%) than 
the pre-conjugate vaccine era (57%). 
Q Resistance to ampicillin was seen in 15% of isolates. 
Q Ampicillin resistance was significantly associated with SNHL. 
Q There was an increase in ampicillin resistance in both CSF and blood cultures 
in the post-vaccine period. 
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DISCUSSION 
6.1 DISCUSSION 
In this chapter the results of the study are placed in the context of 
previously published research. The present study has confirmed some previously 
reported risk factors, but has also identified a number of others which have not 
previously been described for invasive H inf uenzae disease. The chapter 
concludes with a description of the methodological strengths and limitations of the 
study. 
6.1.1 Incidence of invasive H influenzae disease in the pre-Hib 
conjugate era 
The average annual incidence rate of 28.4 per 100 000 children aged less 
than 5 years reported for this study in the pre-conjugate vaccine period is the same 
as that obtained for the same time period in the PHLS six region study (28.4)"o and 
in other health regions of Britain (28.3 in the North West region '233 28.1 in Wales249 
and 26.3 in the Northern region249). The incidence is slightly higher than that 
reported from the Republic of Ireland (25.4)23° and France (2 1.0), "' but lower than 
those reported from Scotland (32.2)266 and parts of Scandinavia, 
(51.9), "' Switzerland (60.2), 209 Australia (58.5)242, and North America (112.0). ''-' 
The case definition used in this study may have underestimated the true 
incidence of disease and consequently the reported rates for invasive H influenzae 
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disease in this study are considered to be minimum estimates. Other contributing 
factors may include children resident in the region and treated in hospitals outside 
the WMHR, cases without definitive bacteriological diagnoses either because 
specimens were not taken for laboratory diagnosis or laboratory diagnosis may 
have been negative because the child had received parenteral antibiotics prior to 
admission. Despite this the annual incidence of invasive H influenzae disease was 
within the range of 26.3 to 36.6 per 100 000 children aged less than 5 years 
reported by the different regions in the PHLS six region study. "' 
When comparing the incidence rates obtained for the West Midlands with 
those reported by the PHLS six region study it is important to bear in mind that the 
methodology used in the latter study was different. It was laboratory-based, 
prospective and employed a broader case definition, including cases detected by 
the presence of Hib antigen249 The current study was mainly retrospective in 
nature, used several sources of case identification and did not include cases 
detected by Hib antigen. The inclusion of Hib antigen positive cases which are 
culture negative should not affect the comparability of the data as in the PHLS six 
region study they accounted for only a small proportion of cases (5 of 772, 
<1%). 249 
Two descriptive studies which overlapped in time have been carried out 
previously in the WMHR. Both were hospital-based studies and both were 
conducted in hospitals in Birmingham. Dyas and George examined the occurrence 
of invasive H influenzae disease in children admitted to Birmingham Children's 
Hospital during the period 1973 to 1984 and identified 83 cases in this 10 year 
period (8.3 cases per year). "' In this study 20 children were admitted to the same 
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hospital in the 2 years (10 per year) before Hib conjugate vaccine was introduced. 
Davey et al reviewed cases of bacterial meningitis admitted to East Birmingham 
Hospital (now Birmingham Heartlands Hospital) between 1968 and 1977.304 They 
identified 51 cases of H influenzae meningitis during this 10 year period (5.1 cases 
per year) compared to the 13 cases (6.5 cases per year) admitted to the same 
hospital in the first half of this study. Although it is difficult to compare our results 
it would appear that invasive H influenzae disease increased with time in the 
WMHR in the pre-Hib conjugate vaccine era. This may have occurred as a result 
of changes in clinical practice, improved diagnostic techniques, improved 
surveillance, increased susceptibility of the at risk population, increased virulence 
of the organism or a true increase in the prevalence of the disease. 
6.1.1.1 Comparison of surveillance systems 
The comparison of cases by the reporting systems which identified them 
revealed that underreporting varied with age and disease entity, and similar results 
have been reported previously. These surveys highlighted the incompleteness of 
meningitis notifications, particularly those due to H inf uenzae meningitis. 
Using data from the PHLS six region study, Macleod specifically examined 
the completeness of reports of invasive H influenzae disease in the pre-vaccine 
era. " On average, 17% underreporting to the regional survey occurred and 24% 
underreporting to the CDSC. It was suggested that the introduction of Hib 
conjugate vaccine might improve the efficiency of reporting. Given the debate and 
publicity surrounding the launch of the vaccine, as well as the BPSU study of 
vaccine failures, this was not an unreasonable assumption. However, in this study 
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the finding that overall underreporting to CDSC from laboratories within the 
WMHR actually increased from 15% in the pre-conjugate vaccine period to 36% in 
the post-vaccine period contradicts this supposition. This observation has not 
previously been reported in the UK, and may have arisen due to complacency on 
the part of clinicians and microbiologists in view of the success of the vaccine. 
6.1.1.2 Excluded cases 
An area of concern was the exclusion from the study of 25 cases due to 
insufficient identifying data or missing case notes. If the 19 cases excluded in the 
pre-conjugate vaccine era had been included in the numerator, then the average 
annual incidence of invasive H influenzae disease would have increased by 10% to 
31.1 per 100 000 (95% CI=26.0 to 34.3). Performing a similar calculation for the 
post-conjugate vaccine data provides an incidence rate of 9.3 (95% CI=7.2 to 
11.8), this was an 11% increase on the original incidence rate. Statistically neither 
result was significantly different from the original HICARE rates however, 
comparison with CDSC data shows that these incidence rates would have been 
29% and 72% greater than those obtained using CDSC data in the pre-conjugate 
and post-conjugate periods respectively. These large differences have social, 
economic and health service implications. 
The problem of missing case notes has been highlighted by a number of 
authors and in this study contributed to a lower disease incidence . 
505,5"4"' This was 
particularly evident in this study for children who died, where 8 of 25 case notes 
could not be located, and to a lesser extent for children of SA origin. 
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6.1.1.3 Impact of Hib conjugate vaccine on public health 
Following the successful introduction of Hib conjugate vaccines in several 
countries in Western Europe and the United States, and the results of Hib conjugate 
vaccine trials in Britain, 167 a dramatic reduction in the incidence of invasive Hib 
disease was anticipated. In this study the greatest reduction in the incidence of 
invasive H influenzae disease in the WMHR was seen six months after the 
conjugate vaccine was introduced, and a 95% reduction in disease incidence was 
seen between 1990/91 and 1993/94. This confirms the success of Hib conjugate 
vaccine in children in the WMHR, and this compares favourably with reductions 
observed in other parts of Britain, 10 Finland '13' Australia, 
"' Canada, 13" and the 
United States"' following the introduction of Hib conjugate vaccine. 
This observation not only indicates a definite change in the epidemiology 
of the disease, but is also said to be indicative of a much greater effect than would 
be expected from vaccination alone. "" It has been suggested that herd immunity 
may be one explanatory factor 28' Results from studies conducted in Britain and 
the United States suggest that vaccination with Hib conjugate vaccine reduces 
nasopharyngeal carriage among the vaccinated population thereby reducing or 
delaying transmission of the organism 289, 'x'' 
Other factors may have been responsible for the observed decline. Changes 
in diagnostic and reporting practices at district and hospital level may have 
occurred. However, these would probably have improved reporting leading to a 
consequent increase in cases. Comparison of disease incidence due to 
meningococcal and pneumococcal meningitis in the same time period by Urwin et 
al in the North East Thames region did not demonstrate similar decreases for these 
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organisms 267 This also indicates that changes in surveillance activity or clinical 
practice could not account for the dramatic decrease in invasive H inf uenzae 
disease. Invasive Hib disease has been shown to exhibit annual and seasonal 
variation. 139,279192 McIntyre et al reported that in Sydney, Australia age-specific 
time-series analysis which took annual and seasonal variation into account 
demonstrated a significant decrease in the incidence of invasive Hib disease which 
was associated with the introduction of Hib conjugate vaccine. "' 
6.1.2 Individual risk factors 
6.1.2.1 Age 
In this study 42% of children identified with invasive disease in the pre- 
conjugate vaccine period were less than 12 months of age. The PHLS six region 
study reported a similar figure (42%). 209 Other British studies with comparable 
reports regarding the age of children have concentrated on H influenzae meningitis. 
The present study found that 46% of meningitis cases were less than 1 year of age 
prior to the introduction of Hib conjugate vaccine. Two separate reports from 
Oxford found that 44%12' and 49%" of children with H influenzae meningitis were 
aged less than 12 months. A report from Wales indicated that 40% of children 
were less than 1 year of age. 142 A similar proportion of children affected at this age 
has been reported from Europe. 11 70'=" 
Slack has suggested that Hib conjugate vaccine would shift the burden of 
disease to an older age group as a result of reduced or delayed transmission of the 
organism. "" The results in the WMHR support this as a shift in the age 
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distribution of those at most risk was observed following the introduction of Hib 
conjugate vaccine from those aged 6-11 months to those aged 24-35 months. 
6.1.2.2 Gender 
The overall male: female ratio of 1.1: 1 reported in this study was in keeping 
with previous epidemiologic reports from different parts of the 
world. 123,1S1 0,232,239,266 However differences in gender distribution were found in 
this study which, to the researcher's knowledge, have not previously been reported 
in Britain. The significance of the increased incidence of H influenzae meningitis 
in girls is uncertain and may have arisen due to chance. However the increased 
risk for girls just failed to reach statistical significance (OR=1.65,95% CI=0.95 to 
2.88: p=0.079) and the confidence intervals were narrow. An example of an 
infectious disease where a female predominance has been reported previously is 
whooping cough. "" Reports regarding this phenomenon for H influenzae are 
scarce. In Finland, Takala et al reported a female predominance in H influenzae 
diseases other than meningitis and epiglottitis which was not statistically 
significant. " Hanna et al found that 65% (26 of 40) of cases of H influenzae 
meningitis observed in Aborigine children aged less than 5 years occurred in girls 
giving a relative risk of 1.89 (95% CI=0.99 to 3.60; p>0.05) when compared to 
Aborigine boys 29 Possible explanations for these findings remain elusive. 
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6.1.2.3 Ethnic group 
A number of population-based studies from the United States, '", "'"' 
Australia19'257,291 and Israel ° have examined incidence rates in multi-ethnic 
populations. They have reported that white populations are at reduced risk 
compared to other ethnic groups occupying the same geographic area, and that a 
greater proportion of invasive H influenzae disease occurs at a younger age among 
children in ethnic minority populations. 
Only one study was located that was conducted outside the UK and which 
provided data on invasive H influenzae disease in one of the major ethnic minority 
groups in the UK. The report was a retrospective hospital-based study which 
examined cases of bacterial meningitis admitted between 1987 and 1994 in 
Bangladesh. "" The authors reported a similar age-distribution to that seen in 
children of SA ethnic origin in the WMHR. In their study, 69% (191 of 277) cases 
occurred in children aged less than 12 months of age. 
The age distribution in children from the SA ethnic group in Britain has not 
previously been described. The South Asian children in this study had an age- 
related pattern of disease similar to that seen in Native Americans, '"-2" Australian 
Aborigines"" . 257 and other children from `deprived societiesi231". In this study 
64% (14 of 22) of cases occurred in children of SA ethnic origin before the age of 
12 months. In the places where ethnic differences have been studied, the factors 
responsible for ethnic age differences in disease risk are not clear. Some authors 
suggest that genetic differences may play a role, while others point to confounding 
socioeconomic factors such as household overcrowding and the number of siblings. 
The results of research into these factors has provided contradictory results. 
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One of the concerns prior to the introduction of Hib conjugate vaccine was 
that immunogenicity may vary according to ethnic group. However, previously 
published epidemiological studies conducted in Britain have consistently failed to 
provide ethnic-specific incidence rates, either before or following introduction of 
the vaccine, or to compare uptake of Hib vaccine in different ethnic groups. Where 
ethnic groups have been reported, the criteria used to classify children into these 
groups are not made clear. "' This survey followed methods of categorisation 
which were compatible with the 1991 population census classification of ethnic 
group. 
Differences in disease distribution have also been noted amongst other 
ethnic groups. One series involving Native Alaskan children failed to report any 
cases of epiglottitis. " Similar results have been obtained in Chile, Hong Kong 
and South Africa. 
196,222,239 Comparable results were obtained for children of SA 
origin in the WMHR where, from 1990-94 only one case of epiglottitis was 
identified. It has been proposed that epiglottitis is more common in populations 
where invasive H influenzae disease is encountered later in childhood, and 
although the mechanism for this remains obscure, the results obtained for SA 
children in the WMHR would appear to support this view. 
Although immunisation rates for the different ethnic groups living in the 
WMHR are unavailable, this study found that children of SA origin were 
significantly less likely to have age appropriate immunisation histories. Support 
for this appears to be provided by other results obtained in this study. The 
incidence of disease fell by 89% in SA children compared to 94% in NSA children, 
causing the proportion of children of SA origin to increase from 8% in the first 
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period of the study to 13% in the second. Although neither of these observations 
reached statistical significance they are compatible with a problem with 
immunisation uptake in this group of the population, or vaccine immunogenicity. 
Further support is provided by a recent report by Bedford et al. 's' They examined 
the immunisation status of 1,411 at primary school in an inner London district. 
They found that 50 of 54 children who had no immunisations were of `Asian' 
origin. 
Ethnic differences have also been noted in the USA following introduction 
of Hib conjugate vaccines. Using data from the National Bacterial Meningitis 
Reporting System (NBMRS), Adams et al reported a significant increase (p<0.001) 
in the proportion of Black American children aged less than 5 years with invasive 
H inf uenzae disease following the introduction of Hib conjugate vaccine. 1' The 
proportion affected increased from 27% in 1989 (pre-conjugate vaccine) to 37% in 
1991 (post-conjugate vaccine). As with the HICARE study, one reason for this 
may be the lower immunisation uptake rates in this ethnic minority group. 
6.1.2.4 Nutritional status 
It is well known that malnutrition reduces a host's resistance to infection 
and that infection is a major cause of morbidity and mortality in malnourished 
children. "' In this study 8% (18 of 228) of cases were below the third centile for 
weight of a population growth chart. "", "' This proportion increased from 6% (11 
of 178) in the pre-conjugate vaccine era to 14% (7 of 50) in the second period of 
the study. Although information on nutritional status as a predisposing factor is 
not mentioned in the majority of studies, two studies from `developing' countries 
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have reported an association between H influenzae meningitis and being 
underweight for age on admission. Nottidge reported from an urban centre in 
Nigeria that 76% of children admitted with H influenzae meningitis were below the 
Yd centile of a weight chart. 124 In Malaysia, Choo et al found that 17% of children 
admitted with H influenzae meningitis were below the 3' centile. 30S Although the 
results obtained in Nigeria and Malaysia are not strictly comparable with those 
obtained in the WMHR, the results in the second period of the study approach 
those reported from Malaysia. The increase in the WMHR may reflect increasing 
deprivation within the study group as this factor just failed to reach statistical 
significance when the two time periods were compared (OR=2.47,95% CI=0.81 to 
7.42; p=0.080). 
6.1.2.5 Anaemia 
Data on anaemia as a risk factor for invasive H influenzae disease is scarce, 
however anaemia has been associated with H influenzae meningitis in a number of 
other studies. Anaemia was found in 35% (72 of 207) of children in this series. 
This is comparable with an earlier report from a Birmingham hospital of 31% of 
children admitted with H influenzae meningitis having anaemia. "' It has been 
suggested that anaemia arises as a result of increased red cell haemolysis following 
invasive disease by the organism. 303 This study could not refute or confirm this 
hypothesis. 
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6.1.3 Family and community risk factors 
6.13.1 Family size and structure 
The results from the present study support the findings of other 
investigators, that the presence of siblings less than 5 years of age is a risk factor 
for invasive H influenzae disease. 'se,: 95 Other researchers however, have reported 
contrasting results. 15 3° These studies have been conducted in different parts of the 
world and the lack of consistency may reflect differences in day-care arrangements 
or, socioeconomic and cultural differences. 
6.1.3.2 Lone parents 
The data obtained in this study showed that overall 14% (32 of 234) of 
cases were from lone parent families. This variable has been reported as a risk 
factor for invasive H influenzae disease in case-control studies carried out in 
Switzerland and the United States. '1", 152 Due to the sample size this could not be 
explored in this study, however 1991 population census data for the WMHR 
indicates that 10% of families are lone parent families. 
6.13.3 Day-care 
The proportion of children admitted to hospital with invasive disease who 
were attending daycare fell from 16% (32 of 199) in the two years prior to 
introduction of the conjugate vaccine to 12% (7 of 59) in the second period of the 
study. This occurred even though none of the children who attended daycare had 
received Hib conjugate vaccine, and they were also less likely to have siblings. 
The decrease may have occurred as a result of herd immunity. The study was not 
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able to accurately ascertain the impact of daycare as a risk factor because of the 
retrospective nature of case finding, lack of an accurate denominator regarding the 
number of children attending daycare, and inconsistent recording of daycare 
attendance in the medical notes. Hib conjugate vaccine however has been 
previously reported to decrease nasopharyngeal carriage in a number of European 
and North American studies and thereby reduce the risk of transmission. 189, " 
6.1.4 Environmental factors 
6.1.4.1 Pre-Hib conjugate vaccine 
Immunisation histories were documented for 167 of 199 (84%) children in 
the two years prior to introduction of Hib conjugate vaccine. Of this population 
81% (136 of 167) were age-appropriately immunised. The figure obtained in this 
study is much lower than the average immunisation uptake for the WMHR in 
November 1991 of 92% for triple antigen at 12 months. 22 The present results are 
however comparable with data reported by Riley et at from Manchester. They 
found that only 75% of children admitted to an acute paediatric medical ward 
during a six month prospective study were fully immunised's' 
Another feature of this study was that none of the children who were behind 
with their immunisations were opportunistically immunised before or at the time of 
discharge. Failure to opportunistically immunise has been reported in a number of 
studies with children admitted to hospital for a variety of diagnoses found not to be 
up to date with their immunisations 117,11114110 Opportunistic immunisation is 
advocated at the primary care level, '. ' however, it may be difficult to carry out due 
to certain policies, one of which may be that only doctors may give injections. "' 
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Jefferson et al have argued that this type of policy contributes to missed 
immunisation opportunities. 
"' 
During the course of this study it was noted that several discharge letters 
from a number of hospitals requested the family's GP to arrange for the child to 
have Hib vaccine following discharge. It cannot be ruled out that verbal advice 
was also given to other parents to contact their GP's and to arrange for the vaccine 
to be given to their child. This suggests lack of ward-based immunisation policies 
and contributes to continued missed opportunities to immunise those most at risk. 
One possible way of improving the immunisation status of vulnerable children is to 
promote the use of parent-held child health records which have been shown to be 
acceptable by both parents and health professionals ZU 
In the present study, factors significantly associated with falling behind 
were being of SA origin and coming from a family with three or more siblings. 
Large families have previously been shown to be associated with failure to 
immunise in a number of studies. 106'toe343 Ethnic minority status has however not 
been reported in great detail with regard to immunisation in Britain, and at the time 
of writing there are no UK ethnic-specific data in the post-Hib conjugate vaccine 
period. The main ethnic minority group studied are children of'Asian' origin and 
the reports are conflicting. Some studies point towards reduced immunisation 
uptake in this sub-group of the population. "-'"', while others report similar or 
better uptake compared with the indigenous population. '54''ss 
In general, failure to immunise is recognised as an outcome of the 
interaction between parental attitudes, social circumstances of the child's family, 
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and the extent of the service arrangements for obtaining 
inlnluni sation. l06,111,343,348,350,357 
6.1.4.2 Post-Hib conjugate vaccine 
Immunisation histories documented in the hospital records were validated 
by checking district child health records of children resident in the WMHR. A 
highly significant level of agreement (p=0.0002) was obtained when comparing the 
two methods indicating that when present in hospital records, immunisation 
histories may be considered a good estimate of the child's actual immunisation 
status. 
Not so encouraging was the finding that the majority of cases admitted in 
the post-conjugate vaccine era had not received Hib conjugate vaccine prior to 
admission, and were not opportunistically immunised while admitted. 
Furthermore, following discharge more than a third had not received the vaccine by 
the time the researcher obtained their data from the child health records. Of those 
who had received conjugate vaccine there had been an average wait of more than 3 
months. These observations were quite surprising as 75% (33 of 44) of children 
admitted in the post-vaccine era were found to be up to date for all other primary 
immunisations. There are no comparable data for this finding and deprivation, 
family size and ethnic group were not associated with a failure to receive Hib 
conjugate vaccine. 
In contrast to these findings a recent report of a case-control study from the 
United States carried out from 1991 to 1994, identified having a single mother 
(OR=7.0,95% CI=1.2 to 40) and low income (OR=11.3,95% CI=1.1 to 109) as 
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risk factors for delay in receiving Hib conjugate vaccine. 15' The wide confidence 
intervals reported are indicative of the small numbers available following 
introduction of Hib conjugate vaccines (57 cases vs 93 controls). Tokhani et al 
also conducted a case-control study examining uptake predictors for Hib 
vaccination in Northern Ireland in the first half of 1993.524 They reported that 
children who had two or more younger siblings were less likely to have been 
immunised (OR=2.32,95% CI=1.22 to 4.43) as were children whose mothers 
smoked (OR=2.82,95% CI=1.41 to 5.62). 
Other factors which may have contributed to the apparently poor uptake of 
Hib conjugate vaccine in the study group are the attitude and knowledge of parents 
and health professionals regarding Hib meningitis and Hib conjugate vaccine. 
Braun et al conducted research prior to the launch of Hib conjugate vaccine 
amongst a group of health visitors and parents. " ' They reported that only 6 of 52 
(12%) health visitors named Hib as a cause of meningitis in young children, and 
only 16 (31 %) would advise parents to immunise their child against Hib. 
Anecdotal evidence gleaned from the hospital notes of some children 
included in this study may add support to these findings. One parent indicated that 
the GP had informed her that her child was "too young" for Hib vaccine when 
presenting for a scheduled immunisation appointment. Another parent had been 
told in similar circumstances that the child "did not need Hib vaccine". If these are 
an accurate record of what transpired then they indicate that GPs may have 
contributed to poor uptake by providing incorrect advice. 
Prior to the launch of Hib conjugate vaccine in October 1992, McGuire 
carried out a study on parental attitudes to Hib conjugate vaccine for the Health 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 255 
Chapter 6: Discussion 
Education Authority in November 1991.526 Her report indicated that parents had 
not heard of Hib meningitis and therefore perceived it as a less dangerous type of 
meningitis than other types of meningitis. 
It is almost 10 years since the Peckham report indicated that parental 
attitude has a marked effect on vaccine uptake. 1°' Experience with pertussiss=' and 
more recently MMRS28 vaccine has illustrated how adverse publicity resulting in 
parental concern can lead to reduced vaccine uptake. Fortunately immunisation 
uptake rates for Hib have been high resulting in a marked reduction in incidence of 
the disease. 
Despite these high uptake rates, the finding of a negative relationship 
between deprivation and district immunisation uptake rates is in agreement with 
previous reports from the UK. The results from a national study by Jarman et al 
suggested that there were marked variations in immunisation uptake rates among 
health authorities and that those with the poorest social conditions had the lowest 
uptake rates. " Using a similar method to that of the HICARE study, Reading et al 
found that a greater proportion of children in the most deprived EDs of 
Northumberland were significantly more likely to be incompletely immunised 
against pertussis by 15 months of age. 52' 
6.1.4.3 Vaccine failures 
The definition of a vaccine failure used in this study was the same as that 
applied by the BPSU in their study. "" Using this definition, 9 vaccine failures 
were identified from the HICARE register. Three of these were true vaccine 
failures, two occurring after three doses of vaccine. Although the number of 
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vaccine failures reported for the WMHR in this study are too small for detailed 
analysis the results are generally comparable to those reported by the BPSU. 476 
Both the BPSU study and the HICARE study reported that following PRP-T 
immunisation one-third of vaccine failures were true vaccine failures. A study in 
Australia conducted from 1993 to 1994, one year after Hib vaccines became 
available, reported a similar proportion of true vaccine failures (9 of 33,27%) 
among Hib cases classified as vaccine failures. "" The study differed from the 
BPSU and HICARE studies as all four conjugate vaccines were in use in Australia. 
Of the recorded Australian vaccine failures, none were due to PRP-T. "° A number 
of authors from the United States°60, '" and Canada"' have also reported the 
occurrence of invasive H influenzae disease following vaccination with conjugate 
vaccines. 
6.1.4.4 Deprivation in the post-Hib conjugate vaccine era 
Following the introduction of Hib conjugate vaccine in October 1992, 
differences in disease experience between children living in the most deprived and 
the more affluent areas of the WMHR appear to have increased. Living in areas 
categorised as having low deprivation appeared to significantly reduce the risk of 
disease. This is in keeping with Blaxter's assertion that behavioural interventions 
such as immunisation have a much stronger influence on the health of the 
economically advantaged than on the health of the disadvantaged., "' 
Contrary to the results obtained in this study an ecological study in the 
North East Thames region which employed the ward as the unit of geographic 
analysis, found no evidence of an association between deprivation (using 
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Townsend deprivation tertiles) and increased risk of H influenzae meningitis. " It 
should be noted that the ward is a larger geographic unit than the ED, which was 
used in this study. It is therefore possible that the size of the unit used in the 
Thames study masked any possible differences as the aggregated groups would be 
more heterogenous than those aggregated using the smaller ED. Furthermore, the 
North East Thames study only provided incidence rates for `white' children aged 
less than 5 years of age. " The results reported from North East Thames were 
similar to those found by Tarr and Peter in Rhode Island. '" They examined H. 
influenzae meningitis in census tracts where the populations were 99.2% white. 
They found that the occurrence of meningitis in these areas was not related to a 
number of socioeconomic variables including low family income and low adult 
educational level. '" 
Other studies which have examined proxies for deprivation such as low 
social class, "' low family income 1* l49, lsI l3 and low adult education 
level19,154, rl7, z9S have produced conflicting results. This may be due to confounding 
due to other socioeconomic and host factors. 
Susser et al30, and more recently Reading et a1352, have argued that 
improvements in the delivery of health services to the whole population may not 
only increase health inequalities but may actually widen them. The improved 
delivery of immunisation services, the introduction of Hib conjugate vaccine, 
together with the 'catch-up' programme and the subsequent high uptake of the 
vaccine is a good example of this type of improvement. This study suggests that 
despite an absolute reduction in disease experience among the study population 
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following the introduction of Hib conjugate vaccine, there has been a relative 
increase for the most deprived group of children. 
6.1.4.5 Components of the Townsend score in the post-Hib conjugate vaccine 
era 
Analysis of the four individual components of the Townsend material 
deprivation score showed a similar picture to that for the overall score. Differences 
in disease experience between the most deprived and the more affluent areas 
became apparent or more pronounced in the post-conjugate vaccine period. 
Owner occupancy is broadly employed as a marker of long-term income 
and financial resources. The relationship between non-owner occupancy and 
invasive H influenzae disease has only been previously examined in a case-control 
study from the Republic of Ireland. Fogarty et al did not find a significant 
relationship between non-owner occupancy (defined as living in local authority 
accommodation) and increased risk of invasive H influenzae disease. 23° The 
significant association observed in the WMHR between living in areas of high non- 
owner occupancy and invasive H influenzae disease has been reported for 
meningococcal disease. In a case-control study which covered 8 districts in West 
England, Stanwell-Smith et al found that cases of childhood meningococcal 
disease were significantly less likely to have parents who were owner-occupiers 
than their control group. " In another case-control study, Stuart et al observed that 
cases living in council owned accommodation in South West England had a higher 
risk of meningococcal disease than their controls. " Case children also tended to 
live in houses which were damp and in poor structural condition. Previous reports 
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have shown that standards of housing and neighbourhood environment are 
generally better in more affluent areas, " and that poor housing has adverse effects 
on the health of children. ", '" 
In the WMHR, a general trend towards increased risk was seen with the 
other three components of the Townsend deprivation score, however none of these 
factors were significantly associated with invasive H influenzae disease. 
The tendency towards a higher incidence of disease in areas with high 
unemployment has not been previously reported for invasive H influenzae disease. 
The observation is however supported by previously published studies. An 
ecological study by Maclure and Stewart on hospital admissions in Greater 
Glasgow found that children living in deprived areas were more likely to be 
admitted to hospital with infectious diseases than those from non-deprived areas. " 
They also reported that parental unemployment was one of the strongest predictors 
of admission for deprived children. Data from a smaller study suggests that these 
children are most susceptible around the time the parent becomes unemployed. "' 
An ecological study at the district level in England reported that areas with high 
levels of unemployment had significantly lower immunisation uptake rates than 
areas with less unemployment. The nature of the study did not allow further 
exploration of this factor. However, individual level studies suggest that stressful 
family events affect the social environment of the child leading to increased 
susceptibility to illness 45,332 
This study did not find a significant association between overcrowded 
households and increased risk of invasive disease. Using a variety of definitions of 
household crowding a number of studies from Britain, " Europe's ° and the 
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United States155'27 have reported similar results. These findings are however, not 
universal, and contradictory results have been reported from the United States and 
Australia. 149,149,151,295,298 
Those studies which have reported a significant association between 
overcrowded households and invasive H influenzae disease have all been case- 
control studies. Two of the five studies reporting the lack of a significant 
association have been ecological studies. Failure to find an association in these 
studies, and the present study, may have been due to aggregated data not being 
sensitive enough to detect a relationship at the individual level. 
Although the social meaning of car ownership may change with time and 
location, in this study it has been used as an indicator of material wealth, especially 
current income. This variable has not previously been examined as a risk factor for 
invasive H influenzae disease. However, a case-control study from South West 
England reported that fewer cases (71%) than controls (80%) had access to a car. 
Although a trend was seen suggestive of a relationship between areas with a high 
proportion of people without access to a car and invasive H influenzae disease in 
the WMHR, it was not statistically significant. Lack of access to a car has been 
associated with low immunisation uptake, " and this may contribute to an 
increased incidence of disease in these areas. 
6.1.4.6 Socioeconomic factors in the post-Hib conjugate vaccine era 
There was evidence in this study of an association between living in areas 
where the population was highly mobile and increasing incidence of invasive H 
influenzae disease. This risk factor has not been previously examined for invasive 
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H influenzae disease. A case-control study of meningococcal disease found that 
children who lived in families who had moved home in the 6 months prior to 
hospitalisation were significantly more likely to have meningococcal disease than 
controls. "' This finding is consistent with previous reports which have associated 
this factor with low immunisation uptake rates and social disadvantage! " '35"37 
Migration may act by introducing carriers with different strains of the pathogenic 
organism to a group of susceptible children, or result from an influx of susceptible 
children. Another explanation is that changes in residence increase levels of stress, 
and this has been shown to have an association with infectious diseases in young 
children . 
4,3" The fording of an increasing incidence of invasive H injluenzae 
disease associated with areas of high migration also seems consistent with that 
reported for non-owner occupancy. 
In this study low child population density of children less than 5 years of 
age was significantly associated with an increased incidence of invasive H 
influenzae disease in both the pre-conjugate and post-conjugate periods. To my 
knowledge there are no comparable data for this finding. Where population 
density has been studied in relation to invasive H influenzae disease, the whole 
population has been examined rather than just those less than 5 years of age. Only 
two reports were identified, both were from the United States and provided 
contradictory results. A study from Rhode Island of census tracts which contained 
populations that were 99.2% white did not find any relationship between H 
influenzae meningitis and population density. " However, the authors of this study 
failed to provide a definition for population density. Fraser et al defined 
population density as more than 100 people per square mile. 150 They found that in 
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Charleston County the incidence of H influenzae meningitis decreased with 
increasing population density in the white population, but could find no association 
with population density in the black population. These results are similar to those 
reported for the WMHR. One possible explanation for the finding in the present 
study are that children living in areas of low population density, are less likely to 
be exposed to the organism and therefore less likely to acquire natural immunity. 
Lone parenthood has been reported as a significant risk factor for invasive 
H influenzae disease. 151'15x This study was unable to confirm such findings which 
have been observed in case-control studies carried out at the individual level. 
6.1.4.7 Geographic distribution 
The incidence of disease in the 'mainly rural' areas was consistently higher 
than that seen in the'mainly urban' areas of the WMHR. This relationship has been 
previously reported"', " and may be linked to herd immunity or reduced 
susceptibility and earlier acquisition of natural immunity in the urban districts 
compared to rural districts due to children being in closer proximity. Other 
researchers have reported different findings. Floyd et al found that the incidence of 
H influenzae meningitis was significantly higher in urban areas than in rural 
areas. 1' Other reports from the United States"' and Denmark" were unable to 
demonstrate any difference between urban and rural areas. The results reported for 
urban and rural areas in this study are consistent with those reported for areas of 
high and low population density in the WMHR (see section 6.1.4.6). 
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6.1.4.8 Seasonal variation 
The bimodal pattern of disease seen in this study has been previously 
described by others. "''" The explosive increase in cases seen during October and 
November in the pre-conjugate vaccine era may be due to recent day-care or school 
attendees. These children either succumb to infection or introduce the organism 
into the household and siblings may then be affected. 
The mean age at admission during the summer months was also 
significantly less than that seen during other seasons of the year. This may have 
resulted from a reduction in the number of susceptible children in the population as 
a result of acquired immunity. This finding may also be related to reduced 
interaction between young children, resulting in reduced risk of transmission of the 
organism. 
A significant association was also observed between seasonality and ethnic 
group. Children of SA origin were less likely to present during the autumn 
compared to other seasons of the year. The reasons for this are not clear, however 
similar seasonal ethnic variations have been described in Israel. It was found that 
seasonal fluctuation in the occurrence of invasive H influenzae disease in the 
Jewish population was related to respiratory disease, whereas in the Bedouin 
population, it was related to seasonal epidemics of gastrointestinal disease. 2'2 
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6.1.5 Clinical features 
In the present study the clinical spectrum of disease were similar in both 
study periods. This contrasts with that reported by the PHLS six region study 
where an increase in the proportion of cases of epiglottitis was observed in the 
post-Hib conjugate vaccine period. "' 
6.1.5.1 Meningitis 
In the WMHR 46% (62 of 136) of meningitis cases occurred in children 
less than 12 months of age in the pre-conjugate vaccine period. This is comparable 
with that reported from the Oxford region (49%), "' Gwynedd (43%), '4= and 
Glasgow (42%)141 during the same period. It is also congruent with the proportions 
of meningitis (37% - 46%)126,270,2" seen in the populations of Western Europe. 
The incidence of H influenzae meningitis fell by 92% between 1990/91 and 
1993/94. This is similar to the reduction seen in the North East Thames region, 267 
other parts of England and Wales, "' and elsewhere in the world. 114,13! %137,454 
It was disappointing to note that a smaller proportion of children with 
meningitis received pre-admission antibiotics in the post-conjugate era (29%) 
compared to the pre-conjugate era (39%). Overall, the results from this study 
indicate that 37% (62 of 168) children received pre-admission antibiotics, and that 
these children were older than those who did not. The age distribution may be 
related to the more overt signs of meningitis in older children. However, receiving 
antibiotics in the week prior to admission meant that these children were brought to 
hospital later than children with other diagnoses. Although the proportion who 
received pre-admission antibiotics is falling in the WMHR, it is still higher than 
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the 17% (53 of 305) reported by the British Society for the Study of Infection 
(BSSI) following a national survey of its members in 1989.205 The study included 
61 (20%) cases of H influenzae meningitis, however it was not possible to 
determine how many of these had received pre-admission antibiotics. 
6.1.5.2 Epiglottitis 
As with other reports of invasive H influenzae disease from Britain and 
Western Europe, epiglottitis was the second most common disease manifestation in 
the WMHR. British studies which have examined epiglottitis in detail are scarce, 
and comparisons have to be made by extrapolating data from the few available 
studies which have examined the epidemiology of invasive H influenzae disease. 
The annual incidence rate found in the pre-conjugate vaccine era in the WMHR 
(3.1 per 100 000 children less than 5 years of age) was similar to that seen in the 
Oxford region (3.7)139 as well as France (2.0), '26 Israel (2.0)2" and the Republic of 
Ireland (3.8). 23" 
Incidence rates for epiglottitis in the WMHR in the first period of the study 
were lower than the 24.6 per 100 000 cases in children less than 5 years of age 
reported from Sweden228 and the 20.4 per 100 000 observed in Australia. "' In both 
of these studies cases of epiglottitis were clinically defined but did not need to be 
blood culture proven. The reduced incidence of this disease in the post-conjugate 
vaccine period in the WMHR is in keeping with data from the United 
States, 135,226,237 
Classically epiglottitis has been reported in older children. Comparing data 
in the present study with that previously reported indicates a shift towards a 
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younger age group. In the present study 41% (13 of 32) cases were aged less than 
24 months. These findings are different from the 26%"' and 32%13' reported in 
recent British studies. They do however more closely resemble a recent report of 
36% from the United States 236 These findings may have implications for clinical 
practice as laryngotracheobronchitis commonly presents at less than 3 years of 
age. 225 
Previous reports have indicated a male predominance, with male: female 
ratios of between 1.4: 1 and 2.1: 1.209,226,231,132 The present study reported a ratio of 
2.6: 1. The reasons for this difference, which was statistically significant, are not 
clear. 
Extra-epiglottic complications are unusual, and pneumonia, observed in 
16% (6 of 32) of epiglottitis cases, was the only complication. This figure is 
similar to the 10% reported by Broughton and Warren from Cambridge. '2 A 
number of studies have reported deaths from epiglottitis, 139 °', 22' In this series there 
were no deaths from epiglottitis and this finding is similar to previous reports u'. 2a' 
6.1.5.3 Pneumonia 
The incidence rate for H influenzae pneumonia in the WMHR in the pre- 
conjugate vaccine period (1.4 per 100 000 children less than 5 years of age) was 
comparable with that reported by Tudor-Williams et al from Oxford (1.2), 121 and 
Quigley et al from the North West (1.7) 133 In both of these studies only culture 
proven type b cases were included. 
Prior to the introduction of Hib conjugate vaccine the infectious disease 
literature was not clear as to whether pneumonia was more likely to be caused by 
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serotypes other than type bH influenzae, and therefore less likely to be prevented 
by Hib vaccine. 244 In the present study the incidence of Haemophilus pneumonia 
fell by 71% when the two study periods were compared. This is in contrast to 
findings reported by Broadhurst et al in the USA, " where there was no change in 
incidence following the introduction of Hib conjugate vaccine. Results 
corresponding to those obtained in the WMHR have been reported recently 
following trials of PRP-T in 'developing' countries. Lagos et at reporting from 
Chile, "' and Mulholland et al reporting from The Gambia, ` both found reductions 
in the incidence of Hib pneumonia following immunisation with the conjugate 
vaccine. 
The paucity of serotyping results for children with pneumonia in the 
WMHR emphasises the need for blood cultures to be taken and serotyped in order 
to confirm these findings in other populations. 
6.1.5.4 Other invasive H influenzae diseases 
The incidence of non-meningitic diseases other than epiglottitis 
experienced in the West Midlands (4.0 per 100 000 children aged less than 5 years) 
was in keeping with previous reports from Britain and Europe (range 5.1 - 
7.0). 121,126,139,233 
6.1.5.5 Morbidity 
The median length of hospital stay in both periods of the study were the 
same, and this suggests that the virulence of invasive H influenzae disease has not 
been altered by the vaccine. 
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All sequelae reported in this study were as a result of H influenzae 
meningitis, and are considered to be an underestimate. Insufficient detail was 
available in the medical notes and the presence of more subtle complications such 
as learning difficulties, motor abnormalities and behavioural problems may have 
been missed. 
The occurrence of SNHL in 10% (10 of 102) cases tested is consistent with 
reports of SNHL ranging between 6% to 16% of survivors of H influenzae 
meningitis. 121,141,122,156,209 The estimate of children with SNHL in this study is 
conservative as only hospital case notes were used, and long-term follow-up was 
not part of the protocol. Furthermore, only 65% of H influenzae meningitis 
survivors in the WMHR had at least one hearing test following discharge. This is 
similar to the 69% of cases determined in a retrospective audit of case notes in a 
British hospital by Riordan et al? " 
In the present study SNHL was significantly associated with symptoms of 
48 hours duration or longer. This is in keeping with a previous report from the 
United States by Nadol, S33 but differs from the findings of a number of other 
studies. In these studies duration of illness was not associated with hearing 
loss ? o',.. a" The latter were prospective studies, whereas this report and that of 
Nadol were both retrospective in nature. 
Antibiotics in the week prior to admission were received by 7 of 10 
children with SNHL. Kaplan et al employed a similar methodology in an earlier 
prospective study carried out in two centres in the United States with a total of 281 
children. 20' They found that 14 of 15 children who received antibiotics in the week 
prior to admission had SNHL following an episode of H influenzae meningitis. 
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Raivio and Koskiniemi used occupational class to classify a cohort of 
children followed-up for 1 to 15 years following an episode of H influenzae 
meningitis in Finland. "' They found a higher proportion of hearing disorders in 
the lower social group compared to the highest. A Canadian study reported that 
children with sequelae of H influenzae meningitis were more likely to have lower 
socioeconomic status. '5' 
This study also found that children from deprived areas (7 of 35) were 
significantly more likely to suffer post-meningitic SNHL compared to children 
from the most affluent areas (0 of 24, p=0.035). In this study deprived children 
were found to have generally poorer nutritional status than their peers from more 
affluent areas and this may be one factor which influenced the risk and severity of 
sequelae. Other risk factors at the individual level may also exert an effect on the 
severity of the disease. 
6.1.5.6 Mortality 
The overall case fatality rate of 3% amongst children with invasive H 
influenzae disease in the WMHR is comparable with that in a number of other 
reports from Britain, "U"' Australia, "' Switzerland, " France, "' and the United 
States27'280. All have mortality rates which do not exceed 5%. 
Most of the deaths in this series occurred prior to admission, and neonates 
and low birthweight babies were found to be at increased risk of death. This is 
concordant with data from a number of other studies. 26""' 
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As with SNHL, children from the most deprived areas (6 of 109) were at 
greater risk of mortality than their more affluent counterparts (0 of 56, p=0.097). 
Again this may be due to factors operating at the individual level. 
A trend towards increased mortality was noted in the second period of the 
study that almost reached statistical significance (p=0.078). This gives cause for 
concern especially as it did not appear to be related to antibiotic resistance. 
Although ampicillin resistance increased in the second period of the study, few 
children were actually given this antibiotic. The results add support to the 
suggestion that the virulence of the organism has not been diminished. "' 
6.1.5.7 Antibiotic regimens 
Cephalosporins have been recommended as empirical therapy for suspected 
H influenzae meningitis because of increasing ampicillin resistance, the emergence 
of chloramphenicol resistance and multiple-drug resistant strains" In this study 
the significantly increased use of cepahlosporins in the post-Hib vaccine period 
may reflect these recommendations. The pre-conjugate vaccine findings are 
generally similar to reports by the BSSI203 and Quigley et al. '" To my knowledge 
there are no data relating to prescribing in the post-conjugate vaccine era for 
invasive H influenzae diseases. Despite the changes in prescribing practice there 
has not been a reduction in the mortality associated with H influenzae meningitis in 
the post-conjugate vaccine period. 
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6.1.5.8 Dexamethasone 
The Meningitis Working Party of the British Paediatric Immunology and 
Infectious Disease's Group reviewed the evidence regarding the use of 
dexamethasone in the treatment of meningitis. "' They decided that there was 
insufficient evidence to recommend its use for H influenzae meningitis in 
particular, or other forms of bacterial meningitis in general in Britain. 
Despite the report of the Working Party, parenteral dexamethasone was 
found to be administered in the WMHR with increasing frequency when the two 
study periods were examined (55% and 65% in the pre-conjugate and post- 
conjugate vaccine periods respectively). 
This study did not find any evidence that dexamethasone reduced mortality, 
SNHL or neurological complications in children with H influenzae meningitis as 
reported by researchers in the United States and Switzerland. """ The data are 
however in keeping with the results of two meta-analyses which examined 
published randomised controlled trials where dexamethasone had been used 
together with antibiotics to treat bacterial meningitis 39'"° Both reported that the 
available evidence did not support the routine use of dexamethasone. 
Unfortunately the present study is a retrospective examination and does not 
permit any firm conclusions to be drawn as treatment regimens were not 
standardised. Perusal of the case notes also indicated that in some cases the timing, 
dosages and duration were not consistent with recommended practice'" 
The use of dexamethasone with regard to its potential for reducing 
morbidity and mortality associated with H influenzae meningitis generated great 
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debate. This debate has now been rendered virtually academic since the advent of 
Hib conjugate vaccine. 
6.1.5.9 Prophylaxis 
Rifampicin has been shown to be effective in eradicating carriage of Hib 
from the nasopharynx and is recommended for the index case prior to discharge 
and for close contacts, especially in households with unimmunised children under 
4 years of age. 403 
In this study there was confusion amongst paediatricians as to who should 
receive prophylaxis, with only approximately 30% of cases with siblings aged less 
than 4 years receiving chemoprophylaxis. A recent Australian study found 
similarly poor compliance levels among medical staff regarding recommendations 
for rifampicin prophylaxis. 537 
There were also significant disease, ethnic, gender and seasonal differences 
amongst cases and contacts who received prophylaxis. The reasons for the gender 
and ethnic differences are not clear and have not previously been reported. Index 
cases of H influenzae meningitis and their contacts were more likely to receive 
prophylaxis than cases with non-meningitic disease and their contacts. Given that 
meningitis attracts more publicity and causes more anxiety than non-meningitic 
invasive H influenzae diseases, then this would be expected. However, the 
recommendation is that all appropriate contacts and all cases of invasive Hib 
disease be given prophylaxis. 403 It is not known whether the differences arose 
because of inadequate knowledge or misinterpretation of the guidelines. The 
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results obtained in this study confirm the assertion by Gilbert at al that poor 
medical compliance reduces the already limited value of prophylaxis "" 
Fewer cases in the WMHR received chemoprophylaxis in the autumn and 
this may have been as a result of inappropriate knowledge regarding 
chemoprophylaxis on the part of newly appointed junior doctors or inadequate 
knowledge on the part of health professionals regarding Hib conjugate vaccines 
ineffectiveness in preventing acquisition and carriage of Hib. Support for these 
were found in the case notes where the dosage and duration of rifampicin for H 
inf uenzae (20mg/kg/day, upto a maximum of 600mg daily)was confused with that 
for meningococcal disease (10mg/kg twice daily for two days in children). "' 
6.1.6 Bacterial epidemiology 
6.1.6.1 Diagnostic tests 
The incidence of non-meningitic diseases may be higher than that reported 
in this study especially in cases where observed clinical features did not lead to 
confirmation by CSF or blood culture. This underlines the need for blood cultures 
to be taken in all cases, especially in the post-vaccine era to confirm serotypes and 
antibacterial sensitivity. 
6.1.6.2 Serotypes 
Of the 154 isolates typed in this study 152 (99%) were serotype b, the other 
two isolates were non-capsulate strains. This confirms the assumption that the 
incidence of invasive H influenzae disease is congruent with invasive type b 
disease, and falls within the range of 81 % to 100% seen worldwide. 121,126,232,233.273,280 
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There was also increased serotyping of isolates in the post-vaccine period which 
may be due to the continuing national surveillance carried out by the BPSU for 
vaccine failures. 
There was some concern that the success of the vaccine would lead to an 
increase in other types of H influenzae as potential pathogens. 16' Serotyping 
provides an epidemiologic marker which can be used to determine whether 
changes in the pattern of H influenzae disease occur in the post-conjugate vaccine 
era. Hargreaves et al reported a progressive increase in the number of infections 
due to non-typeable H influenzae in England and Wales. 140 These pathogens rose 
slowly from 45 cases in 1990/91 to 67 cases in 1993/94. The authors 
acknowledged that their results may have been influenced by improved 
surveillance and awareness following the introduction of Hib conjugate vaccine. 
Data from the USA has provided contrasting results. Anderson et al used 
national laboratory-based surveillance data to determine the impact of Hib 
conjugate vaccine on all cases of H influenzae disease 4S9 They found that 
incidence rates had fallen substantially for both H influenzae type b disease and 
non-type b among children aged less than 5 years. 
6.1.6.3 Antibiotic resistance 
Antibiotic resistance to ampicillin was found in 19% of strains isolated 
from patients in the WMHR in the pre-conjugate vaccine period. This is in 
keeping with reports from other parts of Britain during the same time period. 
Anderson et al reported that 15% of isolates were resistant to ampicillin in the 
PHLS six region study249 Similarly, Howard found ampicillin resistant strains in 
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12% of isolates in Wales. "' Comparable data has also been reported from 
Australia (16%)256 and the Republic of Ireland (16%). 23° Sweden appears to have a 
much lower antibiotic resistance rate (6%). 271.2n Several countries in Western 
Europe, such as Spain (60%)'=' France (55%)126 and Switzerland (21%)209 have 
much higher rates which approach or exceed those seen in `developing' countries 
such as Barbados (40%), 3' Hong Kong (26%), 239 Thailand (24%), 243 and Nigeria 
(11%). 124 Strains resistant to chloramphenicol or cephalosporins were not 
identified in the WMHR although there have been reports of chloramphenicol 
resistance in upto 2% of isolates in Britain. '"'2" A number of British studies have 
also reported that up to 2% of isolates may be resistant to both chloramphenicol 
and ampicillin. 142,249 Both the Republic of Ireland (2%)u° and France (3%)126 have 
reported strains resistant to both ampicillin and chloramphenicol. However, 
Campos et al reported that 57% of isolates in Spain were resistant to both 
antibiotics. 127 The observed differences in antibiotic resistance may be as a result 
of differences in prescribing patterns, different methods of collecting and testing 
specimens or due to different strains of the organism. 
Resistance changed over the course of this study with ampicillin resistance 
increasing in the post-conjugate vaccine period to 19% from 14% in the pre- 
conjugate vaccine era. This observation has also been reported by the PHLS six 
region study where ampicillin resistant Hib isolates increased from 15% in the pre- 
conjugate period to 22% in the post-conjugate vaccine period. "' 
A significant association (p=0.045) was noted between ampicillin resistant 
H influenzae isolates and subsequent SNHL in the WMHR. To my knowledge this 
has not been previously reported. This finding has important clinical implications 
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as children whose isolates exhibit ampicillin resistance may require more careful 
follow-up and evaluation for SNHL. 
The spread of multiply resistant strains and the increasing frequency of 
antibacterial resistance are of some concern. In addition, the problems noted with 
the monitoring of chloramphenicol levels in this and other studies has led to the 
promotion of cephalosporins as alternative first-line antibiotics in the treatment of 
H influenzae meningitis. 
6.2 METHODOLOGICAL ISSUES 
6.2.1 Study limitations 
The present study has several potential limitations which need to be 
addressed. The design of the study presented in this thesis was an ecological one 
which focused on the relationship between invasive H influenzae, deprivation and 
other markers of socioeconomic disadvantage. Ecological studies risk the 
`ecological fallacy' thereby making it difficult to attribute area socioeconomic data 
to the individual. 
The analysis of multiple variables is more likely to produce statistically 
significant associations by chance. However, in this study many highly significant 
probability (p) values as well as narrow confidence intervals were obtained. These 
reduce the likelihood that the results were obtained by chance. 
The small numbers of cases limits the conclusions which may be drawn 
from the study and their generalisability. Multivariate analysis was not used in this 
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study as the numbers in each category or sub-category would have been small, 
especially in the post-conjugate vaccine era. 
In a retrospective study, it is difficult to draw conclusions regarding the 
absence of a factor since the fact that it has not been documented is not a reliable 
indicator of whether it had been present or not at that particular time. 
Retrospective studies are therefore limited in the amount and quality of data 
collected at the individual level. This study was therefore unable to consider other 
potential risk factors suggested by the literature at the individual level, such as 
smoking and breast-feeding. Much of the data on these factors were either poor or 
entirely absent from the case notes and reflect poorly on the quality of paediatric 
medical notes. 
Efforts were made to ensure that case ascertainment was as complete as 
possible. However, analyses of sub-groups resulted in small numbers in some 
instances, and this manifested as wide confidence intervals. It is possible that 
some cases were missed for a variety of reasons. One assumption made was that 
all children with invasive H influenzae disease were hospitalised and had their 
diagnoses confirmed microbiologically. Some children hospitalised outside the 
region, or those who had received pre-admission antibiotics resulting in negative 
cultures may have been missed. Similarly, different clinical practices for obtaining 
cultures may have affected ascertainment, particularly for non-meningitic cases. 
As the study was not restricted to Hib cases it is possible that a number of 
other serotypes or non-typable invasive H inJluenzae cases which are not vaccine 
preventable would have been included. This approach however, was justified as 
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the results demonstrated that although only 60% of cases had specimens serotyped 
99% of these were serotype b. 
Death certificates, and discharge diagnoses using the International 
Classification of Disease (ICD) codes for the various manifestations of invasive H 
influenzae were not used to identify cases. Previous research using these methods 
has indicated that the reliability of these sources is questionable, especially with 
regard to quality and completeness. Furthermore, mortality in this study was 
equivalent to that seen in studies where identification of deaths were actively 
sought. 
One of the criteria for inclusion in the study was the location of case notes. 
However, the reliance on historical data collected by different people using 
different interviewing techniques, illegible handwriting and incomplete social and 
clinical information, may have contributed to incomplete data sets. Failure to 
locate case notes resulted in a number of children being excluded from the study. 
Although this may have led to an underestimate of the incidence of disease the 
rates were still comparable with those reported from other parts of Britain. 
Data extraction from the medical records of each patient was carried out by 
the researcher. This may have led to researcher bias as there would have been 
more incentive to search for as much information as possible for the study. 
However, there would have been less likelihood of interobserver variation. In 
order to minimise intraobserver variation, a standard proforma was used to abstract 
data. 
Ethnic origin was obtained by dividing cases into two groups, children of 
South Asian and non-South Asian origin. It is recognised that neither group is 
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homogenous and that children of African-Caribbean origin were not identified 
separately. The criteria for dividing children according to ethnic origin were the 
last names and first names. In most cases African-Caribbean children have names 
which are similar to Caucasian names, it was therefore not possible to distinguish 
them. Even if this had been possible, their anticipated numbers would have been 
small as they constitute only a small proportion of the population in the West 
Midlands. 
The geographic classification of districts into'mainly rural' and 'mainly 
urban' meant that a number of urban areas were classified within the 'mainly rural' 
category and vice versa. More discriminatory operational criteria may have 
produced different results but would have resulted in the use of much smaller 
numbers. 
Accurate population data were available only at one point in time during 
the period of this study. Changes outside the 1991 census year have not been taken 
into account and may have led to an underestimate in the population at risk. 
6.2.2 Study strengths 
This study has a number of strengths which lend support to the plausibility 
of its findings. Strong associations were observed in relation to the main 
objectives of the study. The results reported in this study were also consistent with 
those previously published by a number of different researchers using different 
methodologies over the last two to three decades. The results are also biologically 
plausible in that children living in the most deprived areas are at greater risk of 
lower immunisation uptake rates, have poorer nutrition and social environments 
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and are therefore at greater risk of disease. In the post-Hib conjugate vaccine era 
this has manifested itself as an increased risk of disease in these children relative to 
their more affluent peers. 
Hospital or laboratory-based studies may be affected by different types of 
bias, particularly selection bias. This study was population-based and therefore 
attempted to avoid selection bias. The denominator consisted of a defined 
susceptible population, that is children aged less than 5 years of age. 
Multiple sources of case ascertainment were used in this study because of 
inherent limitations in each of the individual systems. The systems are however 
linked to each other and taken together provide a comprehensive picture of the 
incidence of invasive H influenzae disease in both periods of the study. The period 
of surveillance involved varying amounts of prospective and retrospective data 
collection from each surveillance system. Nevertheless, complete case 
ascertainment was attempted throughout for each surveillance system, and the 
database is considered to be comprehensive. 
The research was carried out in the WMHR using a defined geographic 
population which has a similar ethnic distribution to that of England and Wales. 
The study straddled the 1991 UK census, and this allowed accurate determination 
of both numerator and denominator. 
The WMHR was not included in the PHLS six region study. It is therefore 
unlikely that contributors to the HICARE study would have assumed that reports to 
the PHLS would be provided to HICARE. 
A clear case definition was used for this study which was limited to culture 
proven cases. This definition was employed in order to increase the precision of 
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the study. This seems justified as a number of cases which might have been 
included with inappropriate diagnoses were excluded. 
The risk factors chosen for the socioeconomic analysis were selected a 
priori. They were all previously defined markers for either deprivation, poor 
immunisation uptake, or both. The Townsend material deprivation score was used 
for this study, and it has been demonstrated to be one of the best indicators of 
material deprivation. 
The geographic unit of analysis chosen for this study was the ED. This is 
the smallest area unit available for ecological analysis. Diggle and Elliott have 
indicated that the use of larger geographic units such as wards, may mask 
differences in deprivation experience amongst the population due to the 
aggregation of data. They recommend the use of enumeration districts as area 
characteristics at this level are said to be more applicable to the individual. 
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CONCLUSION AND RECOMMENDATIONS 
Various aspects of the health literature have been reviewed and the data 
obtained from HICARE analysed. The emphasis has been on the effect of Hib 
conjugate vaccine on the epidemiology and ecology of invasive Haemophilus 
influenzae disease following its introduction into the UK immunisation schedule. 
This, the final chapter attempts to draw together the threads of the previous chapters 
and to provide recommendations and pointers to areas requiring more information. 
7.1 CONCLUSION 
This four year study has described the epidemiology of invasive H influenzae 
disease and explored its relationship with deprivation in the WMHR both prior to and 
following the introduction of Hib conjugate vaccine using an ecological approach. To 
my knowledge this study provides the first detailed account of the relationship 
between deprivation and other socioeconomic risk factors and invasive H influenzae 
disease in the UK. The study is also the first to describe in detail the epidemiological 
changes brought about by the introduction of Hib conjugate vaccine in an ethnically 
and socioeconomically diverse population. 
This study has indicated that the age-group of those most at risk has shifted to 
an older age group. Significant ethnic differences in age distribution were observed, 
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as well as different ethnic disease experiences in relation to gender, disease 
distribution and immunisation uptake. 
Almost everyone is aware of the maxim 'prevention is better than cure', but 
rarely practice it. The sense of security surrounding the success of Hib conjugate 
vaccine and its efficacy should be tempered by the numerous missed vaccination 
opportunities. The clinical spectrum and virulence of the disease has not changed and 
invasive H influenzae disease still results in mortality and significant neurological 
sequelae. Despite new and more powerful antibiotics H influenzae meningitis remains 
potentially fatal and a potential cause of disability. Although a reduction in the 
proportion of children with neurological sequelae were noted in the post-conjugate 
vaccine period, case-fatality increased. The continued prevention of invasive Hib 
infections appears to be the measure which will continue to have the greatest impact. 
With regard to socioeconomic analyses, disease gradients were demonstrated 
in relation to almost all the socioeconomic census variables examined. A number of 
these were statistically significant in the second half of the study. This thesis has 
therefore provided an original contribution to the continuing debate on inequalities in 
health by pointing out that although Hib vaccine has greatly reduced the incidence of 
disease, children from deprived areas remain at relatively greater risk than their peers 
who live in more affluent areas. 
The inherent limitations of this type of study are also acknowledged. It is 
recognised that ecological studies are useful in identifying possible risk factors and 
generating ideas for further research. 
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It has been said that "infectious diseases are now under control". Hib 
conjugate vaccine appears to have tamed invasive Haemophilus influenzae disease, but 
recent experience with pertussis in England indicates that when a significant decrease 
in vaccine uptake occurs a marked increase in incidence will follow. There are also 
lessons to be learnt from the re-emergence of tuberculosis and other diseases 
previously thought to be under control. It is therefore important to maintain, expand 
and improve immunisation uptake and surveillance. This can be achieved by targeting 
individuals as well as areas in order to prevent Hib related morbidity and mortality 
reemerging as major public health problems. 
7.2 RECOMMENDATIONS 
The success of Hib conjugate vaccine in the WMHR has resulted in an 
improvement in the overall health of the child population. Unfortunately the health of 
the poorest or most deprived children has not improved relative to that of children 
from more affluent areas. However, it remains unclear as to whether this has occurred 
as a result of economic, social, cultural, behavioural or environmental factors. 
History has demonstrated that health and poverty are intertwined, and that 
consequent to reductions in poverty there were improvements in health. If it is not 
possible to eradicate poverty, then there must be policies across all government 
departments which improve the overall socioeconomic conditions of deprived people. 
The following recommendations are therefore made from the results of this study: 
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7.2.1 Incidence of disease 
Educate health professionals who contribute to the surveillance of H 
influenzae disease of the need to continue notifying and reporting Hib 
disease. The organism is still capable of causing considerable morbidity 
and mortality and they should not become complacent as a consequence 
of the success of the vaccine. 
2 The extent of underreporting detected in this study indicates that the 
quality of the data available should be assessed before it is used for the 
formulation and implementation of health policies. 
3 Improve the efficiency of locating medical records, especially those of 
children from ethnic minorities who may have similar names. Use of a 
single unique number, possibly the NHS number may be appropriate. 
4 The recording of information in case notes should be improved, 
particularly for the collection of socioeconomic data and the child's 
immunisation history. A short standardised proforma could be 
employed. 
There should be some mechanism for the storage and retrieval of the 
case notes of children who have died. 
6 Disease registers for other infectious diseases may be organised using 
the HICARE register as a template. This will provide high quality data 
in anticipation of the introduction of new vaccines, and prevent the type 
of underreporting seen with invasive H inf uenzae disease. 
7.2.2 Individual risk factors 
Children of SA origin with H influenzae meningitis were hospitalised 
later than their NSA peers. This may indicate lack of awareness of SA 
parents as to the type and severity of the symptoms. Meningitis 
campaigns should therefore contain material targeted at this population. 
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2 The pattern of immunisation uptake in children of SA origin suggests 
that this population should be targeted for health education and health 
promotion. Similar provisions should be made for other disadvantaged 
groups. 
3 The increased proportion of children who were underweight for age in 
the second period of the study suggests that there may be a need for 
improved nutrition among children in the WMHR in order to promote 
protection from disease. 
7.2.3 Family and community risk factors 
Ensure that daycare facilities maintain registers of communicable 
illnesses in attendees. 
2 Daycare facilities should keep a register of the immunisation status of 
new admissions and encourage parents to immunise their child if he or 
she is found to be incompletely immunised. 
Health personnel should be more aware of the preventive aspects of 
medicine, and the importance of public health should be strongly 
emphasised in the medical and nursing school curricula. 
7.2.4 Environmental risk factors 
Education regarding immunisation and its importance for parents and all 
health professionals. The benefits of personal immunity rather than 
community immunity should be emphasised. 
2 The use of parent-held child records may improve immunisation uptake, 
especially if parents are asked to bring them along whenever their child 
is admitted to hospital. 
3 This study has shown that GIS is a useful tool in the analysis of health 
data in relation to socioeconomic circumstances. GIS has been used to 
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identify where the areas of highest deprivation are, and it is within these 
areas that improved immunisation services which target disadvantaged 
families may help to reduce inequalities and reverse the `inverse care 
law'. 
3 Deprived areas and individual families should be targeted in order to 
improve immunisation uptake rates and reduce inequalities. This may 
require making vaccination more accessible and visiting families in their 
homes to bring children up-to-date with their immunisations. 
4 Computer generated appointments for those children living in deprived 
areas should be flagged, and health professionals informed that the child 
is at risk of not completing the primary immunisation schedule. 
5 Parental poverty and deprivaticn impinge on the health of children, and 
the issue of deprivation needs to be addressed. One way to alleviate the 
social and economic disadvantage of deprived families is by educating 
them about social security benefits available to them, improving housing 
stock and employment opportunities. Therefore, multidisciplinary and 
cross-agency working to provide co-ordinated and comprehensive social, 
educational and health care for the child and family should be 
encouraged. 
7.2.5 Clinical features 
Education for parents and health professionals regarding the features of 
meningitis as many children were brought to hospital late. This may be 
undertaken in a structured manner in primary and secondary care 
settings. It should also be undertaken opportunistically during child 
health checks. 
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2 Education for health professionals regarding chemoprophylaxis for H 
influenzae, and how it differs from that for meningococcal disease. 
Alternatively, this chemoprophylaxis may be left to the hospital 
pharmacist or CCDC. 
3 The use of dexamethasone for H influenzae meningitis is still not 
resolved and may need further study. However, given the success of the 
vaccine this is unlikely as there would be insufficient numbers. 
Physicians should therefore be educated on the appropriate usage of the 
drug. 
4 If chloramphenicol is given then appropriate monitoring of blood levels 
should be conducted. 
5 In the light of the increase in ampicillin resistance and the problems with 
chloramphenicol, this study supports the recommendation that 
cepahalosporins be used for the treatment of invasive H influenzae 
diseases. They are equally as effective as ampicillin and 
chloramphenicol, can be administered less often and do not require 
regular serum assays. 
6 Parents should be made aware of the necessity to attend follow-up 
appointments, especially in cases where the child had meningitis. This 
may require co-operation at the primary care level. 
7 Appropriate hearing tests should be carried out for all children following 
an episode of meningitis and hospital physicians should make the 
referrals directly rather than asking the family GP to do so. 
8 Discharge letters should be written for all children following invasive H 
influenzae disease not just those with meningitis. This would be 
especially relevant for those attending daycare, childminders or school. 
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7.2.6 Laboratory investigations 
Appropriate specimens and cultures should be taken and sent to the 
laboratory for typing and antibacterial sensitivity. 
2 Continued surveillance is required regarding antibiotic resistance. This 
study has shown that ampicillin resistant H inf uenzae have increased in 
recent years. 
3 Blood specimens of young children with pneumonia should be 
accompanied with requests for serotyping of any H inJluenzae strains 
identified. This will assist in determining the effect of Hib conjugate 
vaccine on the epidemiology of H influenzae pneumonia. 
4 The current reliance on clinical suspicion as a basis for the notification 
of disease is inadequate. Laboratory reports give a more accurate picture 
and should be incorporated into the statutory system. 
7.3 FURTHER RESEARCH 
This study has identified factors associated with increased incidence of 
invasive H influenzae disease in children from deprived areas relative to children in 
affluent areas following a public health intervention. As a result of the study design 
only tentative findings can be reported. An analytical study design would be required 
before firm conclusions could be drawn. Although Hib conjugate vaccine has been a 
success there are still areas where more knowledge is required. 
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Continued surveillance of invasive H influenzae disease to determine 
any changes in serotypes causing disease and define populations at risk. 
2 Immunogenicity of the vaccine in ethnic minorities is yet to be 
ascertained in the UK. 
3 Determination of ethnic-specific rates in other areas for comparison 
with the data reported in this study would be valuable. 
4 The exact role of reduced oropharyngeal carriage in herd immunity is 
yet to be determined. If the effect is real, then incidence rates in those 
above 5 years should also fall. 
5A post-Hib conjugate vaccine survey of immunisation uptake and 
attitude to immunisation by ethnic group. 
6A further study looking at deprivation and invasive H influenzae 
disease in a different health region or nationally, but with more 
differentiation between ethnic groups. 
7 The epidemiology of H influenzae pneumonia needs to be ascertained 
in the post-conjugate vaccine era to determine the effect, if any, of Hib 
conjugate vaccine on the incidence H inf uenzae pneumonia. 
8 Evaluation of the knowledge, attitude and practice of doctors, 
especially junior doctors, towards chemoprophylaxis. 
9 Determination of paediatric ward policies with regard to opportunistic 
immunisation. 
10 Continued monitoring of antibiotic resistance to inform treatment for 
invasive H influenzae disease. 
11 Determination of environmental risk factors, if any associated with Hib 
conjugate vaccine failure. 
12 The apparent increase in mortality since the introduction of the vaccine 
warrants further investigation. 
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13 Research is required into the apparent association between SNHL and 
deprivation, and SNHL and increased ampicillin resistance, and 
whether there is a similar relationship with other causes of meningitis. 
14 An update of the Peckham report to determine the current knowledge 
and attitude of parents and health professionals towards immunisation. 
This is especially relevant in the light of the increasing number of 
vaccines becoming available and the recent debate surrounding adverse 
events associated with vaccines. 
15 An economic evaluation of the impact of the reduced Hib caseload on 
hospital bed utilisation and community resources. 
7.4 LONG-TERM PLANS 
The experience gained from this study has already been utilised in constructing 
and maintaining a regionwide meningococcal disease register. The HICARE register 
has already provided a sampling frame for further research and can be used to follow- 
up these children, especially for the detection of sequelae following meningitis. 
7.4.1 Dissemination of results 
It is intended that the results of this study are disseminated widely. 
Presentations have already been made at the local, national and international level at 
child health and public health conferences (see appendix 3). Manuscripts are being 
prepared or have been submitted to peer-reviewed journals. 
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7.4.2 Data storage 
It is intended that paper copies of correspondence, laboratory records, reports, 
data recording forms and other manual items used during the study will be stored for 
several years at the University of Warwick, after identifiers have been removed. 
Data on computer will be downloaded onto disks and stored securely and 
separately from the paper records. 
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Appendix I 
IN STRICT MEDICAL CONFIDENCE 
CONSULTANT PAEDIATRICIAN'S NAME 
HOSPITAL No. LABORATORY No. 
SECTION I: PERSONAL DETAILS 
I NAME: 
First name: Last name: 
2 DATE OF BIRTH: 19 
3 SEX: 002 
4 INDEX ADDRESS: 
POSTCODE 
5 PARENT/MAIN CARER 
6 FAMILY HISTORY 
7 NAME & ADDRESS OF FAMILY GP 
POSTCODE 
8 SEEN BY GP IN WEEK PRIOR TO ADMISSION Yes [ No 
9 INITIAL GP DIAGNOSIS 
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IN STRICT MEDICAL CONFIDENCE 
SECTION II: CLINICAL DATA 
1 DATE OF ADMISSION: 119 
2. MODE OF ADMISSION Self I GP 2 Other 
a 
3 TIME OF ADMISSION: hours minutes AM/PM 
4. DURATION OF ILLNESS BEFORE ADMISSION (TICK ONE): 
Less than 24 hours 1 24-48 hours 
[] 
2 More than 48 hours[ 3 Unknown 
E9 
5. ANTIBIOTIC TREATMENT IN 48 HOURS BEFORE ADMISSION: 
Yes , NoE2 
IF YES. please indicate : 
ANTIBIOTIC DOSE ROUTE FREQUENCY DATE 
STARTED 
DATE 
STOPPED 
RECEIVED 
z 
6. WEIGHT ON ADMISSION: kg 
7. TEMPERATURE ON ADMISSION: oC 
8. SIGNS & SYMPTOMS PRESENT ON ADMISSION: 
Bulging/full ant. Fontanelle , Neck stiffness 
Convulsions 2 Otitis media 14 
Diarrhoea 3 Pallor ,s 
Drooling . Peripheral shutdown 16 
Dysphagia , Photophobia 
Fever 6 Poor feeding 
Headache , Rash (specify state)  
Irritability 
Jaundice 9 Respiratory symptoms =o 
Lethargy to Soft tissue swelling (specify state) 21 
Limb/joint pain (specify site) it 
Sore throat 
Limb/joint swelling (specify site) [] 12 Vomiting 
Other (specify) 24 
9. COMMENTS: 
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10. STATE OF CONSCIOUSNESS ON ADMISSION: 
Awake/fully conscious , OR DESCRIBE 
Drowsy 2 
Semi-conscious 3 
Unconscious 4 
Not documented S 
11. DIAGNOSIS ON ADMISSION 
Meningitis Septic arthritis s 
Epiglottis 2 Osteomyelitis 7 
Bacteraemia/Septicaemia , Other diagnosis 
(specify) 
Cellulitis 4 
Pneumonia L-J 5 
12. SEIZURE ACTIVITY DURING ADMISSION 
None 
Yes, within 24 hours of admission , 
Yes, between 24-48 hours after admission 
Yes, more than 48 hours but less than 72 hours after admission 
Yes, more than 72 hours after admission 
13. Other complications during admission? Yes 
[I No 3 
IF YES, specify: 
14. THERAPEUTIC REGIME: 
DRUG DOSE ROUTE FREQUENCY DATE 
STARTED 
DATE 
STOPPED 
RECEIVED 
2 
3 
4 
5 
6 
7 
9 
10 
11 
12 
15. Was dexamethasone given? 
No not given 
Yes, before antibiotics , 
Yes at the same time as antibiotics 3 
Yes, but after antibiotics (specify how long after): 
Other (specify): 
16. Time first antibiotics given: 
hours minutes AM/PM 
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IN STRICT MEDICAL CONFIDENCE 
17. Was child admitted to ITU or equivalent? Yes No 
IF YES, date of admission to ITU: 19 
18. Date of discharge from ITU: Ir 19 
19. COMMENTS DURING ADMISSION: 
20. PROCEDURES: 
21. OUTCOME: Survived, no complications detected on discharge 
Survived, complications on discharge 2 
Died 
22. DATE OF DISCHARGE: Iý 19 
23. FINAL DIAGNOSIS: 
Meningitis Septic arthritis 
Epiglottitis 2 Osteomyelitis 6 
Bacteraemia/Septicaemia , Other diagnosis (specify) 
Cellultitis 4 
24. DISCHARGED TO: Home 
Died 2 
Other place (specify and give reason) 3 
25. COMPLICATIONS ON AT AFTER 3 AFTER 6 
DISCHARGE FOLLOW-UP MONTHS MONTHS 
None 
Ataxia 
Behaviour problems 
Convulsions 
Facial palsy 
Hearing loss 
Hemiparesis 
Hydrocephalus 
Impaired vision 
Language problems 
Quadriparesis 
Recurrent meningitis 
Strabismus 
Others (specify) 
1 1 1 1 
2 2 2 2 
3 3 3 3 
4 4 4 4 
S S S S 
6 6 6 6 
7 7 7 7 
9 9 9 9 
10 10 10 10 
11 11 11 11 
12 12 12 12 
13 13 
H 
13 11 
14 14 14 14 
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28. COMMENTS ON DISCHARGE: 
29. CCDC/PUBLIC HEALTH CONSULTANT NOTIFIED? 
Yes =, No 2 
30. BPSU NOTIFIED: Yes , No 
az Not appropriate [J 9 
SECTION III: PAST MEDICAL HISTORY 
1. BIRTH WEIGHT: lb oz OR Ir " kg 
2. GESTATION: weeks 
3. PREVIOUS ADMISSIONS FOR MORE THAN 24 HOURS IN THE LAST 6 
MONTHS?: 
Yes I, No l1 2 
IF YES. indicate below: 
DATE OF 
ADMISSION 
DATE OF 
DISCHARGE 
DIAGNOSIS COMMENTS 
2 
3 
4. HISTORY OF TREATMENT FOR A CHRONIC ILLNESS: Yes [] , No 
[] 
, 
IF YES_ indicate the chronic illness and date of diagnosis (if date unknown, put in unknown): 
CHRONIC ILLNESS DATE DIAGNOSED 
19 I 
Z 
19 
19 
5. Recent illnesses: 
6. IMMUNISATION STATUS PRIOR TO ADMISSION (not including Ilib vaccine status) 
Appropriate for age Children should have received the following vaccines by: 
Incomplete 26 months: 
3 dose: of DTP + polio (Ilib after Oct. 1992) 
None 3 
15 months: Measles/MMR 
Not recorded 
7. Comment on Hib immunisation record: 
Yes, received Hib vaccine during/after Oct. 1992 
No, did not receive Hib vaccine during/after Oct. 1992 2 
Not appropriate, case occurred before Oct. 1992 3 
Not recorded 9 
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IN STRICT MEDICAL CONFIDENCE 
if Hib immunisation received, record dates below: 
DOSE DATE RECEIVED 
First dose 1 19 
Second dose 2 19 
Third dose 3 19 
8. Were any missed immunisations given prior to discharge? Yes 0, No 02 
SECTION IV: PROPHYLAXIS/TAKE HOME MEDICATION 
1. Prophylaxis to index child: Yes No 12 
2. Prophylaxis to contacts: Yes No 12 
IF YES. indicate below 
RELATIONSHIP AGE DRUG DOSE ROUTE FREQUENCY DURATION 
Index child 
s 
4. 
s" 
6- 
7* 
8 
9" 
3. Take home antibiotics for index child: Yes a, No Iz 
IF Yts, maicate oeiow 
DRUG DOSE ROUTE FREQUENCY DURATION 
SECTION V: FOLLOW UP 
1. Follow up date: Yes, see below a, No, not given a, 
Follow up date: 19 
2. Was child brought for follow up? Yes E, No J2 
3. COMMENTS: 
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4. Discharge letter to GP from unit? Yes F7 I No 
[] 
2 
IF YES, date of letter: 19 
5. Did GP request information re: immunisation/other following 
discharge? 
Yes E, No 1s 
6. COMMENTS: 
7. Was hearing test requested? Yes 
[, No [] 2 Not appropriate 
[J 
3 
2 RPrnrd dates of all teste finclndinLy hearing tests) reauested: 
TEST DATE 
REQUESTED 
DATE 
CONDUCTED 
OUTCOME/COMMENTS 
z 
6 
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SECTION VI: INVESTIGATIONS DURING ADMISSION 
Microscopy, culture and sensitivity 
LUMBAR PUNCTURE PERFORMED: 
Within 24 hours of admission 
Between 24-48 hours after admission 2 
More than 48 hours but less than 72 hours after admission 3 
More than 72 hours after admission 4 
No s 
DATES AND RESULTS OF REQUESTS FOR CSF INVESTIGATIONS: 
INVESTIGATION DATE 1 DATE 2 DATE 3 DATE 4 
1 Appearance 
2 Gram stain (POS/NEG) 
3 Culture (POS/NEG) 
4 Glucose (nunol/L) 
5 Protein (g/L) 
6 WBC - total (x10 /1) 
7 WBC - PMN (total) 
8 WBC-PMN(%) 
9 WBC - Lymphocytes 
10 Red cells (x10 /I) 
11 Antibiotics (RES/SEN) 
12 Serotype 
13 Biotype 
14 R-lactamase 
15 Other test 1 
16 wer test 2 
BLOOD CULTURE PERFORMED: 
Within 24 hours of admission 
Between 24-48 hours after admission 
More than 48 hours but less than 72 hours after admission 
More than 72 hours after admission 
No 
s 
a 
s 
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IN STRICT MEDICAL CONFIDENCE 
HATES AND RESULTS OF REOUESTS FOR BLOOD CULTURE: 
INVESTIGATION DATE 1 DATE 2 DATE 3 
Culture (POS/NEG) 
z Antibiotics 
(RES/SEN) 
5. OTHER CULTURES: Yes D, No[] 2 
INVESTIGATION 
Microscopy 
Z Culture (POS/NEG) 
3 Antibiotics 
(RES/SEN) 
INVESTIGATION 
Microscopy 
2 Culture (POS/NEG) 
3 Antibiotics 
(RES/SEN) 
Haematology 
A FRC - DATES AND RESULTS OF REOUESTS: 
INVESTIGATION 
Hb (g/dl) 
2 Glucose (mmol/L) 
Protein (g/L) 
WBC - total (x10 /1) 
5 WBC - neutrophils 
6 WBC - lymphocytes 
WBC - monocytes 
WBC - eosinophils 
9 WBC - basophils 
,o WBC - other 
11 Platelets (x109/1) 
12 RBCs (1012/1) 
 Film (comments) 
Other I (specify) 14 
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7. SERUM ELECTROLYTES, UREA & CREATININE Yes [1 No _ 
INVESTIGATION DATE 1 DATE 2 DATE 3 
I Sodium 
2 Potassium 
3 Urea 
4 Creatinine 
5 Other I (specify) 
6 Other 2 (specify) 
7 Other 3 (specify) 
8. OTHER HAEMATOLOGY INVESTIGATIONS Yes [, No [1 2 
INVESTIGATION DATE 1 DATE 2 DATE 3 
Radiology 
9. RADIOLOGICAL INVESTIGATIONS Yes a, No F71 2 
INVESTIGATION DATE I DATE 2 DATE 3 
I CXR 
2 SXR 
3 CT SCAN 
4 Ultrasound 
5 Other I (specify) 
6 Other 2 (specify) 
Other investigations 
10. OTHER INVESTIGATIONS YesEj, No E2 
INVESTIGATION DATE 1 DATE 2 DATE 3 
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SECTION VII: MATERNAL & BIRTH HISTORY - ONLY 
COMPLETE THIS SECTION IF THIS IS A NEONATAL CASE 
IF THIS CASE IS A NEONATE, COMPLETE THIS BOX AND REST OF SECTION 
MOTHER'S NAME: 
LAST NAME FORENAME(S) 
HOSPITAL No: LABORATORY No. 
1. MATERNAL DATE OF BIRTH: I 19 
2_ PREVIOUS OBSTETRIC HISTORY: 
DATE MATURITY TYPE OF 
DELIVERY 
COMPLICATIONS SEX BIRTHWEIGI IT PRESENT 
I IEALTH 
2 
4 
6 
3. PLACE OF DELIVERY: 
Home 
Hospital z 
Other (specify) 3 
Not recorded 4 
4. ATTENDED ANTENATAL CLINIC 
Yes , No 
LJ 
2 Not recorded 
LJ 
9 
5. DATE OF LMP: 19 
6. ESTIMATED DATE OF DELIVERY: 19 
7. ACTUAL DATE OF DELIVERY: 19 
8. MATURITY FROM DATES: weeks 
9. ASSESSED MATURITY: weeks 
10. TIME OF DELIVERY: hours minutes AM/PM 
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11. METHOD OF DELIVERY: 
Normal vertex 
Elective CS 1 
Breech 3 
Forceps 4 
Vacuum/Venthouse 
Emergency CS 6 
Other (specify): 
12. IF ASSISTED DELIVERY, REASON(S) 
13. LENGTH OF LABOUR: hours I minutes 
12. INFANT WAS: 
Preterm 
Term 2 
Post-term 3 
15. BIRTHWEIGI-IT: kg 
16. APGAR SCORE AFTER 1 MINUTE: 
17. APGAR SCORE AFTER 5 MINUTES: 
18. CLINICAL FINDINGS IN NEONATE AT BIRTH: 
4 
zs 
ý6 
19. RESUSCITATION GIVEN: 
20. CORD BLOOD pH: 
21. DATE AND TIME OF ADMISSION TO SCBU: 19 TIME: 
22. DATE OF DISCHARGE 19 
23. WEIGHT ON DISCHARGE: kg 
24. OUTCOME: Survived, no complications on discharge 
Survived, complications on discharge 2 
Died 
3 
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25. 
26. 
OBSTETRIC COMPLICATIONS AT TIME OF DELIVERY: 
Preterm labour i 
Maternal fever 2 
Pyrexia 3 
Rupture of membranes (specify date & time) 4 
Vaginal discharge s 
Other (Specify) 6 
Haemophilus influenzae isolated from: 
NN blood , Other (specify) 
Maternal blood 2 
Placenta 3 
Vagina 4 
27. Method of contraception used: 
Pill , Not recorded 
IUD 2 
Other (specify) 3 
28. MOTHERS MEDICAL HISTORY THIS PREGNANCY: 
29. MOTHER'S ADMISSION DATE: 119 
30. MOTHER'S DISCHARGE DATE: 19 
31. MATERNAL INVESTIGATIONS THIS PREGNANCY 
INVESTIGATION DATE I DATE 2 DATE 3 
z1) MnTI-BFR°C TFIF. RAPEUTIC REGIME: 
DRUG DOSE ROUTE FREQUENCY DATE STARTED DATE STOPPED 
1 
z 
4 
Qs 
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33. COMMENTS 
SECTION VIII: UNIT GUIDELINES FOR TREATMENT & 
PROPHYLAXIS 
1. TREATMENT 
2. FOLLOW UP 
3. PROPHYLAXIS 
SECTION IX: CASE IDENTIFICATION 
SOURCES FROM WHICH THIS CASE HAS BEEN IDENTIFIED: 
I Laboratory notifications to PHLS Yes No , 2 Statutory notifications to CCDC Yes No 2 
3 Search of laboratory records Yes No 2 
4 Other source I (specify) Yes No 2 
5 Other source 2 (specify) Yes No 2 
6 Other source 3 (specify) Yes No 2 
IDENTIFYING HOSPITAL: 
DATE OF DATA COLLECTION: I 119 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 339 
Appendix 2 
APPENDIX 2 
Data tables 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 
Appendix 2 
Data tables for results in chapter 5 section 4.2 
tertile population all cases Inc rate all 95%LL all 95%UL all 95%LCI all 95%UCI all 
townsend score 1 (low) 98825 56 14.17 42.3 72.72 10.70 18.40 
2 (medium) 101012 78 19.30 61.66 97.35 15.26 24.09 
3 (high) 151162 110 18.19 90.41 132.58 14.95 21.93 
350999 244 17.38 210.59 272.36 15.00 19A0 
unemployed 1 97216 60 15.43 45.79 77.23 11.78 19.86 
2 104907 72 17.16 56.34 90.67 13.43 21.61 
3 148876 112 18.81 92.22 134.77 15.49 22.63 
350999 244 17.38 210.59 272.36 15.00 19.40 
overcrowded 1 90939 71 19.52 55.45 89.56 15.24 24.62 
2 106395 66 15.51 51.04 83.97 11.99 19.73 
3 153665 107 17A1 87.69 129.3 14.27 21.04 
350999 244 17.38 210.59 272.36 15.00 19.40 
no car 1 97652 55 14.08 41.43 71.59 10.61 18.33 
2 112604 89 19.76 71.47 109.52 15.87 24.32 
3 140743 100 17.76 81.36 121.63 14.45 21.60 
350999 244 17.38 210.59 272.36 15.00 19.40 
not owner-occupied 1 114636 76 16.57 59.88 95.13 13.06 20.75 
2 101321 60 14.80 45.79 77.23 11.30 19.06 
3 135042 108 19.99 88.59 130.39 16AO 24.14 
350999 244 17.38 210.59 272.36 15.00 19.40 
all movers 1 103880 64 15A0 49.29 81.73 11.86 19.67 
2 122312 72 14.72 56.34 90.67 11.52 18.53 
3 124845 108 21.63 88.59 130.39 17.74 26.11 
351037 244 17.38 210.59 272.36 15.00 19.40 
local movers 1 112148 70 15.60 54.57 88.44 12.16 19.72 
2 125883 90 17.87 72.37 110.63 14.37 21.97 
3 113006 84 18.58 67 104 14.82 23.01 
351037 244 17.38 210.59 272.36 15.00 19A0 
child density 1 69195 66 23.85 51.04 83.97 18.44 30.34 
2 109690 78 17.78 61.66 97.35 14.05 22.19 
3 172122 100 14.52 81.36 121.63 11.82 17.67 
351007 244 17.38 210.59 272.36 15.00 19.40 
lone parents 1 82139 59 17.96 44.91 76.11 13.67 23.17 
2 110553 75 16.96 58.99 94.01 13.34 21.26 
3 158345 110 17.37 90.41 132.58 14.27 20.93 
351037 244 17.38 210.59 272.36 15.00 19.40 
% of children <5 years 1 59059 48 20.32 35.39 63.64 14.98 26.94 
2 108312 71 16.39 55.45 89.56 12.80 20.67 
3 183636 125 17.02 104.05 148.93 14.17 20.28 
351007 244 17.38 210.59 272.36 15.00 19.40 
KEY 
inc rate ails incidence rate 1990-1994 
95%LL s 95% lower limit 
95%UL a 95% upper limit 
95%LCI a 95% lower confidence Interval 
95%UCI = 95% upper confidence Interval 
PhD Babatunde Olowokure: The impact of Hib conjugate vaccine: WMHR 1990-1994 340 
Appendix 2 
Data tables for results in chapter 5 section 4.2 
teile population pre-hib Inc rat pro 95%LL 95%UL 95%LCI 95%UCI 
townsend score 1 (low) 98825 46 23.27 33.68 61.36 17.04 31.04 
2 (medium) 101012 62 30.69 47.54 79.48 23.53 39.34 
3 (high) 151162 82 27.12 65.22 101.78 21.57 33.67 
350999 190 27.07 163.94 219.02 23.35 31.20 
unemployed 1 97216 49 25.20 36.25 64.78 18.64 33.32 
2 104907 57 27.17 43.17 73.85 20.58 35.20 
3 148876 84 28.21 67 104 22.50 34.93 
350999 190 27.07 163.94 219.02 23.35 31.20 
overcrowded 1 90939 57 31.34 43.17 73.85 23.74 40.60 
2 106395 50 23.50 37.11 65.92 17A4 30.98 
3 153665 83 27.01 66.11 102.89 21.51 33A8 
350999 190 27.07 163.94 219.02 23.35 31.20 
no car 1 97652 45 23.04 32.82 60.21 16.80 30.83 
2 112604 70 31.08 54.57 88.44 24.23 39.27 
3 140743 75 26.64 58.99 94.01 20.96 33A0 
350999 190 27.07 163.94 219.02 23.35 31.20 
not owner-occupied 1 114636 65 28.35 50.17 82.85 21.88 36.14 
2 101321 45 22.21 32.82 60.21 16.20 29.71 
3 135042 80 29.62 63.44 99.57 23A9 36.87 
350999 190 27.07 163.94 219.02 23.35 31.20 
all movers 1 103880 54 25.99 40.57 70.46 19.53 33.91 
2 122312 56 22.89 42.3 72.72 17.29 29.73 
3 124845 80 32.04 63.44 99.57 25.41 39.88 
351037 190 27.06 163.94 219.02 23.35 31.20 
local movers 1 112148 57 25.41 43.17 73.85 19.25 32.93 
2 125883 70 27.80 54.57 88.44 21.67 35.13 
3 113006 63 27.87 48.41 80.6 21A2 35.66 
351037 190 27.06 163.94 219.02 23.35 31.20 
child density 1 69195 50 36.13 37.11 65.92 26.82 47.63 
2 109690 60 27.35 45.79 77.23 20.87 35.20 
3 172122 80 23.24 63.44 99.57 18.43 28.92 
351007 190 27.06 163.94 219.02 23.35 31.20 
lone parents 1 82139 50 30.44 37.11 65.92 22.59 40.13 
2 110553 55 24.87 41.43 71.59 18.74 32.38 
3 158345 85 26.84 67.9 105.1 21.44 33.19 
351037 190 27.06 163.94 219.02 23.35 31.20 
% of children <5 years 1 59059 36 30.48 25.21 49.94 21.34 42.28 
2 108312 60 27.70 45.79 77.23 21.14 35.65 
3 183636 94 25.59 75.96 115.03 20.68 31.32 
351007 190 27.06 163.94 219.02 23.35 31.20 
KEY 
Inc rate pre s incidence rate 1990-1992 
95%LL   95% lower limit 
95XUL = 95% upper limit 
95°%LCI. 95% lower confidence interval 
95%UC1.95% upper confidence interval 
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tertile population post-hib Inc rat post 95%LL 95%UL 95%LCI 95%UCI 
townsend score 1 (low) 98825 10 5.06 4.8 18.39 2.43 9.30 
2 (medium) 101012 16 7.92 9.15 25.98 4.53 12.86 
3 (high) 151162 28 9.26 18.61 40.47 6.16 13.39 
350999 54 7.69 40.57 70.46 5.78 10.04 
unemployed 1 97216 11 5.66 5.49 19.68 2.82 10.12 
2 104907 15 7.15 8.4 24.74 4.00 11.79 
3 148876 28 9A0 18.61 40.47 6.25 13.59 
350999 54 7.69 40.57 70.46 5.78 10.04 
overcrowded 1 90939 14 7.70 7.65 23.49 4.21 12.92 
2 106395 16 7.52 9.15 25.98 4.30 12.21 
3 153665 24 7.81 15.38 35.71 5.00 11.62 
350999 54 7.69 40.57 70.46 5.78 10.04 
no car 1 97652 10 5.12 4.8 18.39 2A6 9.42 
2 112604 19 8A4 11.44 29.67 5.08 13.17 
3 140743 25 8.88 16.18 36.91 5.75 13.11 
350999 54 7.69 40.57 70.46 5.78 10.04 
not owner-occupied 1 114636 11 4.80 5.49 19.68 2.39 8.5E 
2 101321 15 7A0 8.4 24.74 4.15 12.21 
3 135042 28 10.37 18.61 40.47 6.89 14.98 
350999 54 7.69 40.57 70.46 5.78 10.04 
all movers 1 103880 10 4.81 4.8 18.39 2.31 8.85 
2 122312 16 6.54 9.15 25.98 3.74 10.62 
3 124845 28 11.21 18.61 40.47 7A5 16.21 
351037 54 7.69 40.57 70.46 5.78 10.04 
local movers 1 112148 13 5.80 6.92 22.23 3.09 9.91 
2 125883 20 7.94 12.22 30,89 4.85 12.27 
3 113006 21 9.29 13 32.1 5.75 14.20 
351037 54 7.69 40.57 70.46 5.78 10.04 
child density 1 69195 16 11.56 9.15 25.98 6.61 18.77 
2 109690 18 8.20 10.67 28.45 4.86 12.97 
3 172122 20 5.81 12.22 30.89 3.55 8.97 
351007 54 7.69 40.57 70.46 5.78 10.04 
lone parents 1 82139 9 5.48 4.12 17.09 2.51 10.40 
2 110553 20 9.05 12.22 30.89 5.53 13.97 
3 158345 25 7.89 16.18 36.91 5.11 11.65 
351037 54 7.69 40.57 70.46 5.78 10.04 
% of children <5 years 1 59059 12 10.16 6.2 20.96 5.25 17.74 
2 108312 11 5.08 5.49 19.68 2.53 9.08 
3 183636 31 8.44 21.06 44 5.73 11.98 
351007 54 7.69 40.57 70.46 5.78 10.04 
KEY 
inc rate post - incidence rate 1992.1994 
95%LL a 95% lower limit 
95%UL " 95% upper limit 
95%LCI a 95% lower confidence interval 
95%UCI 95% upper confidence interval 
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INTERNATIONALER KONGRESS 
, 
PUBUC HEALTH - ENTWICKLUNGEN UND POTENTIALE` 
vorn ä bis 8. Oktober 1999 in Freiburg & Br. 
Kongrtss-Sekretariat 
Deutsche Koordinierungsstelle 
iitr Gesundheitswissenschaften 
an der A: L UniversiNtt Freiburg 
Hebelstrade 29 -D 79104 Freiburg 
Tel. 0761t203-3521 - Fax 0761/703-5516 
e-mail: dkewiäunidnibure. de 
Dr. Babakunde Olowokure 
CDSC West Midlands 
2nd Floor, Lincoln House 
Heartlands Hospital 
GB B95SS Birmingham 
08.06.99 
Int. Kongress Public Health - Entwicklung und Potentiale" 
vom 6. Bis S. Oktober 1999 in Freiburg L Br. 
Sehr geehrte Frau Dr. Olowokure, 
wir freuen ums, Ihnen mitteilen zu können, daß Ihr Abstract als Vortrag angenommen wurde. 
Es ist vorgesehen, daß Ihr Vortrag 
Olawokure, B.; Blair, L; Spencer, N.; Hawks, 1.: Sarteglaace of Hiemopbllas iafnemme disease: 
eoEparisioa of sarveWaace systems *ad reporting patterns is the pre$ib and poet-Rib coajagate 
vacdae periods 
im Rahmen der 7. Jahrestagung der DAE - Deutsche Arbeitsgemeinschaft für Epidemiologie - in der Veranstaltung 
DAE - Iafektioasepidemlologie 
(Mod.: A. Ammon, A. Kriimer) 
gehalten wird, die am Freitag in dem Zeitblock von 13.30 bis 1530 stattfinden wird. 
In diesem Zusammenhang möchten wir Sie noch darauf hinweisen, daß die verbindliche 
schriftliche Anmeldung sowie der Eingang der Teilnehmergebühr bis zum 12. Juli 1999 vom 
Organisationskomitee als notwendige Voraussetzung dafür festgelegt wurde, daß Ihr Abstract wie 
vorgesehen in der Zeitschrift Das Gesundheitswesen" abgedruckt werden kann. 
Mit freundlichen Grüßen 
Ihr 
Prof. Dr. med. J. v. Troschke 
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Title: Surveillance of Haemophilus influenzae disease: comparison of 
surveillance systems and reporting patterns in the pre-Hib and post-Hib 
conjugate vaccine periods 
Authors: Babatunde Olowokure, lain Blair, Nick Spencer, Jeremy Hawker 
Address: Dr B Olowokure, CDSC West Midlands, 2°d Floor, Lincoln House, 
Heartlands Hospital, Birmingham B9 5SS, England 
Aim: Vaccination programmes require surveillance systems to evaluate the effect 
of the vaccine on disease incidence. In England and Wales surveillance systems 
for communicable diseases are primarily passive, and underreporting of cases is 
known to occur. The aim of this study was to establish the incidence of 
Haemophilus influenzae disease in the two years before and immediately following 
the introduction of Hib conjugate vaccine in the West Midlands region of England 
using two different surveillance systems, one active and the other passive. 
Method: The study period was from October 1990 to September 1992 (pre-Hib 
conjugate vaccine) and from October 1992 to September 1994 (post-Hib conjugate 
vaccine). The data from voluntary laboratory reports sent to the Public Health 
Laboratory Service (PHLS) Communicable Disease Surveillance Centre (CDSC) 
were compared with an active laboratory-based system which used data from 
several sources. The active system aimed to identify all cases of laboratory 
confirmed invasive H influenzae disease in children <5 years of age resident in the 
West Midlands region, and admitted to hospital in the region, during the study 
period. 
Results: A comparison of cases reported to the active and passive surveillance 
systems over the four year period showed that a total of 258 cases were identified 
by the active system compared to 208 cases reported to the passive system. 
Underreporting was seen to vary with time and other parameters. Fifteen 
per cent of cases identified by the active surveillance system were not reported to 
the CDSC in the period prior to the introduction of the vaccine. This proportion 
more than doubled in the two years following introduction of the vaccine to 36%. 
There was also apparent variation in the reporting of cases according to age. It was 
found that in children aged <2 years, approximately 24% of cases identified by the 
active surveillance system were not reported to the CDSC. This was almost four 
times more than the estimated 7% underreporting in children 2 years of age or 
older. There were no differences in reporting by sex or ethnic group. 
Incidence rates for invasive H influenzae disease in the West Midlands 
based on reports to CDSC for the pre-Hib and post-Hib conjugate vaccine periods 
were found to be 24.2 (95% CI=20.7 to 28.1) per 10' children <5 years old and 5.4 
(95%=CI 3.8 to 7.4) 105 respectively. The corresponding figures obtained utilising 
data from the active surveillance system were 28.3 (95% CI=24.5 to 32.6) 10' and 
8.4 (95%=CI 6.4 to 10.8) 10' respectively. 
Conclusion: The results obtained in this study provide further support for the 
importance of ensuring the quality of surveillance data prior to using it to evaluate 
an intervention, and confirm the value of using several sources of data to approach 
full case ascertainment. Given the publicity surrounding the launch of the vaccine 
and the national study of Hib vaccine failures, it was reasonable to assume that the 
introduction of Hib conjugate vaccine might improve the efficiency of reporting. 
However, in this study the introduction of Hib conjugate vaccine was associated 
with increased underreporting. To our knowledge this observation has not 
previously been reported and may have arisen due to a number of factors, including 
complacency on the part of physicians and microbiologists in reporting cases 
following the success of the vaccine in virtually eliminating Hib disease. These 
findings have implications for resource allocation and education of health care 
workers regarding the continued reporting of diseases following interventions such 
as immunisation. 
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ENVIRONMENTAL RISK FACTORS FOR INVASIVE HAEMOPHILUS 
INFLUENZAE DISEASE IDENTIFIED WITH GEOGRAPHIC INFORMATION 
SYSTEMS IN THE POST-HIB CONJUGATE VACCINE ERA 
Babatunde Olowokure'-, lain Blair', Nick Spencer' 
' Section of Child Health, University of Warwick, UK 
2 Communicable Disease Surveillance Centre (CDSC), West Midlands, UK 
' Department of Public Health, Sandwell Health Authority, UK 
Address for correspondence: Dr Babatunde Olowokure, CDSC (West Midlands) 
253 Yardley Green Road, Birmingham B9 5QA, England 
email: bolowokure@cdscwmid. demon. co. uk 
Introduction 
Since the Black report, evidence has accumulated regarding the association between 
inequalities in health and deprivation. In Britain the nature of this problem associated with 
invasive Haemophilus influenzae (HI) disease has been poorly described. This study 
combines health data, geographic data, a geographic information system (GIS), and 1991 
census data to identify environmental risk factors for invasive HI disease in the two years 
immediately following the introduction of HI type b (Hib) conjugate vaccine. 
Methods 
Several data sources, including laboratory reports and notifications, were used to obtain data 
on diseases caused by invasive HI in the West Midlands region of England in children under 
5 years of age from October 1992 to September 1994. GIS was used to map the distribution 
of invasive HI cases using postcode of residence and to determine enumeration districts 
(EDs). Townsend deprivation scores (an area indicator of deprivation derived from 1991 
census data) were then obtained for each of the EDs and grouped into three deprivation 
categories affluent, intermediate and deprived. The GIS was used to select a further 8 
environmental variables for evaluation. 
Results 
Univariate analysis indicated that 4 variables were associated with invasive HI disease. 
Relative to children living in areas of high deprivation, there was a significantly reduced 
risk of invasive disease for children in more affluent areas (OR=0.73,95% CI=0.54 to 
0.99). Residence in areas with a high proportion of rented accommodation (p 0.0025), high 
population mobility (p = 0.001 3) and low child population density (p0.039) were 
associated with increased risk of invasive HI disease. 
Conclusions 
This analysis suggests that in the post-Hib conjugate 
socioeconomically deprived environments are at increased 
combining health and population data with GIS assist: 
referenced environmental risk factors for populations. 
vaccine era children living in 
risk of disease. Furthermore, 
in identifying geographically 
89 
Appendix 3 
PhD Bahatunde Olowokurc: 'Hic, impact ot'IIib conjugate vaccine: 
WMI Ik I990-I991 
Proceedings of the Royal College of Paediatrics and Child Health Annual Meeting 1997; Vol 1: 88 
Thursday 17th April 1997 
IMMUNOLOGY AND INFECTIOUS DISEASES 
Muhammad BJ', Andrew P. Mitchell T, 0'Ca lagban C. 
G160 
dents of Chid Health* and Microbiology, 
University of Leicester 
GROUP ABSTRACTS 
Invasive Haemophllus tnfluenzae disease and Hib 
coniu¢ate vaccine: describing the äe 
epidemioloav in the West Midlands 
G162 Olowokure B, Blair I. Spencer N. 
Sections of Child Health, and Public Health, School 
of PGME, University of Warwick, England. 
Densely ciliated ependymai cells line the aqueducts and the ventricular surface 
of the brain. forming a barrier between OF and neuronal tissue. We have 
developed a unique ex-vivo method to assess ependymal ciliary function. Using 
this model to investigate pneamococcsl meningitis we have shown the 
pneumococcal toxin'pneumolysin' is extremely toxic to ependymal cilia. 
Our study aims were to determine the effect on brain cilial function of 
(a) Wild type pneumococci and a mutant variety (without the penumolysin 
gene); (b) antibiotic induced lyais of pneumococci; (c) anti-pneumolysin 
antibody in preventing ciliary and epeadymal cell damage. 
Method Ciliary beat frequency, from epeadymal sips from Vistar rats, was 
measured using a high speed camera (1000 Limes/sec) (Kodak Ektapro) 
attached to a microscope, at 37'C. Following ban line readings epeadymal 
strips were incubated with Wild type or Mutant pneomococci at colony counts 
of 10'. 107, and 10'. Experiments were repeated with penicillin lysed solutions 
of the same bacteria at similar colony counts, with or without the addition of 
anti-pneumolysie antibody. Seventy ependyaaal edges were studied in total. 
Itesdls: Chary beat frequency of control ependyma (n-12) was 39(2.3)Hz and 
did not change over a4 hour period. Wild type pneumoeoccl at 10' and l0' 
caused ciliuy stasis within 30 minutes and 3.5 hours respectively. No effect 
was seen at a colony count 106. Poeumolysio negative poeumocoeci at 10s 
caused ciliary stasis after 60 minutes but so effect was seen at colony counts of 
1e. Penicillin lysed pneumococci caused rapid ciliary stasis (30 sees to 2 
minutes) at 10' which was completely prevented by prior addition of anti- 
pneumolysin antibodies. 
Conclolon: At higher colony counts pneumococeal bacteria affected the 
chary best 6roqucncy. Penicillin lysis markedly accelerated this toxic process. 
The toxicity was completely blocked by anti-pneumolysin antibodies. Further 
work is underway to determine the therapeutic role of anti-jmcumolysin 
antibodies in pneumecoccal meningitis. 
Mcrobial growth inhibition in plasma dWing 
inkttion: effects of iron and zinc avabb ty. 
G161 Goldes B. E. & aohay P. A 
Dept of Child Health, University of Aberdeen 
Calproteetin is an abundant calcium and Inc binding 
neutrophil protein which inhibits the growth of microorganisms 
in culture medium and abscess fluid by depriving them of zinc. 
We hypothesised that this also occurs in plasma because, during 
bacterial infection, plasma calprotectin rises from <1mg4 to up 
to 5Omgdl well above the MIC for many bacteria and fungi. 
Therefore, we related the growth of Candida kefyr (24hr 
change in total viable count) to calprotectin (gyred by 
EUSA) and zinc concentrations in plasma samples from 49 
infected children and 20 age-matched controls. In the same 
samples, we also related Candida growth to plasma iron and 
transfertin saturation (TS). We then compared the effects of 
zinc and iron supplementation on Candida growth in the same 
plasma. Candida growth was lower (p <0.001) in infected 
plasma than in control plasma and inversely related to 
ealprotectin concentration (r s -0.33, p <0.005). However, 
growth was not related to plasma zinc and was not affected by 
zinc supplementation of either infected or control plasma. In 
infected plasma, plasma iron and TS were low. Candida growth 
correlated positively with plasma iron (p <0.01) as well as TS (p 
-0.001); and iron supplementation of infected plag ma returned 
Candida growth to that obtained in control plasma. 
Thus, it appears that zinc availability, in contrast to iron 
availability, has no effect on Candida growth in plasma. 
This work was supported by the Wellcome Trust. 
AIMS: To describe the epidemiology of invasive Haeeeophi us 
influenza. (E11) disease in a defined population in the period prior to 
(Oct. 1990-Sep. 1992), and immediately following (Oct 1992- 
Sep. 1994) the introduction of Hib conjugate vaccine. METHODS: 
258 cases were identified from a retrospective register of invasive 
HI cases compiled using several sources. 199 cases were identified 
in the first period of the study, and 59 in the second. RESULTS: 
The age-specific incidence rate for invasive HI disease was 27.3/10: 
in children <5 years of age in the 2 years prior to Hib conjugate 
vaccine, and 8.1/10' in the immediate post vaccine era. There were 
104 cases (52.3%) in children aged 6-18 months of age in 1990-92, 
and 22 cases (37.2%) In 1992-94. Children aged 24-47 months 
-accounted for 17.6% and 32.2% of cases in the pre- and post- 
vaccine periods respectively. HI meningitis was seen more in girls 
: than boys both before (51.5"%) and after (55.6%) the introduction of 
Hib vaccine. Three (5.1 %) of the children identified in the post- 
-vaccine era were too young to receive Rib vaccine, 18 (30.5%) had 
no documented vaccination history. Nine (153%) had received the 
-vaccine, and at least 7 of these were vaccine failures. 
CONCLUSIONS: This is an early report of the effect of Hib 
conjugate vaccine on the epidemiology of invasive HI disease. The 
data suggests that the vaccine has prevented many cases of invasive 
HI. However, there appears to be a shift to an older age group, and 
vaccine failures have been identified. 
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TIE PERIODICITY OF IMPORTED VIVAX MALARIA 
IN BIRMINGHAM. M. Dedicoat. P. Venkatesan and C. 
Ellis, Department of Infection, Birmingham Heartlands 
Hospital, Birmingham, UK. 
Objectives: The majority of patients admitted to our 
Infectious Disease Unit with vivax malaria present in the 
summer months. Most return from Northern Pakistan 
where malaria transmission peaks during the monsoon 
months of July to September. We reviewed cases to see 
whether time of presentation related to the time of travel or 
another factor. 
Methods: Patients with Vivax malaria were identified, from 
notification slips between -1/1/88 and 31/12/97. 
Results: 300 cases were identified with 176 returning from 
Northern Pakistan. The median time from arrival in the UK 
to development of symptoms was 105 days (range 0-1080 
days). Of the latter 112 (64%) presented between June and 
September but only 65 (37°%) returned to the UK in these 
months. Those returning in winter months were more likely 
to develop clinical malaria in our summer. 
Conclusions: The time of presentation of vivax malaria in 
patients from Northern Pakistan returning to Birmingham 
does not relate purely to the timing of travel. The majority 
of cases in Birmingham occur during the months of peak 
transmission in Pakistan. Seasonal environmental factors 
may partly determine timing of clinical presentation. 
AN AUDIT OF THE OUTCOME OF SCREENING NEW ARRIVALS TO THE 
UK FOR TUBERCULOSIS 
K. Raodife, U. ScboY, L h* 
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RISK FACTORS FOR INVASIVE HAEMOPHILUS 
INFLUENZAE (HI) DISEASE IN THE POST- 
CONJUGATE VACCINE ERA. B. Olowokure'. 2. I. 
Blair', J. Hawke, N. Spencer'. Section of Child Health, 
University of Warwick', Communicable Disease 
Surveillance Centre, West Midlands1 and Department of 
Public Health, Sandwell Health Authority. 
Introduction: This study combines health data and 1991 
census data with a geographic information system (GIS) 
to identify environmental risk factors for invasive HI 
disease in the two years immediately following the 
introduction of HI type b (Hib) conjugate vaccine. 
Methods: Several data sources, including laboratory 
reports, were used to identify diseases due to invasive HI 
in the West Midlands in children under 5 years of age 
from 1992 to 1994. Townsend deprivation scores were 
obtained for enumeration districts of residence. Three 
groups of deprivation were obtained, affluent, 
intermediate and deprived. Results: There was a 
significantly reduced risk of invasive disease for children 
in more affluent areas (OR=0.73,95% CIO. 54-0.99). 
Residence in areas with a high proportion of rented 
accommodation (p<0. O1), high population mobility 
(p<0.01) and low child population density (p<0.05) were 
associated with increased risk of invasive HI disease. 
Conclusions: In the post-Hib conjugate vaccine era 
inequalities in the disease experience of children were 
associated with the introduction of Hib conjugate vaccine. 
CI! RYSEOBA CT ERI UM ME1 VINCOSEPTICUM 
OUTBREAK ASSOCIATED WITH COLONISATION 
OF WATER TAPS IN A NEONATAL INTENSIVE 
CARE UNIT. 
Dr S. N. Hoaue. Dr J. Graham, Professor S. Tabagchali, 
Department of Medical Microbiology. St. Bartholomew's 
and The Royal London School of Medicine and Dentistry. 
Guyseobacterhum meningompticum is a gram negative, 
ubiquitous organism that can exist in hospital water 
systems and can cause fatal meningitis in neonates. 
From august 1994 to July 1996 a multi-resistant 
Cmeningosepticum was isolated from eight ventilated 
babies (six from endotracheal secretions, one from a 
surface swab and one from blood culture, cerebrospinal 
fluid and endotracheal secretions). 
Six babies had overlapping admissions and two babies 
became colonised six months later. Initial environmental 
screening was negative. Further screening included the 
inside of sink taps which yielded Cmeningasepdcwn with 
identical antibiograms to the babies' isolates. The reference 
laboratory were unable to type the isolates. 
Infection control involved, using sterile water for toileting 
and using alcohol hand rub after hand-washing. Whilst 
repair and chlorination of the water system, and changing 
the taps took place. 
To date, further screening has been negative and there have 
been no further cases. 
